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Abstract
The preprotachykinin-A (PPT-A) gene encodes the neuropeptides substance P,
neurokinin A, neuropeptide K and neuropeptide y, each derived by alternative mRNA
splicing and post-translational processing of precursor polypeptides.
This study set out to characterise the cis-acting elements which control
expression of the rat PPT-A (rPPT-A) gene through analysis of 1300 bp of promoter
sequence spanning nucleotides -865 to +447 relative to the transcriptional start site. By
the use of exonuclease protection assays, DNasel footprinting and electrophoretic
mobility shift analysis several potential regulatory elements have been identified both 5'
and 3' of the major transcriptional start site.
The rPPT-A gene is expressed endogenously, at high levels, in dorsal root
ganglion (DRG) neurons, however this tissue cannot be obtained in sufficient quantity
for biochemical analysis. To date, there are no cell lines which express the rPPT-A
gene at high levels, either endogenously or when transfected with plasmids containing
regions of the promoter linked to reporter genes. Therefore, the well characterised
HeLa cell line was used as a source of protein extract as it has been shown to express a
large array of transcription factors, many of which are expressed in DRG neurons.
By use of the exonuclease protection assay a protein/DNA interaction site was
identified within the rPPT-A promoter, close to the transcriptional start site. In order to
map this and any other sites more accurately, DNasel footprinting analysis was carried
out and identified elements were then further characterised by electrophoretic mobility
shift assays. Several potential regulatory elements which contain the potential binding
sites for a number of distinct transcription factors were identified . These include four
AP-l-like sites, one of which also resembles a cyclic AMP response element (CRE), a
purine-rich element and six E-box motifs. There are also two regions rich in dT
nucleotides, resembling octamer binding protein motifs, and two regions rich in dG
nucleotides. Other elements include one located between the TATA box and
transcriptional site, another which appears to bind both single-stranded and double-
stranded DNA-binding proteins in a tissue specific manner and two elements which
have yet to be further characterised. Some of the elements located 3' of the major
transcriptional start site differ in their binding characteristics depending on whether
extracts of neuronal or non-neuronal tissue were used.
The rPPT-A promoter is therefore bound by a variety of proteins, some of
which may bind in a tissue-specific manner, thus potentially allowing for stimulus-
dependent and tissue-specific gene regulation. It is hoped that the sites identified by this
study will act as a foundation for studies of the regulation of the rPPT-A promoter in
DRG neurons.
In a complementary study it was demonstrated, by electrophoretic mobility shift
assays using the mouse CI300 neuroblastoma cell line, that nerve growth factor (NGF)
induces a protein, termed C1300-Oct, which recognises the octamer binding protein
consensus sequence. As NGF has been shown to regulate the rPPT-A gene in DRG
neurons and the rPPT-A promoter contains at least two potential octamer binding
protein sites, it is postulated that NGF-inducible octamer binding proteins, including
C1300-Oct, may be involved in the regulation of rPPT-A gene expression.
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This study set out to investigate how the rat preprotachykinin-A (rPPT-A) gene
is regulated at the transcriptional level.
The rPPT-A gene encodes the precursors of the tachykinins (literally 'fast-
acting') which are a family of neuropeptides displaying a wide but selective distribution
throughout both the central and peripheral nervous systems. The peptides vary in length
but share substantial amino acid sequence homology and are characterised by the
common COOH-terminal amino acid sequence, essential for their biological activity,
Phe-X-Gly-Leu-Met-NH2 where X is a hydrophobic or an aromatic residue (Erspamer,
1971).
The tachykinin Substance P (SP) was first purified by Chang et al. (1971) and
its structure was elucidated as the undecapeptide Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-
Gly-Leu-Met-NH2- SP was originally the only representative tachykinin in mammals,
however further mammalian tachykinins have subsequently been described. These
include neurokinin A (NKA) (Nawa et al., 1984; Krause et al., 1987), and the NH2-
terminal extended derivatives of NKA, NKA (3-10) (Tatemoto et al., 1985),
neuropeptide K (NpK) (Tatemoto et al., 1985) and neuropeptide y (Npy) (Kage et al.,
1988) and finally neurokinin B (NKB) (Kotani et al., 1986; Bonner et al., 1987).
1.1.1. Genes encoding tachykinins.
In mammals the tachykinin peptides are derived by post-translational processing
of polyprotein preprotachykinin (PPT) precursors. There are two genes that encode the
tachykinin peptides. The PPT-A gene (or SP/NKA gene) encodes SP, NKA, NKA (3-
10), NpK and Npy (Nawa et al., 1983, 1984; Krause et al., 1987) and the PPT-B gene
encodes NKB (Kotani et al., 1986; Bonner et al., 1987).
The PPT-A gene is approximately 8.4 Kbp long and consists of seven exons
interspersed by six introns (Figure 1). Sequences in exon 3 encode SP and sequences
in exon 6 encode NKA. The coding region of the PPT-A gene consists of 123 bp of the
3' end of exon 2, exons 3-6 and 47 bp of the 5' end of exon 7. Alternative mRNA
splicing of the primary transcript results in the generation of four mRNAs termed a-,
(3-, y-, and 8-PPT-A mRNA (Nawa et al., 1983, 1984; Kawaguchi et al., 1986; Krause
et al., 1987; Harmar et al., 1990). Exons 6 and 4 are separately excluded in the splicing
process resulting in the formation of a-PPT-A and y-PPT-A mRNA respectively, (3-
PPT-A mRNA contains regions from all exons (Nawa et al., 1983, 1984; Kawaguchi
et al., 1986; Krause et al., 1987) and 8-PPT-A mRNA lacks both exon 4 and exon 6
(Harmar et al., 1990).
Figure 1. Schematic diagram of the rat preprotachvkinin-A gene.
The primary transcript of the rPPT-A gene is depicted at the top. The boxes, numbered
1 to 7, denote exons and are separated by introns, depicted as lines. Sequences in exon
3 encode substance P (SP) and sequences in exon 6 encode neurokinin A (NKA).
The primary transcript undergoes alternate mRNA splicing to generate four mRNA
species: a, (3, y, and 5.
The polypeptide precursors encoded by these mRNA species then undergo post-
translational processing to generate the neuropeptides SP, NKA and the NH2-terminal
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Differential post-translational processing of the PPT-A mRNAs results in the
production of SP from all four PPT-A mRNAs, NKA, NKA (3-10) and/or NpK from
(3-PPT-A mRNA (Tatemoto et al., 1985; MacDonald et al., 1989) and NKA, NKA (3-
10) and/or Npy from y-PPT-A mRNA (Kage et al., 1988; MacDonald et al., 1989). 5-
PPT-A mRNA is predicted, in addition to SP, to encode a novel COOH-terminal
peptide of 22 amino acids unique to the 8-PPT transcript (Harmar et al., 1990).
Tissue-and species-specific patterns of splicing of the primary transcript have
been reported for the bovine and the rat PPT-A genes. For example, Northernblot and
in situ hybridisation studies have shown that bovine (3-PPT-A mRNA is more abundant
in CNS tissue compared to a-PPT-A mRNA, whereas a-PPT-A mRNA predominates
in thyroid and gut (Nawa et al., 1984). In rat tissues y-PPT-A mRNA was found to be
the most abundant form with the splicing pattern of the primary transcript being
relatively constant in all tissues studied (Krause et al., 1987, 1989; Carter and Krause,
1990). To date, 5-PPT-A mRNA has only been reported in rat dorsal root ganglia
(DRG) (Harmar et al., 1990).
In an analogous situation to the PPT-A gene, the PPT-B gene consists of 7
exons interspaced with six introns with sequences encoding NKB contained in exon 5.
The PPT-B gene gives rise to two PPT-B mRNAs through the use of two different
promoter sites. Both mRNA species contain exons 1-7 and encode a propeptide of 126
amino acids which is processed to produce NKB, the sole biologically active peptide of
the PPT-B gene (Kotani et al., 1986; Bonner et al., 1987).
1.1.2. Distribution of tachykinins.
A number of techniques have been used to study the distribution of PPT-A
mRNAs and tachykinin peptides in the CNS and other tissues. Such techniques include
radioimmunoassays combined with chromatographic techniques (Ogawa et al., 1985;
Arai and Emson, 1986; Too et al., 1989), PCR, in situ hybridisation, nuclease
protection and Northern blot assays (Nawa et al., 1983, 1984; Krause et al., 1987,
1989; Carter and Krause, 1990, Harmar et al., 1990; Bannon et al., 1992). High levels
of SP, NKA and NpK immunoreactivity have been detected in the spinal cord and in
sensory neurons of the DRG (Ogawa et al., 1985; Arai and Emson, 1986; Too et al.,
1989). PPT-A mRNAs have been detected in a wide range of CNS tissues including
the spinal cord, DRG, hippocampus, cerebellum, striatum and basal ganglia (Nawa et
al., 1983, 1984; Krause et al., 1987, 1989; Carter and Krause, 1990; Harmar et al.,
1990; Bannon et al., 1992).
Northern blot, in situ hybridisation and nuclease protection assays have also
shown that the different PPT-A mRNAs are expressed in a variety of peripheral tissues
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including the intestine, the stomach, the thyroid and the retina (Nawa et al., 1983,
1984; Krause et al., 1987, 1989; Carter and Krause, 1990).
1.1.3. Central roles of tachykinins.
Substance P (SP) is found in discrete neuronal pathways of the central nervous
system and is thought to act as a neurotransmitter in primary sensory neurons (Otsuka
et al., 1982).
Early evidence to support the role of SP as a neurotransmitter came from studies
concerning the distribution of SP in the spinal cord. Such studies demonstrated that SP
is more abundant in the sensory neurons of the dorsal horn, where DRG neurons
terminate, than in the ventral horn (Lembeck, 1953). Subsequently it was shown that
SP is highly concentrated in the nerve terminals of DRG sensory neurons (Takahashi
and Otsuka, 1975). Immunohistochemistry later confirmed these findings and allowed
the localisation of SP to nerve terminals forming synapses with dorsal horn cells
(Barber et al., 1979).
Further evidence supporting a neurotransmitter role for SP comes from the
finding that SP, extracted from frog dorsal roots, is a powerful stimulant of spinal
neurons (Otsuka et al., 1972). Additionally, when the isolated dorsal roots of the spinal
cords of new born rats are stimulated there is a marked increase in the amount of
immunoreactive SP in the solution perfusing the preparation (Otsuka and Konishi,
1976; Akagi et al., 1980; Yaksh et al., 1980).
The presence of other tachykinins, such as NKA and NpK, have also been
demonstrated in primary sensory neurons (Minamino et al., 1984; Dalsgaard et al.,
1985; Hua et al., 1985; Ogawa et al., 1985). Additionally, SP and NKA are co-
released from nerve terminals (Saria et al., 1984) and have been shown to have similar
actions on effector cells (Hua et al., 1985; Nilsson et al., 1985).
DRG neurons are believed to be mediators of pain perception and a number of
lines of evidence point to SP as a candidate factor responsible for mediating the
transmission of nociceptive information to the spinal cord. Such evidence includes the
finding that capsaicin, which causes a desensitisation to chemical noxious stimuli,
evokes the release of SP and in fact depletes SP, from dorsal roots (Gasparovic et al.,
1964; Jessel et al., 1978; Nagy et al., 1981). Additionally, iontophoretic application of
SP onto the dorsal horn exerts a powerful excitatory action on a subpopulation of
dorsal horn neurons which are also excited by a peripheral noxious stimulus (Henry,
1976; Randic and Miletic, 1977). SP has also been found to be released during noxious
mechanical or thermal stimulation (Kuraishi et al., 1985; Wiesenfeld-Hallin, 1986) and
noxious stimulation has been found to lead to the induction of the PPT-A gene in rat
DRG (Noguchi et al., 1988). Furthermore, the number of dorsal horn projection
neurons in rats expressing PPT-A mRNA was found to increase following noxious
stimulus (Noguchi and Ruda, 1992), providing further evidence that tachykinin
peptides act as neurotransmitters in nociceptive CNS pathways.
1.1.4. Peripheral roles of tachykinins.
The majority of SP synthesised in the dorsal roots is transported to the
periphery (Brimijion et al., 1980; Harmar and Keen, 1982). Consequently, SP has
been demonstrated in a variety of peripheral nerves, including phrenic (Malthe-
Sorensen and Oktedalon, 1982) and sciatic nerves (Lundberg et al., 1978; Brimijoin et
al., 1980; Lembeck et al., 1981). Additionally, SP-containing nerve fibers have been
demonstrated in the skin (Hokfelt et al., 1975; Dalsgaard et al., 1983), around blood
vessels (Furness et al., 1982), in the rat mammary nipple (Traurig et al., 1984), in
different areas of the eye (Keen et al., 1982; Dalsgaard, 1988), in the spleen, thymus
and lymph nodes (Felten et al., 1985; Fink and Weihe, 1988; Popper et al., 1988;
Weihe et al., 1989; Kurkowski et al., 1990) and in the intestine (Bienenstock et al.,
1987).
In the cornea, capsaicin treatment results in a depletion of SP (Keen et al.,
1982) and capsaicin treatment of blood vessels results in a depletion of SP from
innervating nerve fibers (Furness et al., 1982; Papka et al., 1984).
In addition to mediating the pathogenesis of pain, peripheral SP is also thought
to be involved in processes such as neurogenic inflammation associated with arthritis
(Pernow, 1985; Donaldson et al., 1992; Smith et al., 1993), stimulating immune
function (Bar-Shavit et al., 1980), hypotension, smooth muscle contraction and cellular
proliferation (Bury and Mashford, 1976; Couture et al., 1979).
1.1.5. Regulators of tachykinins.
The ability of the nervous system to respond to different types of stimuli
depends on an extensive repertoire of adaptive responses, one of which is a change in
the biosynthesis of neurotransmitter molecules.
The tachykinins and their precursor mRNAs have been shown to display a
significant degree of plasticity in their expression levels. A number of factors have been
identified as potential regulators of the tachykinins. One such regulator is the
neurotrophic factor nerve growth factor (NGF). NGF has been shown to regulate the
expression of PPT-A mRNA in adult rat DRG neurons (Lindsay and Harmar, 1989).
DRG neurons require NGF for survival during development, but once mature they
appear to survive in the absence of NGF (Johnson et al., 1986). NGF deprivation in
adults rats, achieved through sciatic nerve section, results in a reduction of substance P
and PPT-A mRNA levels in lumbar DRG and this effect can be reversed by the
application of NGF to the nerve (Fitzgerald et al., 1985; Henken et al., 1990).
Evidence that the effects of added NGF are due to direct stimulation of SP biosynthesis
came from the findings of Lindsay and Harmar (1989). Adult DRG neurons grown in
the absence of NGF were shown by Northernblot and radioimmunoassays to display a
reduced level of SP and its precursor mRNA, whereas cultures grown in the presence
of NGF displayed an increase in PPT-A mRNA and SP levels over a time course of
five days (Lindsay and Harmar, 1989).
Deafferentation of rat neonatal superior cervical ganglion (SCG) results in
increased levels of SP and its mRNA (Kessler et al., 1981; Roach et al., 1987). The
mechanisms underlying this increase are thought to involve immune cytokines which
are released during such injury. It has been shown that interleukin-1 (3 (IL-1 (3) results in
a dramatic increase in SP-like immunoreactivity and in PPT-A mRNA in cultured
neonatal SCG (Jonakait and Schotland, 1990; Jonakait et al., 1990; Freidin and
Kessler, 1991; Hart et al., 1991). This response was shown to require the presence of
non-neuronal cells (Freidin and Kessler, 1991). Subsequently, it was demonstrated that
leukaemia inhibitory factor (LIF), which also promotes SP expression in SCG cultures
(Nawa and Sah, 1990; Freidin and Kessler, 1991; Rao et al., 1992), acts as an
intermediate molecule stimulating cells to produce SP (Shadiack et al., 1993). It
appears that IL-1 (3 does not directly act on neurons but rather that LIE, produced by IL-
1 (3 stimulated non-neuronal cells, acts as at least one of the molecular intermediates of
IL-1 (3 to promote SP expression (Shadiack et al., 1993).
Brain tachykinins are functionally closely linked to dopaminergic transmission
in the mammalian brain (Bjorklund and Lindvall, 1984). It has been shown that, in the
basal ganglia, factors which modulate dopaminergic transmission also influence the
synthesis and in vivo release of tachykinins (Ritter et al., 1984; Bannon et al., 1986,
1987; Lindefors et al., 1989; Lindefors, 1992). Haloperidol, a dopamine receptor
antagonist, has been shown to inhibit PPT-A mRNA expression in the basal ganglia
(Bannon et al., 1986, 1987; Lindefors et al., 1989; Lindefors, 1992) and amphetamine,
an indirect dopamine agonist, induces PPT-A mRNA expression (Ritter et al., 1984;
Bannon et al., 1987; Lindefors, 1992). Dopaminergic neurons of the midbrain are also
thought to regulate PPT-A mRNA expression as it has been shown that there is a
down-regulation of PPT-A mRNA expression by a specific set of dopaminergic
neurons in the midbrain during rat brain development (Brene et al., 1992).
1,1.6. Tachykinin receptors.
SP and other tachykinins mediate their actions through G-protein linked
receptors. A large number of G-protein-linked receptors exist, characterised as sharing
a common structure of seven transmembrane (TM) domains, including the well
characterised (3-adrenergic receptor and the visual pigment rhodopsin. Tachykinins, on
binding to their receptors, are thought to activate phospholipase C (PLC). This results
in the stimulation of phosphatidyl inositol turnover and a resulting increase in
intracellular inositol 1,4,5-triphosphate (IP3) which evokes Ca2+ release from
intracellular stores. PLC activation also results in protein kinase C (PKC) activation
through diacylglycerol (DAG) (Womack et al., 1988; reviewed in Zeiglgansberger and
Tolle, 1993).
All of the tachykinins are able to induce similar biological actions, although their
rank order of potency at inducing individual physiological responses differs,
suggesting that they may act through different receptors. Subsequently, ligand binding
studies and molecular biological techniques have identified three tachykinin receptors,
NK1, NK2 and NK3, preferentially bound by SP, NKA and NKB respectively
(Mizrahi et al., 1985; Buck and Burcher, 1986; Masu et al., 1987; Yokota et al., 1989;
Shigemoto et al., 1990).
1.2. Eukarvotic RNA polymerase II transcription.
1.2.1. An overview.
Many of the factors which have been shown to be potential regulators of rPPT-
A gene expression may exert their actions through the regulation of the initiation of
mRNA synthesis. A number of distinct DNA sequence elements, usually located
upstream of the start point of transcription, are involved in regulating the synthesis of
mRNA. These include minimal promoter elements, upstream activating sequences
(UASs) and enhancers.
Minimal promoter elements commonly include a TATA box motif, located
around -30 from the site of transcription initiation, and sometimes also include an
initiator element(s). Such minimal promoter elements control the site of transcription
initiation and cellular factors exist with which they will functionally interact.
UASs and enhancers can act to regulate the initiation of transcription by RNA
polymerase II from the minimal promoter. UASs can act at a short distance while
enhancer elements can be located up to several thousand base pairs from the
transcription initiation site (Dynan and Tjian, 1985). These types of elements will be
discussed in more detail in Section 1.2.3.
The control of transcription initiation by RNA polymerase II requires the co¬
ordinated interaction of transcription factors with different types of cis-acting DNA
sequence elements. Two classes of transcription factors exist. Firstly, the general
transcription factors, which will be covered in the following sections, are essential for
initiation and are sufficient to direct a basal level of transcription from many minimal
promoters. Secondly, trans-acting DNA binding proteins, which will be covered in
Section 1.2.3., bind to upstream activating sequences and enhancers to regulate the
frequency of transcriptional initiation (Dynan and Tjian, 1985).
1.2.2. Minimal promoter.
The initiation of transcription by RNA polymerase II is a highly complex
process and requires the action of multiple initiation factors. Transcriptionally active
extracts were first prepared and fractionated from crude cellular extracts over 10 years
ago (Weil et al., 1979; Matsui et al., 1980). Subsequent studies have resulted in the
purification of many of the general transcription factors and in the cloning of the genes
encoding these factors.
The following sections will give a general overview of the initiation of
transcription by RNA polymerase II from the minimal promoter regions of TATA-box
containing promoters. This will include a section covering the properties of RNA
polymerase II itself, a section describing the general transcription factors and how they
are thought to interact with each other to initiate transcription and a section covering
initiator elements.
1.2.2.1. RNA polymerase II.
Eukaryotic cells contain three distinct forms of nuclear DNA-dependent RNA
polymerases that transcribe different sets of genes. RNA polymerase I is responsible
for synthesising rRNA precursors (class I), while RNA polymerase II transcribes
protein-coding genes (class II) and RNA polymerase III transcribes 5S and tRNA
genes (class III).
RNA polymerase II has been purified to near homogeneity from more that 20
organisms, from plant and animal tissues, cultured cells and lower eukaryotes
(reviewed by Sawadago and Sentenac, 1990). Such studies have demonstrated that
RNA polymerase II is a multi-subunit enzyme of molecular mass 500-600 KDa
consisting of two large polypeptides (Mr > 140 KDa) and a number of smaller
polypeptides ranging in size from 10 KDa to 40 KDa (reviewed by Sawadago and
Sentenac, 1990). The genes encoding RNA polymerase II have been cloned from yeast
cells (Ingles et al., 1984), Drosophila (Ingles et al., 1983) and mouse and human cells
(Cho et al., 1985).
The largest subunit of RNA polymerase II has an unusual COOH-terminal
domain (CTD) composed of tandemly repeated copies of a serine-rich heptapeptide with
the consensus sequence Tyr-Ser-Pro-Thr-Ser-Pro-Ser (reviewed by Young, 1991).
This CTD consensus sequence occurs 26-27 times in yeast RNA polymerase (Allison et
al., 1985; Nonet et al., 1987) and 52 times in the enzyme from mammalian cells
(Corden et al., 1985; Allison et al., 1988). RNA polymerase II comes in two forms,
IIA and IIO, which differ only in the extent with which their CTDs are phosphorylated.
The CTD can be phosphorylated by a DNA-dependent protein kinase (DNA-PK) at
multiple sites in vivo (Cadena and Dahmus, 1987). The IIA form is the non-
phosphorylated state while the IIO form is phosphorylated. It is thought that the kinase
which specifically phosphorylates the CTD may provide the signal for RNA
polymerase II to initiate mRNA synthesis once it is assembled into a stable complex at
the promoter (reviewed by Peterson and Tjian, 1992).
Genetic and biochemical experiments have demonstrated the functional
importance of the CTD of RNA polymerase II in transcriptional initiation. Deletion
mutants that remove most or all of the CTD are lethal to yeast, Drosophila and mouse
cells (Nonet et al., 1987; Allison et al., 1988; Bartolomei et al., 1988; Zehring et al.,
1988). Additionally, monoclonal antibodies specific for the CTD have been shown to
inhibit transcription initiation from a variety of promoters in vitro (Dahmus and
Kedinger, 1983). Other such monoclonal antibodies inhibit the formation of stable
initiation-competent complexes and transcription initiation from the adenovirus major
late (AdML) and mouse dihydrofolate reductase (DHFR) promoters in vitro (Thompson
et al., 1989; Conaway et al., 1992a).
The CTD of RNA polymerase II has been shown to interact with components of
the general transcription factor TFIID (Conaway et al., 1992a; Usheva et al., 1992). As
certain activators of transcription are thought to communicate with the basal
transcriptional apparatus by interactions with TFIID (Section 1.2.3.2.) (Pugh and
Tjian, 1990; Smale et al., 1990; Dynlacht et al., 1991; White et al., 1991; Pugh and
Tjian, 1992) it has been suggested that trans-acting DNA binding proteins may regulate
RNA polymerase II transcription through direct or indirect interactions with the CTD.
I.2.2.2. The general transcription factors.
The development of soluble extracts capable of reproducing in vitro the accurate
transcription of class II promoters has been a major breakthrough for investigating both
the general and regulatory mechanisms of transcription initiation by RNA polymerase
II.
Studies of initiation in such extracts has resulted in the purification of many of
the general transcription factors and the cloning of their genes. Accurate RNA
polymerase II transcription can be reconstituted using highly purified components of
the general transcription factors (TFIIA, -B, -D, -E, -F, -H and -J) which will be
discussed in the following subsections.
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1.2.2.2.a. TFIID and TBP.
TFIID, the pivotal factor in the basal transcription apparatus, is a multiprotein
complex which binds to the TATA box by way of a critical subunit, the TATA-box
binding protein (TBP).
TBP.
The first committed step in the formation of a complete preinitiation complex at
the core promoter is the binding of TBP to a sequence element centred around the
TATA box (reviewed by Sawadogo and Sentenac, 1990).
As the mammalian TBP is highly labile and difficult to purify (Nakajima et al.,
1988), most investigations initially centred around the yeast TBP protein. Purification
of yeast TBP revealed that it is composed of a single 27 KDa polypeptide which is
capable of binding specifically to the TATA region of many promoters and of
substituting for human TBP in basal transcription (Buratowski et al., 1988; Cavillini et
al., 1989; Hahn et al., 1989a; Horikoshi et al., 1989; Schmidt et al., 1989a). The
subsequent isolation of cDNA clones encoding the yeast TBP (Cavallini et al., 1989;
Eisenmann et al., 1989; Hahn et al., 1989a; Horikoshi et al., 1989; Schmidt et al.,
1989a) led quickly to the isolation of cDNA clones encoding homologous proteins of
approximately 37 KDa from a wide variety of species, including Drosophila (Hoey et
al., 1990; Muhich et al., 1990), mouse (Tamura et al., 1991) and humans (Hoffman et
al., 1990; Kao et al., 1990; Peterson et al., 1990).
Analysis of the deduced amino acid sequence of the different TBPs reveals that
they are composed of a bi-partite structure, comprising a COOH-terminal domain of
180 amino acids, which shows a high degree of conservation between different
organisms, and a non-conserved NH2-terminal domain, varying in size in a species
dependent manner (Greenblatt, 1991a; Pugh and Tjian, 1992). A series of studies have
demonstrated that the COOH-terminal domain of TBP appears to constitute the
functional core of the molecule, being required for a basal level of activity. Limited
proteolysis to remove the NH2-terminal domain of yeast TBP results in a COOH-
terminal domain protein which retains the ability to bind effectively to minimal promoter
elements and to activate basal levels of transcription (Lieberman et al., 1991).
Additionally, TBP mutants lacking the NH2-terminal region have been shown to be
fully functional in promoter binding and basal transcription (Hoey et al., 1990;
Peterson et al., 1990; Kelleher et al., 1992). Genetic evidence is consistent with the
conserved COOH-terminal domain constituting the core of the molecule, as it has been
shown for yeast TBP that the COOH-terminal domain contains all the functions
essential for normal yeast cell growth and for response to acidic transcriptional
activators in vivo (Cormack et al., 1991; Gill and Tjian, 1991; Poon et al., 1991;
Reddy and Hahn, 1991; Zhou et al., 1991).
The COOH-terminal domain is rich in basic amino acids and contains two 60-
amino-acid direct repeats interrupted by a lysine-rich spacer region of 40 amino acids
(Cavallini et al., 1989; Hoejimakers, 1990; Nagai, 1990). Overlapping the more
COOH-terminal direct repeat is a region similar in sequence to prokaryotic sigma
factors (Horikoshi et al., 1989; Hoffmann et al., 1990; Jaehning, 1991). Sigma, a
loosely associated component of the bacterial RNA polymerase, is required for accurate
initiation of transcription and contains diverse activities such as RNA polymerase
binding, promoter recognition and DNA melting (reviewed by Helmann and
Chamberlin, 1988; Lonetto etal., 1992).
The direct repeat sequences within the COOH-terminal domain of TBP have
been shown to be required for promoter binding (Reddy and Hahn, 1991; Yamamota et
al., 1992) yet it appears that TBP cannot be divided into distinct DNA-binding and
transcriptional activation domains. Studies have shown that deletion of amino acids
anywhere within the entire COOH-terminal domain abolishes both promoter binding
and transcriptional activation (Horikoshi et al., 1990).
DNase 1 and chemical footprinting analysis have demonstrated that TBP binds
to a small promoter region centred around the TATA box (Hahn et al., 1989a, 1989b;
Horikoshi et al., 1989; Kao et al., 1990) and unlike sequence-specific DNA binding
proteins, TBP binds to and dissociates from TATA elements very slowly (Schmidt et
al., 1989b; Hoopes et al., 1992). Although TBP is transcriptionally most active when
bound to the consensus TATA element, TATAAA (Wobble and Struhl, 1990), it has
been shown to bind to nearly all permutations of the canonical TATA sequence as well
as a variety of nonconsensus TATA elements (Hahn et al., 1989b; Singer et al., 1990).
In fact it has been shown that human TBP will even recognise and bind to DNA
sequence elements located 30 bp upstream of several promoters, such as the simian
virus 40 (SV40) major late promoter, which lack definable TATA elements, albeit with
weaker affinities than it binds to consensus TATA box sequences (Wiley et al., 1992).
TFIID.
Efforts to purify TFIID from higher eukaryotes have been hampered by its low
abundance in cells and by its tendency to suffer degradation or dissociation into smaller
transcriptionally active species during purification (Nakajima et al., 1988). TFIID has
subsequently been shown to be a high molecular mass, multi-subunit complex
composed of TBP and additional polypeptides, termed TBP-associated factors (TAFs)
(Pugh and Tjian, 1992). It has been proposed that the TAFs associated with TBP
participate in promoter recognition and are required for transcriptional activation by
upstream activator proteins (Dynlacht et al., 1991; Greenblatt, 1991a; Tanese et al.,
1991; Pugh and Tjian, 1992).
It has been shown that TBP is essential for transcription from all three classes
of eukaryotic genes and that its associations with TAFs appear to specify which
polymerase can initiate transcription from a given gene (reviewed by Sharp, 1992).
Thus, several forms of TFIID possessing molecular masses of approximately 700 KDa
(Conaway et al., 1990a; Zhou et al., 1992), 300 KDa (Timmers and Sharp, 1991;
Lobo et al., 1992) and 230 KDa (Comai et al., 1992) have been identified in extracts of
human cells. The 700 KDa form appears to be required for transcription by RNA
polymerase II from class II promoters, the 300 KDa form is termed B-TFIID and
appears to be required for transcription from class III promoters lacking a TATA box
(Lobo et al., 1992) and the 230 KDa form appears to be involved in transcription by
RNA polymerase I from class I promoters, as it was found to co-purify with the RNA
polymerase I initiation factor SL1 (Comai et al., 1992).
Using antibodies directed against TBP, attempts have been made to identify the
factors associated with the TFIID complex by immunoaffinity purification procedures.
Multiple TAFs which associate tightly with TBP have subsequently been identified.
These consist of six prominent polypeptides in Drosophila cells, ranging in molecular
mass from 31 to 150 KDa (Dynlacht et al., 1991) and approximately ten polypeptides
(10-250 KDa) in mammalian cell extracts (Pugh and Tjian, 1991; Tanese et al., 1991;
Zhou et al., 1992). Zhou et al. (1992) reported the purification of the TFIID complex
from HeLa cells. It was demonstrated that TFIID appears as a single purified
multisubunit complex of about 700 KDa, termed Holo-TFIID, composed of TFIID and
several TAFs ranging in size from 28 to 250 KDa. Holo-TFIID appeared to represent
the native TFIID as it was capable of supporting in vitro transcription from an RNA
polymerase II promoter (Zhou et al., 1992).
The 250 KDa subunit of the TFIID complex has subsequently been identifed as
the cell-cycle regulatory protein CCG1 (Hisatake et al. 1993a; Ruppert et al., 1993).
CCG1 is a nuclear DNA-binding protein which is important for cell cycle progression
(Sekiguchi et al., 1988, 1991). CCG1 contains regions of sequence displaying
homologies with known DNA-binding and transcriptional activation domains,
including an HMG box (Section 1.2.3.1.1.j.) and a domain rich in proline residues
(Section 3.1.2.3.). On the basis of these homologies, it was suggested that CCG1
might be a sequence-specific transcription factor involved in the regulation of genes
controlling progression through the cell cycle (Sekiguchi et al., 1991). Based on its
ability to interact with TBP it has now been suggested that CCG1, in addition to
serving a major cell cycle function, forms part of the TFIID complex and may play a
role in both recruiting other TAFs to the complex and in receiving signals from various
transcriptional regulators (Hisatake et al. 1993a; Ruppert et al., 1993).
Studies using in vitro transcription from various promoters have shown that
whereas TBP requires only a short sequence element centred around the TATA motif to
direct transcription, TFIID appears to recognise and interact with a large promoter
element. Both the initiator element (Section 1.2.2.4.) and the TATA box motif were
shown to be required for transcription from the AdML promoter using rat liver extract,
however when yeast TBP was used only the TATA box was required for efficient
transcription (Conaway et al., 1990b, 1991). Similarly, transcription driven from a
synthetic promoter was shown to require both the TATA box and the initiator elements
when human TFIID was used, yet only sequences in the vicinity of the TATA box were
required for transcription directed by human and yeast TBP (Nakatani et al., 1990;
Smale et al., 1990). In vitro binding data using DNase 1 footprinting analysis of the
AdML and human histone 4 promoters is also consistent with TFIID interacting with a
larger region of core promoters than does TBP (Sawadogo and Roeder, 1985b;
Nakajima et al., 1988; Van Dyke and Sawadogo, 1990).
From the observation that both TBP and TFIID can interact with the TATA box
motif, it seems likely that the ability of TFIID to recognise a larger region of minimal
promoters than TBP may be accomplished through the co-operative interactions of TBP
with the TATA box and of the TAFs with initiator elements and other parts of the
minimal promoter. TFIID has been shown to direct transcription from the core regions
of promoters lacking definable TATA boxes (TATA-less) and it is predicted that the
binding of TFIID to these TATA-less promoters is independent of TBP and is achieved
through the actions of the TAFs (Pugh and Tjian, 1990, 1991, 1992). The role of the
TBP-subunit of TFIID in such TATA-less promoters is unclear but it has been
suggested that human TBP will bind weakly, but specifically, to sequences located
upstream of the transcriptional start site of such promoters (Wiley et al., 1992).
Therefore, it may have a qualitatively similar function to that at TATA-box containing
promoters in correctly positioning RNA polymerase II and the transcription apparatus at
minimal promoter elements.
Thus, it appears that TBP, in association with accessory factors, forms the
TFIID complex and it is this factor which binds stably to the minimal promoter regions
of TATA-box containing promoters to form the first stage of transcriptional initiation by
RNA polymerase II.
1.2.2.2.b. TFIIA.
TFIIA was originally identified as a HeLa cell-derived factor possessing
transcriptional stimulatory properties (Matsui et al., 1980; Samuels and Sharp, 1986).
Reports describing the purification of TFIIA from mammalian sources revealed variable
subunit compositions, consisting of a single 43 KDa protein (Egly et al., 1984), a 38
KDa protein (Usuda et al., 1991), two subunits of 12 and 19 KDa (Samuels and
Sharp, 1986), or a heterotrimer containing of subunits of 12, 19 and 35 KDa (Cortes et
al., 1992; Coulombe et al., 1992). TFIIA purified from yeast exists as subunits of 43
and 12 KDa (Hahn et al., 1989c; Ranish and Hahn, 1991). The two yeast genes
encoding these subunits have subsequently been cloned and the recombinant proteins
are transcriptionally active in yeast cells and will function interchangeably with the
mammalian factors in basal transcription (Ranish et al., 1992). Recently, a cDNA clone
encoding the largest subunit (a) of human TFIIA has been cloned (Ma et al., 1993). A
separate study reported the isolation of a human cDNA clone, hTFIIA/a, which
encodes a 55 KDa protein (DeJong and Roeder, 1993). This single cDNA was shown
to contain the sequences of both the 19 KDa and the 35 KDa subunits and therefore
encodes both of these subunits (DeJong and Roeder, 1993).
The role of TFIIA in directing accurate transcription by RNA polymerase II has
remained elusive. It has been shown that TFIIA promotes stable binding of TFIID to
the core promoter (Davison et al., 1983; Reinberg et al., 1987; Buratowski et al., 1989)
and that it will bind stably to both TBP (Ranish and Hahn, 1991; Usuda et al., 1991;
Cortes et al., 1992; Ma et al., 1993) and to TFIID (Ma et al., 1993). However,
reconstituted transcription systems have failed to show a consistent requirement for
TFIIA. The in vitro requirement of TFIIA for the synthesis of specific transcripts
ranges from no requirement (Sawadogo and Roeder, 1985a; Van Dyke et al., 1988;
Conaway et al., 1990a; Sayre et al., 1992), to a stimulatory effect (Egly et al., 1984;
Cortes et al., 1992) or even an absolute requirement (Samuels and Sharp, 1986;
Reinberg et al., 1987). It appears that the requirement of this factor for basal
transcription may depend on both its source and on the degree of its purification. No
requirement for TFIIA is observed in highly purified systems from yeast (Sayre et al.,
1992) and rat (Conaway et al., 1990a), yet it was found to be required in a
reconstituted transcription system from human cells when a partially purified
preparation of TFIID was used. However when this was replaced by purified TBP,
TFIIA was no longer required (Cortes et al., 1992). Additionally, mutations to TBP
which abolish its ability to interact with TFIIA have no effect on TBPs ability to
support in vitro transcription from the AdML promoter (Buratowski and Zhou, 1992;
Yamamoto et al., 1992).
Thus, at present thereaireconflicting data concerning the role of TFIIA as a basal
transcription factor.
I.2.2.2.C. TFIIB.
A great deal of interest has recently been centred around the transcription factor
TFIIB. The reason for this interest stems from the fact that TFIIB is thought to be one
of the main factors involved in the transcription of DNA by RNA polymerase II and it
is also thought to be involved as a target of trans-acting activator proteins.
TFIIB was initially purified to homogeneity from rat liver (Conaway et al.,
1987) and subsequently from human cells where it exists as a single 35 KDa
polypeptide (Ha et al., 1991; Malik et al., 1991; Moncollin et al, 1992). cDNAs
encoding the human (Ha et al., 1991; Malik et al., 1991), Drosophila (Wampler and
Kadonaga, 1992) and rat (Tsuboi et al., 1992) factors have since been isolated.
The sequence of TFIIB from humans and other organisms has several notable
features. At the NH2-terminus there is a conserved cysteine-rich sequence postulated to
form a Zn2+-binding region. The COOH-terminus mostly comprises two imperfect
repeats, each of about 75 amino acids, with a cluster of basic residues at the end of the
most NH2-terminal repeat spaced in such a manner that they could potentially form an
amphipathic a-helix.
It has been shown that TFIIB will form a complex with TFIID through protein-
protein interactions (Lin and Green, 1991). TFIIB is also thought to bind a protein
complex consisting of RNA polymerase II and TFIIF thereby facilitating their binding
to the core promoter region (Tschochner et al., 1992). The fact that TFIIB appears to
act as a bridging factor, using protein-protein contacts to bind both TBP and the RNA
polymerase II-TFIIF complex, has led to the suggestion that it may consist of two
functionally distinct domains. Deletion analysis has subsequently shown that the
COOH-terminal region, containing the direct repeats and associated basic regions, is
necessary and sufficient for interaction of TFIIB with TBP but is inactive in
transcription (Barberis et al., 1993; Buratowski and Zhou, 1993; Hisatake et al.,
1993b). By contrast, the NH2-terminal region, containing the putative Zn2+-binding
domain, was found to be dispensable for binding to the TBP-DNA complex but was
shown to be required for transcriptional activity. It was shown that the NH2-terminal
region of TFIIB is probably involved in the incorporation of RNA polymerase II-TFIIF
into the preinitiation complex through protein-protein interactions with RNA
polymerase II, TFIIF, or both (Barberis et al., 1993; Buratowski and Zhou, 1993;
Hisatake et al., 1993b).
1.2.2.2.d. TFIIF.
TFIIF (also termed RAP 30/74 and (3/y) appears to exist as a heterodimer
composed of subunits of relative molecular mass 30 and 58 KDa (termed RAP 30 or (3
and RAP 74 or y respectively). The subunits constituting TFIIF were first identified on
the basis of their ability to bind immobilized RNA polymerase II (reviewed by
Greenblatt, 1991b) and subsequently were purified from rat liver (Conaway and
Conaway, 1989a) and human cells (Flores et al., 1990; Kitajima et al., 1990). The
genes encoding both subunits have now been cloned (Sopta et al., 1989; Aso et al.,
1992; Finkelstein et al., 1992), and both have been shown to be required for
transcriptional activity from a number of cellular genes (Conaway and Conaway,
1989a; Flores et al., 1990; Kitajima et al., 1990; Aso et al., 1992; Finkelstein et al.,
1992). TFIIF does not appear to bind DNA and contrary to original reports (Sopta et
al., 1989), it does not appear to posses an associated DNA helicase activity (Flores et
al., 1990; Kitajima etal., 1990; Finkelstein et al., 1992)
It has been shown that TFIIF can associate with RNA polymerase II in solution
(Sopta et al., 1989; Flores et al., 1990; Kitajima et al., 1990) and the smaller subunit,
RAP 30, has been shown to bind directly to RNA polymerase II (McCraken and
Greenblatt, 1991; Killeen and Greenblatt, 1992). Sequence analysis of RAP 30 has
indicated homology with bacterial sigma factor in the RNA polymerase-binding region,
and both factors appear functionally homologous (Sopta et al., 1989; McCraken and
Greenblatt, 1991; Killeen and Greenblatt, 1992). Whether the RAP 74 subunit also
binds to RNA polymerase II is unclear. Recombinant RAP 30 has been shown to bind
immobilised RNA polymerase II in the absence of RAP 74 suggesting that TFIIF binds
solely through the RAP 30 subunit (Killeen and Greenblatt, 1992). However, other
studies have provided evidence which suggests that RAP 74 acts to stabilise the
interaction of RAP 30 with RNA polymerase II (Garrett et al., 1992).
Another region of RAP 30, which also shares sequence homology with
bacterial sigma, has shown to be required for transcriptional activity (Garrett et al.,
1992). This particular region in bacterial sigma has been established as playing a role in
the recognition and binding to TATA-like sequences of prokaryotic promoters (Lonetto
et al., 1992). Although purified TFIIF does not bind DNA, this region may participate
in promoter recognition or DNA binding in the context of the preinitiation complex.
TFIIF has been shown to prevent non-specific binding of RNA polymerase II
to free DNA and has also been shown to dissociate non-productive pre-formed
complexes between RNA polymerase II and DNA (Killeen and Greenblatt, 1992).
Again bacterial sigma plays a similar role to this in preventing the non-specific binding
of E.coli RNA polymerase to non-promoter sites on DNA. How TFIIF acts to suppress
such non-specific binding is unclear but it may be a property of the RAP 30 subunit
since it can be achieved with recombinant RAP 30 produced in E.coli (Killeen and
Greenblatt, 1992). However, RAP 30 alone is incapable of dissociating non-productive
RNA polymerase II-DNA complexes (Killeen and Greenblatt, 1992), suggesting that
both RAP 30 and RAP 74 may play an important role in controlling the binding of
RNA polymerase II to DNA.
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1.2.2.2.e. TFTTH.
Purified rat TFIIH (or 5) appears to have a native molecular mass of 400 KDa
and consists of eight polypeptides, ranging in molecular weights from 35 to 94 KDa
(Conaway and Conaway, 1989b; Conaway et al., 1992b). Human TFIIF (or BTF2)
appears to have a native molecular mass of 200 KDa and also appears to consist of
eight polypeptides, ranging from 32 to 90 KDa (Gerard et al., 1991, Fischer et al.,
1992).
TFIIH appears to posses both kinase and transcriptional activities (Lu et al.,
1992). As already mentioned, the CTD of the largest subunit of RNA polymerase II is a
substrate for phosphorylation (Section 1.2.2.1.). It has been shown that the non-
phosphorylated form of RNA polymerase II (IIA) is recruited to the preinitiation
complex (Lu et al., 1991) and that the CTD is subsequently phosphorylated to produce
the transcriptionally active IIO form (Cadena and Dahmus, 1987; Payne et al., 1989).
Lu et al. (1992) demonstrated that TFIIH contains a kinase activity capable of
phosphorylating the CTD of RNA polymerase II. This activity was demonstrated in
absence of any other factors, although factors which promote the association of RNA
polymerase II into the preinitiation complex greatly stimulated the TFTIH-kinase activity
(Lu et al., 1992).
It appears that transcription and kinase activity are both contained within the
multisubunit TFIIH. TFIIH separates into two fractions on phosphocellulose and both
fractions have been shown to posses transcriptional and kinase activities (Lu et al.,
1992). Additionally, monoclonal antibodies directed against the 62 KDa subunit of
TFIIH act to inhibit both transcriptional and kinase activities (Lu et al., 1992).
Therefore, TFIIF! clearly has a crucial role to play in assembly of the
preinitiation complex. It has been shown to enter the complex (Conaway et al., 1992b),
associate stably with RNA polymerase II in solution (Gerard et al., 1991) and contains
both a kinase activity and transcriptional activity.
1.2.2.2.f. TFIIE.
Human and rat TFIIE are thought to exist as heterotetramers composed of
subunits of 34 and 56 KDa (OC2P2) (Ohkuma et al., 1990; Conaway et al., 1991;
Inostroza et al., 1991). The cDNAs encoding both subunits have been isolated
(Ohkuma et al., 1991; Peterson et al., 1991; Sumimoto et al., 1991) and initial reports
suggested that the 56 KDa subunit possesses the transcriptional activity with the 34
KDa subunit having a stimulatory role (Ohkuma et al., 1990; Inostroza et al., 1991).
However, it now appears that both subunits are required for optimal reconstituted
basal-level transcription (Conaway et al., 1991; Ohkuma et al., 1991; Peterson et al.,
1991; Sumimoto et al., 1991) and both are also sufficient to reconstitute Spl-activated
transcription (Peterson et al., 1991).
TFIIE does not appear to bind DNA on its own (Ohkuma et al., 1990; Conaway
et al., 1991; Inostroza et al., 1991) and although the 56 KDa subunit possesses a
sequence with similarity to a highly conserved sequence found in protein kinases, no
DNA-dependent ATPase activity has been reported for purified or recombinant TFIIE
(Buratowski et al., 1989; Inostroza et al., 1991; Peterson et al., 1991; Cortes et al.,
1992; Flores et al., 1992). TFIIE has, however, been shown to associate stably with
the preinitiation complex after RNA polymerase II and TFIIF (Inostroza et al., 1991;
Peterson et al., 1991) and reports suggest that it will associate stably with RNA
polymerase II and TFIIF in solution (Flores et al., 1989; Buratowski et al., 1991).
1.2.2.2.g. TFIIG and TFIIJ.
TFIIJ was found to co-purify with TFIIA through several chromatographic
steps (Cortes et al., 1992) and appears to be required for transcription directed by yeast
or human TBP (Cortes et al., 1992).
TFIIG has been shown to be chromatographically distinct from the human
factors TFIIA, TFIIB, TFIIF, and TFIID (Sumimoto et al., 1990) and may in fact
composed of a mixture of TFIIH and TFIIJ (Flores et al., 1992).
As neither factor has been purified to homogeneity as yet, little more is known
about the characteristics of each or their potential roles in the initiation of transcription.
1.2.2.3. Mechanisms of transcriptional initiation by RNA polymerase II.
Various approaches have been used to identify and characterise the intermediate
steps in the complex reaction pathway leading to specific transcription initiation by
RNA polymerase II. These approaches include footprinting analysis (Van Dyke et al.,
1988), native gel electrophoresis (Buratowski et al., 1989) and studies carried out in
reconstituted transcription systems. Based on these studies a working model has
evolved for the assembly of the functional preinitiation complex involving a multistage
process and the action of at least five initiation factors and an ATP cofactor. A
diagrammatic representation of this working model is shown in Figure 2 and is
described below.
Step 1. TBP binds stably to the core promoter around the TATA box region to form an
initial complex (reviewed by Sawadogo and Sentenac, 1990).
Step 2. The initial complex serves as the recognition site for RNA polymerase II (Fire
et al., 1984; Reinberg et al., 1987) which, assisted by at least two additional initiation
factors, TFIIB (Buratowski et al., 1989) and TFIIF (Flores et al., 1991), binds
productively to the initial complex to form the site-selected complex.
Figure 2. A model for assembly of the functional preinitiation complex.
Initiation of transcription by RNA polymerase II from the core regions of TATA box-
containing promoters is a multistage process requiring the action of the general
transcription factors, TBP/TFIID, TFIIB, TFIIE, TFIIF, TFIIH, TFIIJ and an ATP
cofactor.
The order in which the components of the functional preinitiation complex are thought
to be recruited onto the template is shown as steps 1 to 4. These factors and their
assembly onto the template are discussed in more detail in Sections 1.2.2.2. and
1.2.2.3.
The TATA box is indicated and the transcriptional start site (+1) is marked by an arrow.
TBP denotes TATA-box binding protein and is part of the larger TFIID protein
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Step 3. RNA polymerase II then, in association with the initiation factors TFIIH
(Cortes et al., 1992; Flores et al., 1992), TFIIE (Cortes et al., 1992; Flores et al.,
1992) and TFIIJ (Cortes et al., 1992), appears to extend its interactions downstream to
form the complete, but inactive, preinitiation complex (Van Dyke et al., 1988;
Buratowski et al., 1989; Flores et al., 1991).
Step 4. In an ATP (dATP)-dependent step this preinitiation complex is converted to an
activated complex, capable of initiating transcription rapidly when provided with the
remaining ribonucleoside triphosphates. ATP has been proposed to serve two functions
in this step. It is proposed to promote conversion of the complete preinitiation complex
from a 'closed' to an 'open' conformation by providing the energy to drive unwinding
of a short stretch of promoter DNA surrounding the transcriptional start site (Wang et
al., 1992). ATP is also proposed to act as a substrate for protein kinases that
phosphorylate the CTD of the largest subunit of RNA polymerase II (Section 1.2.2.1.).
Thus, it appears that the initiation of transcription by RNA polymerase II
requires the action of a number of initiation factors. These are thought to act in concert
to promote selective binding of RNA polymerase II to the core promoter and
subsequently to promote conversion of the site-selected complex to the complete
complex. Exactly how assembly of the complete preinitiation complex is promoted by
the initiation factors is not fully understood, but it is thought to be a complex process
involving multiple steps and factors. Evidence suggests that at least some of the
initiation factors, individually or in combination, are capable of interacting with RNA
polymerase II in the absence of DNA (Flores et al., 1989; Buratowski et al., 1991),
therefore it is possible that RNA polymerase II assembles with all or a subset of its
initiation factors prior to entering the initiation complex.
I.2.2.4. Initiator elements.
Initiator (Inr) elements are found in the vicinity of the transcription initiation site
of several eukaryotic genes, both containing TATA boxes, such as the histone H2A
promoter (Grosschedl and Birnstiel, 1980), the Ad-ML promoter (Smale et al., 1990;
Roy et al., 1991), the adeno-associated virus type 2 promoter (Seto et al., 1991) and
the HIV-1 promoter (Du et al., 1993) and also in genes lacking well-defined TATA
boxes, such as the lymphocyte-specific terminal deoxynucleotidyltransferase (TdT)
promoter (Corden et al., 1980) and the SV40 late promoter (Ayer and Dynan, 1988).
Some promoters contain multiple Inr elements, such as the HIV-1 and Ad-ML
promoters (Du et al., 1993) which contain two such elements located 3' of the
transcriptional initiation site, both contributing to promoter strength in vitro and in vivo.
The Inr sequence has been found to be both necessary and sufficient to direct
basal transcription from several promoters, including the TATA-less TdT promoter
(Smale and Baltimore, 1989) and the TATA-box containing Ad-ML (Roy et al., 1991;
Du et al., 1993) and adeno-associated virus type 2 promoters (Seto et al., 1991).
Multiple types of Inr elements are thought to exist as not all elements are
homologous in sequence (Ayer and Dynan, 1988; Smale and Baltimore, 1989) and
electrophoretic mobility shift assays, using different Inr elements as oligonucleotide
probes, have shown that different complexes are formed which display distinct
mobilities and antigenic cross-reactivity (Seto et al., 1991). A weak consensus
sequence for Inr elements has however been defined (Corden et al., 1980), as shown
below:
5'-PyPyCAPyPyPyPyPy-3'
Several factors have been shown to exist which specifically recognise Inr
elements from a range of different promoters. These include upstream stimulatory
factor (USF) and TFII-I (Roy et al., 1991; Du et al., 1993) which recognise the AdML,
HIV-1 and TdT Inr elements, a factor termed YY1 initially identified as binding to the
adeno-associated virus type 2 Inr element (termed P5+1) (Seto et al., 1991; Shi et al.,
1991) and the Inr-binding protein of SV40, termed IBP-s (Wiley et al., 1993). A recent
study investigated the properties of multiple types of Inr elements and demonstrated that
they all appear to be recognised by the same universal binding protein (Javahery et al.,
1994). It was proposed from this study that the different proteins reported to bind Inrs
such as USF, TFII-I and YY1 may augment promoter strength and act in conjunction
with a universal protein (Javahery et al., 1994).
Different Inr elements have been shown to both activate or repress transcription
from different promoters. For example, IBP-s has been shown to act as a cellular
repressor of transcription (Wiley et al., 1993) and it has been shown that certain other
identified Inr elements, such as those from the HIV-1 (Kato et al., 1991) and adeno-
associated virus type 2 promoters (Seto et al., 1991; Shi et al., 1991), can act to both
activate or repress transcription depending on their context within the promoter. It was
proposed from these findings that the factors which bind to Inr elements may interact in
different ways with TFIID, RNA polymerase II and other components of the general
transcriptional machinery depending on the exact location of each element. Factors
which bind around the transcriptional start site are postulated to interact with the general
transcription factors to enhance transcription and factors which bind to TATA box
elements are postulated to block the binding of TFIID, thereby repressing transcription
(Kato et al., 1991).
1.2.3. Upstream regulatory sequences.
Upstream activating sequences (UASs) and enhancer elements act to regulate
the frequency of transcriptional initiation by RNA polymerase II at the minimal
promoter.
UASs are typically short (8-12 bp) gene-specific motifs which act as binding
sites for transcriptional activators (upstream element binding proteins) (reviewed by
Guarente, 1987; Johnson and McKnight, 1989; Struhl, 1989). Such motifs include
CCAAT box elements (Christy et al., 1989; Friedman et al., 1989; Crossley and
Brownlee, 1990) and Spl binding sites (Jones and Tjian, 1985). UASs can act to
stimulate transcription either constitutively or in response to specific stimuli such as
serum stimulation (Triesman, 1985), heat shock (Bienz and Pelman, 1986) or steroids
(Renkawitz et al., 1984). They can operate in either orientation, but show a decrease in
activity with increasing distance from the TATA box (McKnight and Kingsbury,
1982).
Enhancers are defined by their ability to act over considerable distances, both
upstream and downstream of the transcriptional start site, and by their independence of
orientation in relation to the gene. They can be longer than UASs, sometimes
comprising hundreds of bases (Edlund et al., 1985), and can contain binding sites for
many different transcription factors (Serfling et al., 1985).
1.2.3.1. Transcriptional activators.
One of the largest and most diverse classes of DNA-binding proteins are the
transcription factors dedicated to binding specific DNA sites (or sets of sites) and to
regulating the transcriptional machinery.
Such transcription factors are modular in nature being comprised of specific
domains. They posses a domain which allows them to recognise and interact with
specific DNA sequences, a separate and independent region required for the regulation
of transcription initiation and, in some cases, a domain that favours protein-protein
interactions (Ptashne, 1988). Consensus sequences can be deduced for sets of
transcription factors which bind to similar DNA sequence elements.
1.2.3.1.1. DNA-binding domains.
The structural characteristics have been reported for more than ten types of
protein-DNA complexes and for more than twenty types of DNA-binding proteins.
From structural studies and sequence comparisons, it has emerged that many DNA-
binding proteins can be grouped into classes that use related structural motifs for the
specific recognition of DNA sequences.
This section will give an overview of the major families of DNA-binding
proteins characterised to date which include the helix-turn-helix proteins, the winged-
helix proteins, the homeodomains and POU domains, zinc finger proteins, leucine
zipper proteins, the helix-loop-helix proteins, helix-span-helix proteins and HMG-
domain proteins.
1.2.3.1.1.a Helix-turn-helix.
The helix-tum-helix (HTH) was the first DNA-recognition motif discovered and
was initially characterised for the X Cro protein (Anderson et al., 1981; Ohlendorf et
al., 1982), the E. coli CAP protein (McKay and Steitz, 1981) and the DNA-binding
domain of X repressor (Pabo and Lewis, 1982).
From a comparison of the sequence of these three proteins, a conserved
recognition domain, termed the HTH motif, was described consisting of an a-helix, a
turn, and a second a-helix, often called the recognition helix, with the helices crossing
each other at an angle approaching 120° (Steitz et al., 1982; Ohlendorf et al., 1983).
Subsequent sequence comparisons have demonstrated that this motif is present
in a large family of prokaryotic DNA-binding proteins (Matthews et al, 1982; Sauer et
al., 1982; Weber et al., 1982). From such comparisons it appears that the most highly
conserved residues include a glycine in the turn and several hydrophobic residues.
These residues are believed to stabilise the arrangement of the two helices in the HTH
motif and to help the motif pack against the rest of the protein. Sequence comparisons
have also shown that the HTH motif always occurs as part of a larger DNA-binding
domain with regions outside the HTH DNA-binding motif, such as an extended NH2-
terminal arm of the X repressor, often being important for DNA sequence recognition
(Jordan and Pabo, 1988, Clarke et al., 1991).
The mechanism by which prokaryotic HTH proteins specifically recognise their
DNA target sites, termed operators, has been investigated by resolving the structures of
several repressor-operator complexes, including the X repressor (Jordan and Pabo,
1988), X Cro (Brennan et al., 1990) and E. coli CAP (Schulz et al., 1991) complexes.
From such cocrystal structures it has been shown that HTH proteins appear to bind
DNA as dimers with the conserved HTH motif of each monomer contacting the DNA in
each half of the operator site.
In addition to possessing DNA-binding domains, HTH proteins often contain
domains involved in regulating activity. For example, the NH2-terminal domain of
CAP allows dimer formation and also binds cAMP, which acts to allosterically alter
DNA binding (McKay and Steitz, 1981). Additionally, the COOH-terminal domains of
X434 and LexA repressors allow stable dimer formation and are involved in the process
of induction (Sauer et al., 1990).
Variations on the canonical structure of the prokaryotic HTH motif have been
discovered. For example, HTH motifs are also found in the eukaryotic homeodomain
proteins (Section c) engrailed (Kissinger et al., 1990), Antennapedia (Otting et al.,
1990) and MATa2 (Wolberger et al., 1991), in the non-classical homeodomain
hepatocyte transcription factor LFB/HNF1 (Ceska et al., 1993; Leiting et al, 1993), in
the c-myb proto-oncogene (Ogata et al., 1992), in the POU-specific domain of Oct-1
(Assa-Munt et al., 1993; Dekker et al., 1993) (Section d) and in the hepatocyte nuclear
factor 3 (HNF-3) fkh family (Clark et al., 1993) (Section b). These proteins together
form the class of variant HTH proteins.
1.2.3.1 .l.b. Winged helix.
Monomeric variant HTH proteins, such as hepatocyte nuclear factor 3y (HNF-
3y), have been shown to posses a novel DNA-binding motif termed the winged-helix
motif (Clark et al., 1993). HNF-3y belongs to the HNF-3 fkh family of proteins which
includes HNF-3 a, HNF-3 (3 and the gene products of the Drosophila fkh and sloppy
paired 1 and 2 (slpl and slp2) (Clark et al., 1993). The members of this family share a
highly conserved 110 residue DNA-binding domain which takes up an a/(3 structure
composed of three NH2-terminal helices, a three stranded antiparallel (3 sheet and three
loops connecting the helices and the strands (Clark et al., 1993). The crystal structure
of the DNA-binding domain of HNF-3y complexed to its DNA target site reveals, in
addition to a HTH-like motif, the presence of a novel winged-helix motif which
contacts the distal parts of the target site and is composed of an a-helix flanked on both
sides by a loop.
1.2,3.l.l.c. Homeodomain.
The homeodomain is a DNA-binding motif which is present in a large family of
eukaryotic regulatory proteins. The conserved residues constituting the homeodomain
were first recognised in proteins important for regulating Drosophila development, such
as Antennapedia (.Antp) (Qian et al., 1989; Billeter et al., 1990). It is now known that
the homeodomain has a much broader role in the regulation of eukaryotic gene
regulation as homeodomain containing proteins have been found in virtually all
eukaryotes examined ranging from yeast to man (reviewed by Scott et al., 1989).
The homeodomain forms a stable, folded structure and is able to bind DNA by
itself (Sauer et al., 1988; Qian et al., 1989; Affolter et al., 1990). From the crystal
structures of the Drosophila engrailed and the yeast a2 homeodomain-DNA complexes
(Kissinger et al., 1990; Wolberger et al., 1991) it has been shown that both complexes
have similar structures consisting of an extended NH2-terminal arm and three a-
helices.
Proteins possessing homeodomains which vary in sequence from the typical
homeodomain have been shown to exist. For example, HNF1 a homeodomain-
containing transcription factor, essential for the liver-specific expression of many
hepatic genes, contains a divergent homeodomain possessing extra sequences upstream
of the third helix (Nicosia et al., 1990).
As mentioned in Section a, homeodomain proteins also belong to the class of
HTH variant proteins. Amino-acid sequence comparisons have shown that the second
and third helices of the homeodomain are similar to the HTH motif of prokaryotic
repressors, although the homeodomain helices are longer (Laughon and Scott, 1984,
Shepherd et al., 1984). Additionally, structural studies of the complexes (Kissinger et
al., 1990; Otting et al., 1990; Wolberger et al., 1991) have shown that the
homeodomain uses the HTH motif in a novel way. A comparison of the A. repressor-
operator and engrailed homeodomain-DNA complexes (Kissinger et al., 1990) shows
that the two HTH units dock against DNA in different ways with critical base contacts
being made by different residues from different portions of the motifs.
Although homeodomains, in isolation, have been shown to possess the ability
to fold correctly and to bind DNA with a similar specificity to that of the intact protein
(Sauer et al., 1988; Qian et al., 1989; Affolter et al., 1990), it seems likely that the
precise DNA-binding specificity is modulated by other regions of the protein. Many
homeodomain proteins contain distinct sequence motifs which flank the homeodomain
and are conserved within specific subfamilies (reviewed by Scott et al., 1989). For
example, the POU-domain proteins (Rosenfeld, 1991) possess neighbouring sequences
which play important roles in DNA recognition (Section d). Conserved sequences
contained within other homeodomain proteins may also have important roles in DNA
recognition, thus modulating their specificity and/or affinity for DNA binding.
Protein-protein interactions may also play an important role in modulating the
interactions of homeodomain proteins with DNA. For example, the yeast homeodomain
protein a2, in addition to forming homodimers, can also form heterodimers with the
related homeodomain protein al and with the yeast transcription factor Mcml (Goutte
and Johnson, 1988; Kelleher et al., 1989). Each of the formed complexes has a
different sequence specificity and may interact with DNA in different ways. The
hepatocyte transcription factor HNFI also binds to its target DNA sequence as a
heterodimer formed with the homologous homeodomain protein vHNFl (Nicosia et
al., 1990; Rey-Campos et al., 1991) and the Paired/Pax class of homeodomain proteins
have been shown to bind cooperatively as both homo- and heterodimers to
palindrominc DNA sequences (Wilson et al., 1993). Thus it appears that
heterodimerization between homeoproteins also occurs in higher eukaryotes, potentially
expanding their regulatory spectrum.
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1.2.3.1.1.d. PQU-domain.
The highly conserved POU-domain was initially recognised through analysis of
the primary sequence of three mammalian transcription factors, Pit-1, Oct-1 and Oct-2,
and a Caenorhabditis elegans (C. elegans) developmental regulator, unc 86. cDNAs
encoding the pituitary specific transcription factor Pit-1, the B-cell specific octamer
binding protein Oct-2 and the ubiquitous octamer binding protein Oct-1 were identified
and cloned (Bodner et al., 1988; Clerc et al., 1988; Ingraham et al., 1988; Ko et al.,
1988; Muller-Immergluck et al., 1988; Scheidereit et al., 1988; Sturm et al., 1988).
These three mammalian proteins and unc 86, a regulator of cell fate in C. elegans
encoded by the unc-86 gene (Chalfie et al., 1981; Finney et al., 1988), were found to
share an extensively conserved domain of approximately 150 amino acids, termed the
POU domain (Pit, Oct, Unc) (Herr et al., 1988). Subsequently, numerous additional
POU-domain genes have been identified in mammals, Drosophila and C. elegans where
they have been postulated to serve a number of different functions and show varying
and overlapping tissue distributions (reviewed in Rosenfeld, 1991).
The POU domain contains two major regions of high homology, a POU-
specific (POUs) domain and a POU-homeodomain (POUhd) (Herr et al., 1988). The
POUs domain lies immediately NH2-terminal to the homeodomain and consists of a 65
to 75 amino acid residue segment. It can be further subdivided into two distinct regions
of particularly high homology, the POUs-A region and the POUs-B region. The
solution structure of POUs has been determined by NMR and consists of four a-helices
connected by short loops (Dekker et al., 1993). A linker corresponding to a poorly
conserved region of about 20 amino acids separates the POUs domain from the 60
amino acid-long POUhd- The POUhd is distantly related to the classical homoedomain
encoded by the homeobox. It is predicted to contain three a-helices corresponding to
those in the classical homeodomains, with the third helix often being referred to as the
'recognition' helix (Herr et al., 1988). Mutational analysis has demonstrated that the
three a-helices from the POUhd carry out different functions than the corresponding
regions of the classical homeodomain proteins (Elsholtz et al., 1990; Ingraham et al.,
1990).
On the basis of the primary sequence throughout the POU-domain, including
the linker region, the POU-domain proteins have been classified into five groups
(POU-I to POU-V) (reviewed by Rosenfeld, 1991). The majority of POU-domain
proteins subsequently isolated can be categorised into one of the five classes, however
some of the POU-domain proteins appear to posses divergent POU-domain sequences
and may constitute novel classes. For example, a recently isolated and characterised
zebra fish POU-domain protein, which is ubiquitously expressed during
embryogenesis, has been shown to posses an unusually divergent POU-domain
(Johansen et al., 1993). A novel POU domain protein has also been reported, termed
TCFpi (T-cell Receptor Factor), which binds to a critical DNA motif in the TCR (3
enhancer (Messier et al., 1993). TCF(3i was shown to posses a DNA-binding POU-
domain in its COOH-terminal region which is distantly related to other POU-domains
and so may also constitute a novel class of POU-domain proteins (Messier et al.,
1993).
In contrast to homeodomain proteins, where the homeodomain is necessary and
sufficient for DNA-binding, the POU-domain is a bipartite DNA-binding motif with
both the POUhd and the POUs domain making contacts with DNA (Rosenfeld, 1991;
Verrijzer et al., 1992). It has been shown that the POUhd and the POUs domain are
both capable, alone, of binding DNA but that both domains are required to achieve high
specificity and affinity of binding (Sturm and Herr, 1988; Ingraham et al., 1990;
Verrijzer et al., 1990, 1992). DNA binding studies and in vitro binding site selection
studies have shown that each of the POU subdomains has a different binding specificity
(Verrijzer et al., 1992). The left hand of the optimal binding site is recognised by the
POUs domain and the right half by the POUhd (Verrijzer et al., 1992).
By the construction of chimeric proteins containing the POUhd and POUs
domains of both Oct-1 and Pit-1, it has been demonstrated that both domains are
involved in mediating the specificity of DNA binding (Ingraham et al., 1990).
Additionally, clusters of basic amino acids located at the NH2- and COOH-terminal
boundaries of the POUhd and at the NH2-terminus of the POUs domain have also been
shown to be important for high affinity binding (Sturm and Herr, 1988; Ingraham et
al., 1990; Treacy et al., 1991).
Although Pit-1, Oct-1 and Oct-2 have been shown to behave as monomers in
solution (LeBowitz et al., 1989; Poellinger and Roeder, 1989; Ingraham et al., 1990)
and to bind to their DNA target sites as monomers, it appears that POU-domain protein-
protein interactions do occur and are critical for function. Homodimerisation has been
reported for Pit-1 and for Oct-2 (LeBowitz et al., 1989; Poellinger et al., 1989;
Ingraham et al., 1990), with Oct-2 co-operative interactions believed to increase
transcriptional activity (Poellinger et al., 1989). Heterodimer formation between
different POU-domain proteins has also been reported (He et al., 1989; Voss et al.,
1991). Such interactions are thought to be mediated through the POUs domain and have
been shown to either enhance or inhibit the action of positive POU-domain regulators.
For example, the inhibitory POU-domain protein I-POU has been shown to specifically
interact with the POU-domain protein cfla, inhibiting its ability to bind and activate a
specific neural promoter (Treacy et al., 1991).
Interactions between POU-domain proteins and other classes of proteins have
also been reported. For example, specific residues in helix 2 of the POUhd of Oct-1
have been shown to be involved in mediating its ability to bind the herpes simplex virus
(HSV) trans-activator VP 16 (O'Hare and Goding, 1988). Additionally, the POU-
domain protein Unc-86 and the homeodomain protein Mec-3 have been shown to bind
to the mec-3 promoter as a heterodimeric protein complex (Xue et ai, 1993). These
heterodimeric interactions appear to result in positive regulation of activity but other
interactions result in negative regulation. For example, protein-protein interactions
between Oct-1 and the glucocorticoid receptor have been shown to result in a hormone-
dependent repression of Oct-1 binding (Kutoh et al., 1992). This interaction was
shown to be mediated by a strong association between Oct-1 and the receptor, possibly
through the POUhd (Kutoh et al., 1992).
Thus, in an analogous situation to many other known transcription factor
families, the POU-domain may serve as both a DNA-binding domain and as a mediator
of protein-protein interactions resulting in both positive and negative regulation of
activity.
1.2.3.1.I.e. Zinc Finger.
Zinc fingers were first discovered in the Xenopus transcription factor TFIIIA
(Brown et al., 1985; Miller et al., 1985) and homologous structures were subsequently
discovered in a number of eukaryotic proteins, including Spl (Kadonaga et al., 1987),
and the early growth response genes, Egr-1 and Egr-2 (also referred to as NGFIA and
NGFIB) (Chavier et al., 1988; Christy et al., 1988; Sukhatme et al., 1988), where they
play an important role in mediating protein-DNA interactions (Berg, 1986; Klug and
Rhodes, 1987).
The TFIIIA-like zinc finger motif is usually present in tandem repeats and is
characterised by the following sequence pattern, derived from the alignment of zinc
finger sequences from a number of proteins:
Cys-X2 or 4-Cys-Xi2-His-X3_5-His
The structure of zinc fingers has been determined (Berg, 1988; Parraga et al.,
1988; Lee et al., 1989 ) and studies have shown that zinc fingers contain an antiparallel
(3-sheet and an a-helix. Two cysteine residues near a turn in the (3-sheet region and two
histidines in the a-helix co-ordinate a central zinc ion and hold the structure together to
form a compact globular domain.
From the crystal structure of three zinc fingers from the mouse immediate early
protein zif 268 (Christy et al., 1988) complexed to DNA, it has been shown that the
zinc fingers bind in the major groove of DNA and wrap part way around the double
helix (Pavletich and Pabo, 1991). Each finger docks against the DNA in a similar
manner, is related to the next by a simple helical motion and makes base contacts with a
three base pair subsite (Nardelli et al., 1991; Pavletich and Pabo, 1991).
The transcription factor Spl possesses three zinc fingers which are closely
related to those of zif 268 (Kadonaga et al., 1987) and are therefore thought to bind
DNA in the same way. However, other zinc finger containing proteins, such as the
human GL1 oncogene, have been shown to contact DNA in a slightly different manner
with some fingers having no contacts with the DNA (Pavletich and Pabo, 1993).
Therefore, it is likely, as is found for HTH motifs, that zinc fingers can dock against
DNA in a number of different ways. Subtle variants are found among TFIIIA-like zinc
fingers, such as the distinctive sequence patterns found in the alternating fingers of the
protein ZFY (Mardon and Page, 1989), which may reflect differences in the structure
or docking arrangements of the fingers (Kochoyan et al., 1991).
1.2.3.1.1.f. Steroid hormone receptors.
Steroid hormone receptors belong to a large superfamily of nuclear receptors
which includes the receptors for the steroid hormones, retinoids, vitamin D, thyroid
hormones and several orphan receptors for which no physiological ligand is yet known
(Beato, 1989). The steroid hormone receptors contain separate domains for hormone
binding, DNA binding and for transcriptional activation (Beato, 1989). The DNA
recognition sites of these nuclear receptors contain two copies of six base pair
sequences, termed half sites, which are orientated as inverted repeats (Kumar and
Chambon, 1988; Tsai et al., 1989). The DNA-binding domain comprises
approximately 70 amino acid residues and contains eight conserved cysteine residues
which can be organised into two zinc fingers. These zinc fingers are very different in
several aspects from those of TFIIIA. The zinc fingers of TFIIIA use a pair of cysteines
and a pair of histidines to co-ordinate a zinc ion where as each zinc finger of steroid
hormone receptors contains four cysteine residues tetrahedrally co-ordinating a zinc ion
(Freedman et al., 1988). Steroid hormone receptor zinc fingers also differ structurally
from TFIIIA zinc fingers. NMR studies have shown that the DNA-binding domains
from the glucocorticoid and estrogen receptors fold into a single globular domain
consisting of a pair of a-helices positioned roughly perpendicular to each other with
each binding a zinc ion (Frankel and Pabo, 1988; Hard et al., 1990; Schwabe et al.,
1990).
From the crystal structure of the glucocorticoid receptor it has been shown that
the peptide binds DNA as a dimer, with the zinc finger domains making base specific
contacts with the half sites (Hard et al., 1990; Luisi et al., 1991). The first helix of each
subunit fits into the major groove with side chains contacting the edge of base pairs.
The second helix of each subunit appears to provide the dimerisation interface and also
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contacts the DNA backbone. Therefore, the zinc fingers from steroid receptors in
addition to playing a role in DNA binding are important mediators of dimerisation.
1.2.3.1.1.g. Leucine zipper.
The leucine zipper was first discovered as a conserved sequence motif in several
eukaryotic transcription factors (Landschultz et al., 1988). It is now known to be
present in a wide range of proteins including the yeast transcription factor GCN4 (Hope
and Struhl, 1986; Oliphant et al., 1989), the mammalian CCAAT/enhancer-binding
proteins (C/EBP) (Landschulz et al., 1989; Cao et al., 1991; Williams et al., 1991),
members of the CREB/ATF (cyclic AMP element binding protein/activating
transcription factor) family (reviewed in Habener, 1990), the proto-oncogene products
Fos and Jun (reviewed by Morgan and Curran, 1991) and the erythroid-specific factor
NF-E2 (Andrews et al., 1993).
Leucine zipper (bZIP) proteins contain a DNA-binding motif of about 60 to 80
amino acids which can be subdivided into two distinct subdomains, a leucine zipper
region which mediates dimerisation and a basic region which contacts the DNA (Hope
and Struhl, 1986; Landschultz et al., 1988).
The leucine zipper domain spans approximately 30 to 40 residues and is
characterised by a heptad repeat of leucines, with a conserved repeat of hydrophobic
residues often found to the NH2-terminal side of the repeat (Landschultz et al., 1988).
The dimerisation regions have been shown by NMR and X-ray crystallography studies
to form two parallel a-helices which form a coiled-coiled structure (O'Shea et al.,
1989; 1991, Saudek etal., 1991).
The basic region contains about 30 amino acids and is rich in arginines, lysines
and other residues conserved throughout the family (reviewed by Kerppola and Curran,
1991). Domain swap experiments have shown that this region is primarily responsible
for the DNA sequence specificity of bZIP proteins (Agre et al., 1989; Suckow et al.,
1993) and it has been proposed to form an a-helix in the dimer complex when bound to
DNA (O'Neil et al., 1990; Patel et al., 1990; Talanian et al., 1990; Weiss et al., 1990).
Two closely related models have been proposed for the structure of bZIP
dimers. In these models the dimer is shaped like Y in which the stem represents the
leucine zipper dimerisation regions and the arms represent the basic regions of each
monomer (Vinson et al., 1989; O'Neil et al., 1990). In the 'scissors grip' model the a-
helix from the basic region is kinked so that it can follow the curve of the major groove
(Vinson et al., 1989) and in the 'induced helical fork' model the a-helix is straight and
so extends away from the DNA after contacting three or four base pairs (O'Neil et al.,
1990).
The existence of the leucine zipper region in bZIP proteins potentially allows for
a large degree of biological control through the formation of both homodimers and
heterodimers. Dimeric complexes are known to form between Fos and Jun family
members (Bohmann et al., 1987), between members of the CREB/ATF family (Hai et
al., 1989) and between members of the C/EBP family (Roman et al., 1990; Cao et al.,
1991; Williams et al., 1991; Hsu et al., 1994). An additional degree of diversity comes
from the findings that proteins from the different families can also heterodimerise
through their leucine zipper domains. Members from the CREB/ATF family can
heterodimerise with Fos or Jun family members (Hai and Curran, 1991) and with
proteins from the C/EBP family (Vallejo et al., 1993). These resulting heterodimers are
each thought to each posses different DNA-binding specificities and affinities and thus
are expected to be targeted to different DNA sites. Heterodimer formation can also act
to limit activity, as illustrated in the case of CREB whose activity is antagonised by the
formation of heterodimers with CREM (Foulkes et al., 1991), and C/EBP(3 (or LAP)
whose activity is limited by the formation of heterodimers with CHOP-10, a protein
which contains a leucine zipper domain but lacks a basic region and therefore does not
bind DNA (Ron and Habener, 1992). The formation of homo- and heterodimers
between bZIP proteins may also be controlled by other proteins such as Tax, which
transcriptionally activates the human T cell leukemia virus type-1 (HTLV-1) promoter
and has been shown to act by promoting the dimerisation of bZIP proteins and so
enhancing their DNA binding (Wagner and Green, 1993).
1.2.3.1.1 .h. Helix-loop-helix.
Helix-loop-helix (bHLH) proteins were initially identified based on the fact that
they posses a DNA-binding motif similar to that of bZIP proteins (Murre et al., 1989a).
Like the bZIP family, bHLH proteins contain an NH2-terminal basic region that
contacts the DNA and a neighbouring region that mediates dimer formation. However,
sequence analysis has demonstrated that the dimerisation region of bHLH proteins,
unlike the leucine-zipper region, forms an a-helix, a loop and a second a-helix, thus
classing them as helix-loop-helix proteins (Murre et al., 1989a). The helix-loop-helix
region is thought to promote dimerisation through its putative amphipathic helices in an
analogous fashion to the leucine zipper region of bZIP proteins (Davis et al., 1990;
Voronova and Baltimore, 1990).
The bHLH family of proteins includes, among others, the muscle-determining
factor MyoD and the immunoglobulin K-chain enhancer binding proteins such as E47,
E12 and E2A (Murre et al., 1989a). Like the bZIP proteins, the activity of bHLH
proteins is modulated by homodimer and heterodimer formation. For example, MyoD
binds DNA most tightly to its E-box DNA target site when it forms a heterodimer with
the E2A protein (Weintraub et al., 1991). Other oligomerization combinations can
completely disable bHLH activity. When MyoD, E12 or E47 associate with the Id
group proteins, which contain a HLH region but lack a basic region, their DNA-
binding and biological activities are eliminated (Benezra et al., 1990; Christy et al.,
1991; Sun etal., 1991).
A family of related proteins containing two different adjacent dimerization
regions, a leucine zipper and a HLH region, termed basic-region helix-loop-helix
leucine zipper (bHLH-Zip) proteins, also exists. Members of this family include the
oncogene products Myc and Max (Murre et al., 1989a) and the transcription factors
AP4 (Hu et al., 1990), USF (Gregor et al., 1990), TFE3 (Beckman et al., 1990) and
TFEB (Carr and Sharp, 1990). Several models have been proposed for the structure of
the bHLH-Zip motif (Anthony-Cahill etal., 1992; Halazonetis and Kandil, 1992;
Vinson and Garcia, 1992; Ferre-D'Amare et al., 1993). The favoured model predicts
that, in an analogous situation to bZIP proteins, the leucine zipper region forms a-
helices and together with the HLH domain interacts with its partner polypeptide in the
dimer with specific amino acids within the basic region mediating DNA binding
(Feldmann et al., 1993).
As for the bHLH proteins, the bHLH-Zip proteins can form a variety of homo-
and hetero-oligomers, resulting in multiprotein complexes with diverse DNA-binding
properties and biological effects. For example, Myc heterodimerises with Max to form
a protein complex which will bind DNA and activate transcription (Blackwood and
Eisenman, 1991; Pendergast et al., 1991; Amati et al., 1992; Kato et al., 1992;
Kretzner et al., 1992), yet Myc does not dimerise with itself readily nor does it bind
DNA alone (Pendergast et al., 1991, Kato et al., 1992, Littlewood et al., 1992). Again,
in an analogous situation to bHLH proteins, other oligomerization combinations can
completely disable bHLH-Zip activity. For example, Max homodimers or
heterodimers, formed by the interaction of Max with the Max interactor proteins Mad
and Mxi (Ayer et al., 1993; Zervos et al., 1993), will bind Myc-Max DNA target sites
with high affinity, yet Mad-Max and Max-Mxi heterodimeric complexes are not thought
to activate transcription and Max-Max homodimers are thought to either repress or only
weakly activate transcription (Amati et al., 1992; Kato et al., 1992; Kretzner et al.,
1992; Ayer et al., 1993; Fisher et al., 1993; Zervos et al., 1993).
Finally, an interesting interaction has recently been reported between a member
of the bHLH family, MyoD, and the bZIP protein, Jun (Bengal et al., 1992; Li et al.,
1992). It appears that Jun can inhibit the transactivation potential of MyoD and that this
may occur through a physical interaction between the leucine-zipper region of Jun with
the helix-loop-helix region of MyoD.
1.2.3.1.1.i. Helix-span-helix.
Proteins possessing helix-span-helix (HSH) motifs include the mammalian
transcription factor AP-2 (Williams and Tjian, 1991). The HSH motif, sufficient for
DNA binding and essential for dimerisation, has been localised to a region of 200
amino acids located towards the COOH-terminal region of the protein (Williams and
Tjian, 1991). The NH2-terminal region of the HSH motif is rich in basic residues and
is predicted to bind DNA with the COOH-terminal end, potentially a-helical in nature,
corresponding to the dimerisation domain. Although the overall organisation of a basic
region and an adjacent dimerisation domain is similar to that of bZIP and bHLH
proteins, AP-2 does not contain a leucine repeat and its dimerisation domain shares no
homologies with, and is twice the length of, the corresponding domains from bZIP and
bHLH proteins (Williams and Tjian, 1991).
1.2.3.1.1.j. HMG domains.
The HMG domain consists of two homologous repeats of an 80-amino-acid
sequence and was first described as being present in the high mobility group proteins
(HMG) (Goodwin et al., 1973; Walker et al., 1980).
This motif has subsequently been discovered, in one or more copies, in many
DNA-binding proteins including the regulator of ribosomal RNA gene transcription,
hUBF (Upstream Binding Factor) (Jantzen et al., 1990) and in the transcription factor
LEF-1 (lymphoid enhancer factor) (Travis et al., 1991).
From the comparison of the DNA binding sites of HMG-domain proteins it
appears that the structure of the DNA may be equally or more important than the actual
sequence of the target site for determining the specificity of binding. HMG1 appears to
bind to a DNA structure termed a four way junction which is formed by the looping of
double stranded DNA to generate an X shape (Bianchi et al., 1989). The structural
specificity of binding was found to reside in the HMG domain and interestingly binding
was found to be independent of DNA sequence (Bianchi et al., 1992).
It has been suggested that HMG-domain proteins may participate in site-specific
recombination reactions by bending or supercoiling DNA and so forming and sealing
loops in the DNA. This has been shown to be the case for the HMG-domain protein
LEF-1 which is involved in site-specific recombination reactions and bends DNA by
approximately 130° (Geise etal., 1992).
Such alterations in the structure of DNA have been shown to be required for
achieving the correct conformation of DNA for transcription. DNA looping is a
favoured model by which enhancer binding proteins interact with promoter bound
proteins (Ptashne, 1986, 1988), suggesting that HMG-domain proteins may play an
important role in the regulation of gene expression.
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1.2.3.1.2. Activation domains.
In addition to multiple types of DNA-binding domains, proteins which regulate
transcription can also possess several types of activation domains.
A majority class possesses a highly acidic activation domain (AAD), enriched in
glutamate and aspartate residues, and other proteins possessdomains which are rich in
glutamine or proline residues.
Additionally, some transcription factors contain domains composed of
combinations of the different domains. For example, the transcriptional activation
domain of c-Jun encompasses a proline-rich sequence interspersed with a negatively
charged domain (Struhl, 1987) and Oct-2 possesses a domain rich in both proline and
glutamine residues (Clerc et al., 1988; Muller-Immergluck et al., 1988; Scheidereit et
al., 1988; Staudteta/., 1988).
1.2.3.1.2.1. Acidic transcriptional activators.
The acidic activators are the most characterised activation domains and appear
unique in that they can apparently function universally in all eukaryotes tested from
yeast to man.
Acidic activators, including the yeast proteins GCN4 and GAL4 and the HSV
virion protein VP 16, have commonly been assumed to posses two features critical for
function, an acidic region and a structure which is either a-helical or unstructured in
nature.
The importance of acidic regions for mediating transcriptional activation in the
yeast proteins GCN4 and GAL4 was demonstrated in a series of early experiments.
Such experiments included deletion analysis of the activation region of GCN4 which
demonstrated that the transcriptional activity of the protein is generally correlated with
the number of negative charges (Hope et al., 1988). Other experiments demonstrated
that the activation of transcription by chimeric proteins formed by the fusion of the
GAL4 DNA-binding domain to random E. coli DNA sequences required no apparent
sequence specificity except for a net negative charge (Ma and Ptashne, 1987a).
Acidic transcriptional activators have been proposed to adopt either an
amphipathic a-helical structure or to exist as unstructured 'acid blobs' (Giniger and
Ptashne, 1987; Ma and Ptashne, 1987a; Ptashne, 1988; Sigler et al., 1988).
The possible involvement of an a-helix for mediating the interaction between
AADs and their target factor(s) was demonstrated in a series of genetic studies. When
the DNA-binding domain of GCN4 was fused to a DNA sequence predicted to fold into
an amphipathic a-helix with a negatively charged face, a high level of activated
transcription was detected (Giniger and Ptashne, 1987). The importance of the acidic
residues residing on one face of the putative a-helix was suggested from the finding
that the GAL4 DNA-binding domain, when fused to a sequence in which the acidic
residues would no longer be on one face, was no longer able to activate transcription
(Giniger and Ptashne, 1987).
Sigler (1988) proposed an alternative structure for AADs in which they exist as
unstructured 'acid blobs' which interact with their target factor(s) through purely ionic
interactions. The findings that progressive deletions of the GCN4 AAD resulted in a
step-wise rather than a dramatic loss of transcriptional activation (Hope et al., 1988)
and that random segments of DNA encoded activator functions (Ma and Ptashne,
1987a) prompted this hypothesis. The notion of an unstructured activation domain was
further supported by studies showing that VP 16 is largely devoid of a secondary
structure in solution (Donaldson and Capone, 1992; O'Hare and Williams, 1992).
Recently, these accepted models concerning the structure and function of acidic
transcriptional activators have been questioned. Firstly, there is no direct evidence that
the activation domains are indeed a-helical and, if so, if this structure is important for
transcription and secondly, point mutations in non-acidic residues of VP 16 and GAL4
can result in significantly reduced activation potentials (Cress and Triezenberg, 1991;
Leuther et al., 1993). Additionally, several studies have demonstrated that there is no
strict correlation between negative charge and activation potential (Ma and Ptashne,
1987b; Hope et al., 1988; Leuther et al., 1993). An alternative model predicts that the
acidic amino acids in such activators are not, as commonly thought, required for
function and that this region is not unstructured or a-helical, but that it may adopt a 13-
sheet structure (Leuther et al., 1993; Van Hoy et al., 1993).
Leuther et al. (1993) studied the COOH-terminus of the GAL4 protein which is
bifunctional, containing both an AAD and a region that binds the negative regulator
GAL80. Mutational analysis allowed the selection of mutants in which one function
was maintained while the other one was altered (Leuther et al., 1993). From such
analysis it was revealed that all of the acidic residues in the COOH-terminus are
dispensable for activation and that mutants with no charge, or indeed an overall positive
charge, are capable of activating transcription at near wild-type levels. It was
concluded, from this finding, that it is not the charge of amino acids that is important
for activation but rather the hydrophobicity of the amino acids which interact with the
target factor(s). Results from such genetic studies also led to the suggestion that the
COOH-terminal region of GAL4 forms an antiparallel (3-sheet structure as deletion of a
region predicted to form part of the (3-sheet was found to almost completely abolish
activation by GAL4 (Leuther et al., 1993). It was concluded from these studies that the
face of the (3-sheet containing most of the hydrophobic residues interacts with the target
factor(s) while the other side may form the binding surface for the GAL80 protein.
In a separate study, Van Hoy et al. (1993) carried out a biophysical analysis of
peptides corresponding to the activation domains of GAL4 and GCN4. The results
from this study also demonstrated that the peptides are not a-helical in structure, but
that in slightly acidic solutions they adopt an extensive (3-sheet structure.
It is not yet clear what role, if any, the (3-sheet structure of such proteins plays
in mediating transcriptional activation. More detailed genetical and physical studies will
be necessary in order to further understand the structure and function of such activation
domains.
1.2.3.1.2.2. Glutamine-rich transcriptional activators.
Spl is a widely characterised sequence-specific DNA-binding protein which
possesses an activation domain rich in glutamine residues (Courey and Tjian, 1988;
Kadonaga et al., 1988). Other transcriptional activators containing glutamine-rich
domains include the product of the Drosophila zeste gene (Biggin et al., 1988) and the
products of a number of homeo-box containing genes such as Antp (Schneuwly et al.,
1986).
Courey and Tjian (1988) used cells derived from Drosophila embryos in order
to carry out a functional analysis of human Spl. From the analysis of a variety of
deletion mutants of Spl four distinct regions outside the DNA-binding domain were
identified which are capable of modulating transcriptional activity. Two of the identified
domains, shown to be functionally redundant of one another, correspond to glutamine-
rich segments in the NH2-terminal portion of the protein. Unlike acidic activation
domains, no relationship was found between charge and activity but some kind of
higher order structure, in addition to glutamine richness, was thought to be required for
high levels of Spl activity (Courey and Tjian, 1988). In addition to the glutamine rich
domains a highly charged segment, also distinct from acidic activation domains, was
shown to be important for Spl transcriptional activity, although it was a great deal less
active than the glutamine rich domains and a domain located at the extreme COOH-
terminal of Sp 1 was also found to be important for influencing transcriptional activity,
in the context of the intact protein (Courey and Tjian, 1988).
1.2.3.1.2.3. Proline-rich transcriptional activators.
Transcription factors which posses activation domains rich in proline residues
include members of the C/EBP family (Mermod et al., 1989), proteins involved in the
developmental control of gene expression in Drosophila, such as thefushi tarazu (ftz)
and Kruppel gene products (Laughon and Scott, 1984; Rosenberg et al., 1986), steroid
hormone receptors (Gronemeyer et al., 1987; Kumar et al., 1987) and the transcription
factor AP-2 (Williams et al., 1988).
Proteins belonging to the C/EBP family have the unusual property of regulating
both transcriptional initiation and DNA replication (Jones et al., 1987). The biochemical
properties of mutant C/EBP polypeptides have been investigated and this has allowed
the identification of a transcriptional activation domain located in the COOH-terminal
region of such proteins which is rich in proline residues (Mermod et al., 1989).
Although all known members of the C/EBP family contain similar proline-rich
domains, the overall sequence varies between different members (Gill et al., 1988;
Paonessa et al., 1988; Santoro et al., 1988). This proline-rich segment has been shown
to be distinct and separate from the DNA-binding and replication domains and has also
been shown to be distinct from either acidic or glutamine-rich activation domains.
1.2.3.2 Mechanisms of action of transcriptional activators.
A major question which has yet to be unequivocally resolved is how
transcriptional activators communicate with an often distant RNA polymerase II to
provoke transcriptional initiation. A favoured model proposes that, by looping out the
intervening DNA, activators contact a factor in the transcriptional basic machinery at the
minimal promoter (Ptashne, 1986, 1988). In support of such a model, evidence has
been presented suggesting that transcriptional activators can bind to either the TATA-
binding protein TBP, its associated complex TFIID (Section 1.2.2.2.a.) and/or the
general transcription factor TFIIB (Section I.2.2.2.C.).
Analyses with affinity chromatography have pointed to TBP as a potential target
for VP16 and for Tat, a potent transactivator of HIV transcripton (Stringer et al., 1990;
Kashanchi et al., 1994). Additionally, mutational analysis has shown that VP 16
molecules which have mutations introduced into their activation regions are defective in
binding to TBP, suggesting that VP 16 TBP protein-protein interactions are important
for mediating transcriptional activation (Ingles et al., 1991).
Other lines of evidence point to both TBP and TAFs, associated with TBP in
the TFIID complex, having a role to play as potential targets. This idea came from the
findings that TBP itself can mediate only basal levels of transcription (Hoffmann et al.,
1990; Peterson et al., 1990) and that the TAFs are required for mediating activated
levels (Sawadogo and Roeder, 1985b; Horikoshi et al., 1988; Nakajima et al., 1988;
Dynlacht et al., 1991; Tanese et ai, 1991). For example, it has been shown that the
AAD of VP16 requires the presence of other components, in addition to TBP, present
in crude TFIID fractions to activate in vitro transcription in HeLa cell extracts (White et
al., 1991, 1992). It has also been demonstrated that stimulation of in vitro transcription
in HeLa cells by a variety of chimeric activators, containing distinct activation domains,
requires the presence of both TBP and unique TAFs (Brou et al. 1993). Additionally, it
has been shown that the activation domain of the adenovirus large El A protein
specifically binds to Holo-TFIID (Boyer and Berk, 1993). It is thought that TAFs
associate with the conserved COOH-terminal domain of TBP to mediate transcriptional
activation as Holo-TFIID assembled with an NH2-terminal deleted form of TBP fully
supports transcriptional activation (Zhou et al., 1993).
TFIIB is also thought to be a target for transcriptional activators (Lin and
Green, 1991). As for TBP, it has been shown that the AAD of VP 16 can selectively
interact with TFIIB and it also been shown that, under some conditions, VP 16 must be
present during incorporation of TFIIB into the preinitiation complex to allow for
activated levels of transcription (Lin and Green, 1991). Additionally, VP16 activation
mutants, in an analogous situation to TBP, are deficient in binding to TFIIB (Lin et al.,
1991). Further evidence to support the suggestion that protein-protein interactions
between TFIIB and activators are important for mediating transcriptional activation
comes from the findings of Roberts et al. (1993). Mutagenesis of the putative
amphipathic helix in TFIIB, which is necessary for interaction with VP 16, was shown
to abolish the ability of TFIIB to both bind VP 16 and to respond to transcriptional
activation. However, TFIIB was still able to function in basal transcription, providing
strong evidence that TFIIB plays a role in both basal and activated transcription.
Evidence also exists for interactions occurring between TFIIB and other classes of
activator proteins. Recently, an interaction between Drosophila TFIIB and the
glutamine-rich activation domain of the fushi tarazu (ftz) gene product was
demonstrated in Drosophila cells (Colgan et al., 1993) and a separate study
demonstrated a specific interaction between human thyroid hormone receptor (3 (hTR(3)
and TFIIB (Baniahmad et al., 1993). hTRP, when localised in the nucleus, is a DNA-
binding protein capable of both transcriptional silencing and hormone-dependent
activation of transcription, with the ligand binding domain (LBD) thought to be
required for the silencing function (Baniahmad et al., 1992). It has been shown that the
LBD binds TFIIB and that thyroid hormone, which converts the receptor from a
silencer to an enhancer, decreases the interaction of the LBD with TFIIB. Thus, it has
been suggested that TFIIB, through binding hTRp, may mediate its ability to silence
transcription (Baniahmad et al., 1993). Therefore, it has been shown that TFIIB may
be capable of mediating both activation and silencing of transcription.
A popular model to explain how activators involve TBP, TFIIB and TAFs in
the activation of transcription initiation predicts that they facilitate their binding to the
promoter (Lin and Green, 1991; Choy and Green, 1993). Lin and Green (1991)
demonstrated that acidic activators enhance the stable entry of TFIIB into the
preinitiation complex, thus increasing a rate limiting step in preinitiation complex
assembly. These studies were further extended to shown that TFIIB interacts with both
TFIID and activator proteins and that this interaction increases the binding of TFIIB to
the preinitiation complex (Choy and Green, 1993). This step alone was shown to be
insufficient for transcriptional activation and a second step, occurring after TFIIB entry,
was shown to be affected by transcriptional activators. It is proposed that activators
may also contact a general transcription factor(s) which assembles after TFIIB or that
they may work through TAFs to affect the assembly of other general transcription
factors (Choy and Green, 1993).
Another model predicts that activators interact with the general transcription
factors to somehow convert them from an inactive to an active form (Ouzounis and
Sander, 1992). In this model the factors are thought to assemble non-productively at
the core promoter, in the absence of activators, to form inactive preinitiation complexes.
In the presence of activators a productive initiation complex may form so allowing for
high levels of transcription. Baniahmad et al. (1993) used this model to explain the
observed transcriptional silencing mediated through TFIIB. It is postulated that, in the
absence of thyroid hormone, hTR(3 stabilises an inactive form of TFIIB in the
preinitiation complex so precluding it from association with other basal transcription
factors. In the presence of hormone however, the interaction of hTR(3 with TFIIB is
blocked and therefore TFIEB is relieved from repression and is subsequently accessible
for the activation of transcription (Baniahmad et al., 1993).
An alternative, but not mutually exclusive, model to explain how activators
facilitate transcription initiation suggests that their binding to the general transcription
factors acts to compete the binding of factors that repress transcription (reviewed by
Hahn, 1993). Several factors have been shown to bind TBP and to repress
transcription, including Drl, Dr2 (Inostroza et al., 1992) and Negative Cofactors 1 and
2 (NCI and NC2) (Meisterernst and Roeder, 1991; Meisterernst et al., 1991). Negative
factors that bind TFIIB may also exist and it is thought that activators may directly
compete with such negative factors for binding to TBP and/or TFIIB and so increase
the rate of transcriptional initiation (Hahn, 1993).
Chromatin-associated proteins, such as nucleosomes and histone HI, are also
thought to play an important role in response to activators. Nucleosomes consist of
160-200 bp of DNA wrapped around an octamer core of histones, bound at the
beginning, the centre and the end by a single molecule of histone HI. The nucleosome
is a highly stable structure and presents a formidable obstacle to transcription (reviewed
by Svaren and Chalkley, 1990). Depletion of nucleosomes in vivo has been shown to
dramatically increase basal transcription (Durrin et al., 1992) and it has been suggested
that transcriptional activators disrupt chromatin structure in a mechanism independent of
replication (reviewed by Svaren and Chalkley, 1990). Proposed models predict that
cofactors or mediators somehow act to facilitate the interaction of transcriptional
activators with the promoter by the modification of chromatin structure (reviewed by
Adams and Workman, 1993). For example, the glucocorticoid receptor is thought to
mediate the effects of hormonal induction on the mouse mammary tumour virus
(MMTV) promoter by displacement of histone HI and disruption of the nucleosome
core, thereby allowing nuclear factor 1 (NF1) and Oct-1 to bind to their target DNA
motifs (Bresnick et al., 1992; Lee and Archer, 1994).
Therefore, there are several models to explain how transcriptional activators act
to provoke transcriptional initiation at RNA polymerase II promoters. The elucidation
of the exact mechanisms by which different activators achieve their end results have yet
to be fully resolved but it is likely that several will exist including those mentioned
above.
In conclusion, it is clear that many different classes of transcription factors exist
possessing the ability to both specifically recognise specific DNA sequence elements
and to regulate the transcriptional machinery. The aim of this study was to identify and
characterise transcription factors binding sites within a region of the rPPT-A promoter
which potentially may act to regulate the transcriptional activity of the rPPT-A gene.
Section 2: Materials and Methods.
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2.1. Materials.
2.1.1. Commonly used solutions.
5 x Agarose gel loading buffer: 0.25% (w/v) bromophenol blue, 0.25%
(w/v) xylene cyanol, ImM EDTA, 30%
glycerol.
MOPS: 41.8g/l MOPS, 4.1 g/1 NaOAc, 3.4 g/1
EDTA.
10 x PBS: 1.37M NaCl, 27mM KC1, 80mM
Na2HP04> 15mM KH2P04.
10 x TBE: pH8.3; 108.9 g/1 Tris base, 55.7 g/1 boric
acid, 4.7 g/1 EDTA.
pH8.8; 162 g/1 Tris Base, 27.5 g/1 boric
acid, 9.5 g/1 EDTA.
TE: lOmM Tris HC1 (pH8), ImM EDTA.
Tris-saturated phenol: Frozen phenol was thawed by bringing to room temperature and
then heating in a water bath to 68°C. 0.1 % hydroxyquinoline was added as a
preservative and phenol was extracted with an equal volume of 0.5M Tris HC1 (pH
8.0) and then extracted with equal volumes of 0.1M Tris HC1 (pH 8.0) until buffer pH
was >7.0. Phenol was finally extracted with 0.1 vol of 0.1M Tris HC1 (pH8.0) and
stored at 4°C under a layer of 0.1M Tris HC1 (pH8.0).
Phenol-chloroform: Tris-saturated phenol as prepared above was mixed with an
equal volume of chloroform.
2.1.2. Bacterial culture medium.
L-Broth: 10g/l tryptone, 5g/l yeast extract, 5g/l NaCl.
L-Agar: L-broth to which 1% bacto-agar was added.
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Ampicillin: A stock of ampicillin was made up at lOOmg/ml and stored at
20°C.
L-Agar plates: L-agar was melted in a microwave oven and left to cool to room
temperature. Ampicillin was added to the agar at a final
concentration of 0.1 mg/ml before pouring into plates and
leaving to set at room temperature. Once set, plates were used or
stored at 4°C for up to one week.
2.1.3. Plasmids.
A series of plasmids were supplied by Dr. Karen Chapman (Department of
Medicine, Western General Hospital, Edinburgh). These contain the following
fragments from the rPPT-A promoter linked to a lac Z ((3-galactosidase) reporter gene
(Mulderry et al., 1993), where +1 corresponds to the first nucleotide of the major









These plasmids were all sequenced (Section 2.2.7.1.) to determine accurately
which regions of the rPPT-A promoter they contain.
The plasmid pPPT was supplied by Dr. J. Quinn (MRC Brain Metabolism
Unit, Edinburgh). It contains a fragment from the rPPT-A promoter, extending from
-3356 to +443, cloned into the vector pUC19 (Quinn, 1992).
2,2. Methods.
2.2.1. Gel electrophoresis.
2.2.1.1. Horizontal agarose gel electrophoresis.
The percentage of agarose used depended on the size range of linear DNA to be
separated. 1% (w/v) agarose (Agarose MP, Boehinger) was used to separate DNA
fragments of ~7 kb to 0.56 kb, 1.5% to 2% (w/v) agarose was used to separate DNA
fragments of ~1 kb to 0.1 kb and 5% (w/v) agarose (NuSeive GTG) was used to
separate DNA fragments or oligonucleotides of < 0.1 kb.
100ml horizontal gel slabs (140mm x 110mm x 30mm) containing the correct
percentage of agarose were placed in horizontal gel electrophoresis apparatus (Gibco
BRL, Model HS) containing sufficient 1 x TBE buffer to cover the gel. Samples were
loaded in 0.2 vol loading buffer and gels were usually electrophoresed at 60mA for as
long as required to see sufficient separation of DNA fragments. After electrophoresis,
gels were stained in 1 x TBE buffer containing ethidium bromide (0.5|lg/ml) for 5 mins
and DNA fragments were visualised using a long wave UV transilluminator. DNA was
photographed using Asa Polaroid film type 667 in a Polaroid Cu-5 camera.
25ml mini agarose gels (83mm x 57mm x 30mm) (Gibco BRL, Model Horizon
58) were also used in some cases to analyse DNA. Typically, these gels were
electrophoresed in 1 x TBE at 60mA until sufficient separation of DNA fragments had
occurred.
2.2.1.2, Vertical gel electrophoresis.
a. 4%/6% Native polvacrylamide gel electrophoresis.
4%/6% native polyacrylamide gels were prepared by mixing 4ml/6ml of 50%
29:1 bis:acrylamide (Biorad, premixed) with 2.5ml of 10 x TBE in a final volume of
50ml. Gels were cross-linked with 50|ll of TEMED, catalysed by 0.5ml of 10% APS
and immediately poured into 150mm x 170mm x 1.5mm glass sandwiches for use in
electrophoretic mobility shift assays (Section 2.2.6.1.), 300mm x 400mm x 0.4mm
glass sandwiches for use in exonuclease protection assays (Section 2.2.6.3.) or
170mm x 880mm x 0.4mm glass sandwiches for use in DNase 1 footprinting assays
(Section 2.2.6.2.), previously sealed with 1% (w/v) agarose. 20-tooth combs (1.5mm)
were placed in the top of the gels, between the plates, and the gels were then left to
polymerise. Polymerised gels for electrophoretic mobility shift assays were attached to
vertical gel electrophoresis apparatus (Gibco BRL, Model VI6-2) containing 0.5 x TBE
buffer and pre-electrophoresed for 30 mins at 100V. Polymerised gels for use in
exonuclease protection assays were attached to vertical gel electrophoresis apparatus
(Gibco BRL, Model S2) containing 1 x TBE buffer and pre-electrophoresed for 1 h at
1000V. Polymerised gels for use in DNase 1 footprinting assays were attached to
vertical gel electrophoresis apparatus (Gibco BRL, Model SA) containing 1 x TBE
buffer and pre-electrophoresed for 1 h at 1000V. Samples were loaded while the gels
were still running. Electrophoretic mobility shift assays were electrophoresed for a
further 1-2 h at 200V, exonuclease protection assays were electrophoresed for 3-4 h at
1500V and DNase 1 footprinting assays were electrophoresed for a further 16 h at
1500V. Following electrophoresis, gels were transferred to Whatman No.l paper and
dried using a heated vacuum gel drier (Biorad Model S83). Radiolabeled samples were
visualised by exposing the dried gels to autoradiographic film for 1-24 h (Section
2.2.1.3.).
b. 6% Denaturing polvacrvlamide/urea gel electrophoresis.
6% denaturing polyacrylamide gels were prepared by dissolving 42g of urea
(Aristar, BDH), 20ml of 30% (29:1) bis:acrylamide (Biorad, premixed) and 10ml of 10
x TBE in a final volume of 100ml. The polyacrylamide solutions were filtered though
Whatman membrane filters (0.45|im) under vacuum and degassed before adding
0.55ml of 10% APS and 55|il of TEMED. Solutions were immediately poured into
300mm x 400mm x 0.4mm glass sandwiches previously sealed with gel sealing tape
(Gibco BRL). 20-tooth combs (0.4mm) were inserted and the gels were left to
polymerise. After polymerisation, gels were attached to vertical gel electrophoresis
apparatus (Gibco BRL, Model S2) containing 1 x TBE buffer and pre-electrophoresed
at 1000V for 30 mins prior to loading samples. Electrophoresis was then carried out for
approximately 2-3 h. Following electrophoresis, gels were transferred to Whatman
No.l paper covered with Saran wrap and dried using a heated vacuum gel drier (Biorad
Model 583). Radiolabeled samples were visualised by autoradiography (Section
2.2.1.3.).
2.2.1.3. Autoradiography.
Detection of radiolabeled material was carried out at -70°C using Fuji RX X-
ray film (18 x 24cm or 30 x 40cm). X-ray film was placed against dried gels inside
autoradiographic cassettes with 2 x or 4 x intensifying screens (in the case of material
containing 32P). After the appropriate exposure time films were developed for 2 mins in
Kodak LX-24 developer (0.25 dilution), rinsed in water, fixed for 1 min in Kodak FX-
40 fixer (0.25 dilution), rinsed once more in water and dried.
2.2.2. Cloning and DNA techniques.
2.2.2.1. Plasmid construction.
pSMl/Q5 and pSMl'/Q5 were constructed as follows: lOfig of plasmid pPPT
was digested with Xba I and EcoR I (Section 2.2.2.2.). Reaction products were
electrophoresed through a 1% low melting point agarose gel (Section 2.2.1.1.) and the
DNA fragment of 3.9 Kb in size, containing rPPT-A DNA sequence, was purified
(Section 2.2.2.3.a.). Purified DNA was then digested with Hinf I which generated 8
fragments, the desired fragment of 604 bp in length was again purified from a low
melting point agarose gel. Sticky ends were filled in with 2mM dCTP, dGTP, dATP,
dTTP, 1 unit of Klenow (large fragment of DNA polymerase I) and 2fil 10 x Klenow
buffer (0.5M Tris HC1 pH7.6, 0.1M MgCl2, lOmM DTT) in a final volume of 20p.l
and incubated at room temperature for 15 mins.
2(ig of pUC19 vector was digested with Sma I and then dephosphorylated by
adding 1 unit of calf intestinal phosphatase (CIP) and incubating at 37°C for 1 h.
Dephosphorylated vector and filled in insert were then ligated (Section 2.2.2.5.) and
competent cells were transformed with the ligation mix (Section 2.2.2.6.). The
transformed ligation mix was spread out on L-agar plates containing ampicillin plus X-
gal and IPTG to allow for blue/white selection. Restriction analysis of DNA minipreps
(Section 2.2.2.7.) confirmed insertion of the rPPT-A DNA fragment in both
orientations. Large scale plasmid preparations (Section 2.2.2.8.) were then carried out
and the insert sequence was confirmed by DNA sequencing (Section 2.2.7.1.).
2.2.2.2. Restriction enzyme digests.
DNA was digested typically using 1 unit of restriction enzyme per l(ig of DNA,
1 x reaction buffer (as specified by the manufacturer) and dH20 to the required volume.
Reaction mixtures were generally incubated at 37°C for 1 h. Digested DNA was
visualised after electrophoresis though an agarose gel (Section 2.2.1.1.). Diagnostic
restriction enzyme digests generally used 0.2 - 0.5|ig of DNA in a final volume of
lOpl Preparative restriction enzyme digests used increasing amounts of DNA in a final
volume of 50|il. Restricted DNAs were then either purified using the Magic™ DNA
clean up system (Promega) or desired fragments were recovered after electrophoresis of
the entire 50(0,1 digests though low melting point agarose gels (Section 2.2.2.3.).
DNA size markers routinely used were Hind III fragments of X which give a
range of DNA fragment sizes between 0.56 and 23 kb or Hinf I fragments of pAT153
which give a range of sizes between 75 bp and 1.631 kb.
2.2.2.3. Purifying DNA from low melting point agarose gels.
a. DNA fragments of > 0.1 kb.
DNA fragments were electrophoresed through low melting point agarose gels,
as described (Section 2.2.2.1.). After visualising on a UV transilluminator, gel slices
containing the DNA fragments of interest were excised using a clean scalpel blade. Gel
slices were placed in 1.5ml Eppendorf tubes and heated to 65-70°C for 10-15 mins or
until the agarose was completely melted. An equal volume of Tris-saturated phenol was
added and the tubes were vortexed for 10 sees before incubating in a dry ice bath for 5-
15 mins. This was followed by a 10 min spin in an Eppendorf bench top centrifuge
after which top aqueous layers were transferred to new eppendorf tubes. The aqueous
layers were then extracted once more with an equal volume of Tris-saturated phenol,
once with equal volumes of Tris-saturated phenol and chloroform:isoamylalcohol
(24:1, v/v) and finally with an equal volume of chloroform:isoamylalcohol (24:1, v/v).
Each extraction involved a 10 sec vortex followed by a 2 min centrifugation in an
Eppendorf bench top centrifuge. DNA fragments were then precipitated with 2.5 vol of
ethanol and 0.15% NaCl (Section 2.2.2.4.).
b. DNA fragments of < 0.1 kb and oligonucleotides.
DNA fragments or oligonucleotides were electrophoresed through 5% NuSeive
agarose gels (Section 2.2.1.1.) and recovered using the phenol extraction protocol,
according to manufacturers instructions.
After visualising on a UV transilluminator, gel slices containing the DNA
fragments were excised using a clean scalpel blade. Gel slices were placed in 1.5 ml
eppendorf tubes and melted at 67°C for 10 mins. 4 to 5 vol of TE (warmed to 67°C)
were added to melted gel slices and mixed well. An equal volume of Tris-saturated
phenol was then added to diluted agarose slices, mixed for 15 sees and centrifuged for
3 mins in an Eppendorf bench top centrifuge. Aqueous top layers were then extracted
once more with an equal volume of Tris-saturated phenol followed by extraction with
an equal volume of phenol/chloroform and finally with an equal volume of
chloroforrmisoamylalcohol (24:1, v/v). DNA present in the aqueous layers was then
ethanol precipitated with 0.1 vol of 3M NaOAc and 2 vol of 95% ethanol (cooled to
-20°C) (Section 2.2.2.4.). After 30 mins at -20°C, reactions were centrifuged in an
eppendorf bench top centrifuge at room temperature for 30 mins. Pellets were washed
with 2 vol of 80% ethanol (cooled to -20°C), stored in a dry ice bath for 15 mins and
re-centrifuged as above. Pellets were dried under vacuum in a Gyrovap for 10 mins or
until they were dry and were finally resuspended in an appropriate volume of TE or
dH20.
2.2.2.4. Ethanol precipitation of DNA.
2-2.5 vol of ethanol and either 0.5 vol of 7.5M NH4AC or 0.1 vol of 3M
NaOAc were added to DNA samples and they were then vortexed for 10 sees. This was
followed by a 5-10 min incubation in a dry ice bath or incubation at -20°C for 30 mins
to overnight and then a 10 min centrifugation in an Eppendorf bench top centrifuge.
DNA pellets were dried at room temperature for up to 30 mins and then resuspended in
an appropriate volume of TE or H20.
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2.2,2.5 DNA ligation.
Ligation reactions were carried out in a final volume of lOjil containing lp.1 of
10 x ligation buffer (0.5M Tris HC1 pH7.6, lOOmM MgCl2, 10mM DTT), ImM ATP,
1 unit of T4 DNA ligase (BCL) and a 1:5 molar ratio of vector DNA:insert DNA
(typically 10-50ng of vector DNA and 50-250ng of insert DNA). Ligation reactions
were incubated at room temperature for 3-4 h.
2.2.2.6. Preparation and transformation of competent E. coli.
A single colony of Escherichia coli strain HB101 was grown overnight in 3ml
of L-broth, diluted into 40ml of L-broth and grown in an orbital shaker at 37°C to an
A600 of 0.4-0.6. Cells were harvested by centrifugation at 6000rpm in a Sorvall SS34
rotor for 5 mins at 4°C. Cell pellets were placed on ice, resuspended in 0.4 vol of ice
cold 0.1M MgCl2 and pelleted as before. The pellets were then resuspended in 0.05 vol
of ice cold 0.1M CaCl2 and left on ice for 45 mins. The cells were pelleted as before,
resuspended in 1 vol of a buffer containing 0.1M MOPS pH6.5, 50mM CaCl2, 20%
glycerol and left on ice for a further 20 mins to acquire full competence. Competent
cells were aliquoted into 1ml eppendorf tubes, snap frozen in a dry ice bath and stored
at -70°C.
l-5jol of ligation mix or lOng of plasmid DNA was added to 100-200(0,1 of
competent HB101 cells and incubated on ice for 30 mins. The mixture was then heat
shocked at 45°C for 2 mins and returned to ice for 2 mins. The cells were added to 1ml
of L-broth and incubated at 37°C for 1 h. They were then briefly pelleted, resuspended
in lOOp.1 of L-broth and subsequently spread on L-agar plates containing 0. lmg/ml
ampicillin which had previously been spread with 40|ll of 2% X-gal (diluted in ethanol)
and 40p,l of lOOmM IPTG. The plates were incubated overnight at 37°C and colonies
which grew on the selective media and appeared white were picked for mini-prep
analysis (2.2.2.7.).
2.2.2.7. Mini-prep analysis of transformed E.coli colonies.
Mini-prep DNA was prepared by the alkaline lysis method. Colonies were
picked from agar plates into 3ml of L-broth containing 0.05mg/ml ampicillin and grown
overnight at 37°C in a rotator. The following day cells from 1ml of the overnight
culture were placed in an eppendorf tube and pelleted in a bench top centrifuge for 1
min (the remaining 2ml of culture was stored at 4°C for use in large scale preparation of
plasmid DNA Section 2.2.2.8.). Pellets were resuspended in 100(ll of ice cold GTE
buffer (50mM glucose, 25mM Tris HC1 pH8.0, lOmM EDTA) and mixed by
vortexing. 200)0.1 of freshly prepared alkaline-SDS solution (0.2M NaOH, 1% (v/v)
SDS) was then added, gently mixed and tubes were placed on ice. 150fol of ice cold
potassium acetate (3.0M KAc, 11.5% (v/v) glacial acetic acid) was added followed by a
5 min incubation on ice. Samples were then centrifuged for 5 mins and supernatants
were added to fresh eppendorf tubes and extracted with 0.5 vol of Tris-saturated phenol
and 0.5 vol of chloroform:isoamyl alcohol (24:1, v/v). The aqueous phases were
precipitated (Section 2.2.2.4.) with 2 vol of ethanol at room temperature for 5 mins.
After centrifugation for 5 mins in an Eppendorf bench top centrifuge, the pellets were
dried at 37°C and resuspended in 50p,l of TE containing 20p,g/ml of DNase-free
pancreatic RNase (Sigma) (prepared by boiling a stock of lmg/ml for 10 mins,
aliquoting into eppendorfs and storing at -20°C). Mini-prep DNA was stored at -20°C
and 5- 10(_l1 was used for restriction analysis.
2.2.2.8. Large scale preparation of plasmid DNA.
2ml of overnight cultures, containing individual colonies picked from agar
plates, were diluted into 300-500ml of L-broth, containing 0.05mg/ml ampicillin and
grown overnight in an orbital shaker at 37°C. The following day cultures were pelleted
by centrifugation at 6000rpm for 5 mins at 4°C in a Sorvall RC-5B centrifuge using a
GSA rotor. After decanting the supernatant, bacterial pellets were resuspended in 12ml
of ice-cold GTE buffer (50mM glucose, 25mM Tris HC1 pH8.0, lOmM EDTA)
containing approximately lmg/ml lysozyme. 24ml of freshly prepared alkaline-SDS
(0.2M NaOH, 1% (v/v) SDS) was then added and suspensions were left on ice for 5
mins. 16ml of ice cold potassium acetate (3.0M KAc, 11.5% (v/v) glacial acetic acid)
was added and suspensions were incubated for a further 10 mins on ice. This was
followed by centrifugation at 4000rpm for 15 mins in a Sorvall GSA rotor at 4°C to
pellet out cell debris and cellular DNA. Supernatants containing the plasmid DNA were
strained though butter muslin into 250ml centrifuge pots and precipitated with 0.6 vol
of isopropanol at room temperature for 30 mins. Plasmid DNA was recovered by
centrifugation at 5000rpm for 15 mins at room temperature in a Sorvall GSA rotor.
Supernatants were drained away and the pellets were washed with 70% ethanol, dried
and resuspended in 1ml of TE. The DNA samples were then brought to a total volume
of 4ml with TE after which 400jil of ethidium bromide (lOmg/ml) was added. Exactly
4.4g of CsCl was then dissolved into the solutions followed by a 5-10 min incubation
on ice. The solutions were centrifuged in 15ml polpropylene tubes (Corning) at
5000rpm for 5 mins at room temperature. Supernatants were transferred to 6ml
polyallamer ultracentrifuge tubes (Du Pont) and topped up with a stock solution
containing l.lg of CsCl in 1.0ml of H2O and 0.1 ml of EtBr (lOmg/ml).
Ultracentrifuge tubes were then sealed with an ultracrimp tool and centrifuged in a
Sorval TV-1665 ultracentrifuge rotor at 45000rpm for 16 h at 20°C. Supercoiled
plasmid DNA bands were visualised by daylight or a long wave UV transilluminator
and recovered with a large bore needle and syringe. Ethidium bromide was removed
from the plasmid DNA by extracting several times with equal volumes of butan-l-ol.
The plasmid preparations were then dialysed for 24 h against three 2 litre changes of TE
at 4°C. The concentration of recovered plasmids was determined by spectrophotometry
(OD26O 1.0 = 50|lg DNA/ml).
2.2.3. Tissue culture growth conditions.
Tissue culture work was performed by E. Clark and C. Morrison. HeLa cells
(Human cervix carcinoma), AtT20 cells (mouse pituitary tumour) and CI300 cells
(mouse neuroblastoma) were grown on 75cm2 tissue culture flasks (J. Bibby Science
Products) in DMEM (Dulbeccos Modified Eagles Medium; Flow Laboratories)
supplemented with 10% fetal calf serum (Globepharm), 2mM glutamine (Gibco BRL),
100 units/ml penicillin and 1 OOpg/ml streptomycin (Gibco BRL).
PC 12 cells (rat adrenal pheochromocytoma) were grown on collagen coated
75cm2 tissue culture flasks (J.Bibby Science Products) in DMEM, 5% fetal calf serum,
10% horse serum, 100 units/ml penicillin and 1 OOpg/ml streptomycin.
2.2.4. Protein techniques.
2.2.4.1. Preparation of whole cell extracts.
C1300, AtT20 and PC12 cells were cultured as described (Section 2.2.3.).
Whole cell extracts were prepared essentially as described by Manley et al. (1980).
Approximately 2 x 106 cells were harvested by scraping the surface of the culture
flasks. The cell pellets were washed once in ice cold 1 x PBS and transferred to
eppendorf tubes. All subsequent steps were carried out at 4°C.
Cells were resuspended in 1.5ml of 1 x buffer A (lOmM HEPES, lOmM KC1,
ImM MgCl2, with protease inhibitors 0.25mM DTT and 0.5mM PMSF, 0.25M stock
made up in isopropanol, added just before use) and were left to swell for 8 mins on ice.
Cells were then pelleted by centrifugation in a bench top eppendorf centrifuge for 2
mins at 4°C. Cell pellets were resuspended in an equal volume of 1 x buffer C ( 20mM
HEPES, 20% glycerol, 0.42M NaCl, 1.5mM MgCl2, 0.2mM EDTA with 0.25mM
DTT and 0.5mM PMSF added just before use) and lysed with 2 strokes of a 1.5ml
plastic homogeniser. The suspensions were left on ice for 20 mins vortexing every 5
mins. The cell lysates were finally centrifuged in a bench top eppendorf centrifuge for 2
mins at 4°C and the supernatants were carefully decanted into fresh eppendorf tubes,
snap frozen in a dry ice bath and stored at -70°C.
2.2.4.2. Preparation of nuclear extracts.
HeLa cells were cultured as described (Section 2.2.3.). Nuclear extracts were
prepared essentially as described by Dignam et al. (1983). Approximately 6 x 106 cells
were harvested by centrifugation at 2500rpm for 10 mins at 4°C in a bench top
centrifuge (Chilspin, MSE). All subsequent steps were carried out at 4°C.
The cell pellets were washed in 3 vol of ice cold 1 x PBS and collected again by
centrifugation at 2000rpm for 10 mins at 4°C in a bench top centrifuge (Chilpsin,
MSE). Cells were then swollen by resuspending in 3 vols of ice cold 1 x buffer A and
were left to stand on ice for 10 mins. Swollen cells were collected by centrifugation at
2000rpm for 10 mins at 4°C in a bench top centrifuge (Chilpsin, MSE). Cells were
resuspended in 2 vol of ice cold 1 x buffer A and lysed under ice with 10 strokes of a
dounce homogeniser (B pestle). The cells were then pelleted by centrifugation at
3000rpm for 10 mins at 4°C in a Sorvall GSA rotor and the supernatants containing
unwanted cellular membranes and nucleic acid material were removed. The pellets were
centrifuged once more at 15000rpm for 25 mins at 4°C in a Sorvall GSA rotor and the
supernatants removed. Pellets were resuspended in 0.05 vol of 1 x buffer C, lysed with
10 strokes of a dounce homogeniser (B pestle) and left to stand on ice for 20 mins. The
nuclear samples were then centrifuged at 38000rpm for 45 mins at 4°C in a Sorval TV-
1665 ultracentrifuge rotor and the supernatants collected. This material was dialysed
against three 1 litre changes of 1 x lOOmM buffer D (20mM HEPES, 20% glycerol,
0.1M KC1, 0.2mM EDTA) and finally clarified by centrifugation in a bench top
eppendorf centrifuge for 10 mins at 4°C. The supernatants containing nuclear material
were then aliquoted into fresh eppendorf tubes and snap frozen.
Nuclear extracts were prepared from rat brain tissue essentially as above after
being dissected from rat adult male Cob Wistars (by Mr. R.C. Dow, MRC, Brain
Metabolism Unit, 1 George Square, University of Edinburgh).
2.2.4.3. Determination of protein concentration.
Protein concentrations of whole cell and nuclear extracts were determined using
the Biorad protein assay. Protein standard solution (BSA) was diluted to a 20|il final
volume in dH^O to give concentrations of 1.0, 0.5, 0.25, 0.125, 0.0625 and 0.031
mg/ml. Each dilution, plus a 20|ll dH^O control, was mixed well with 1ml of Biorad
protein assay solution, previously diluted 1 part in 5 with dH20. Protein standards
were then transferred to plastic cuvettes and the A595 of each was obtained using a
Shimadzu UV/60 spectrophotometer to produce a standard calibration curve.
An appropriate volume of protein extract (typically l-5(ll) was then mixed with
lml of the diluted Biorad protein assay solution and the A595 was measured as above.
Protein extract concentrations were calculated by relating the A595 of protein extract to
the standard curve.
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2.2.5. Radioactive labelling of DNA.
2,2.5.1. Preparation of oligonucleotide probes.
Oligonucleotides (Oswell DNA services, Edinburgh), for use in electrophoretic
mobility shift assays, were labelled either at the 5' end with T4 polynucleotide kinase or
at the 3' end using the Klenow fragment of E. coli DNA polymerase. In some cases
oligonucleotides were purified from 5% NuSeive agarose gels before use (Section
2.2.2.3.b.).
a. 5' End labelling.
Double stranded oligonucleotides (lOOng) were 5' end labelled at room
temperature using 15p,Ci of [y32P] ATP (Amersham, 3000Ci/mmol), 10 units of T4
polynucleotide kinase and 1 x kinase buffer (10 x; 1M Tris HC1 pH8.0, 0.1M MgCl2,
lOOmM DTT). After 30 mins dH20 was added to a total volume of 50p,l and the
reactions were terminated by extraction with an equal volume of Tris-saturated phenol.
Labelled oligonucleotides were separated from unincorporated label by centrifugation
though Nu-Clean sephadex D25 disposable spun columns (IBI) and the total volume
was brought up to lOOpl with dH20.
b. 3' End labelling.
Double stranded oligonucleotides (lOOng) (with TCGA or TA overhangs) were
filled in at room temperature using 25pQ of [a32P] dTTP (Amersham, 3000Q/mmol),
5 units of the Klenow fragment of E.coli DNA polymerase and 1 x Klenow buffer (10
x; 0.5M Tris HC1 pH7.6, 0.1M MgCl2, lOmM DTT). Octamer oligonucleotide (with a
GAG overhang) was filled in as above using 25[iCi of [a32P] dCTP in the place of
dTTP. After 20 mins dH20 was added to a total volume of 50pl and the reactions were
terminated by extraction with an equal volume of Tris-saturated phenol. Labelled
oligonucleotides were separated from unincorporated label by centrifugation though
Nu-Clean sephadex D25 disposable spun columns (IBI) and the total volume was
brought up to 100(il with dH20.
2.2.5.2. Labelling DNA probes for DNase 1 footprinting assays.
The plasmids used in DNase 1 assays are listed in materials (Section 2.1.3.).
The method used to generate suitable substrates for DNase 1 footprinting assays are
outlined in Figure 3.
Typically, lOgLg of each substrate plasmid was linearised by digestion in the
polylinker with 10 units of Sal I (Section 2.2.2.2.). Enzyme activity was terminated by
passing linearised plasmids over Magic™ DNA clean up system columns (Promega).
The 5' ends were dephosphorylated with CIP (24 units, at 37°C for 1 h). The CIP was
inactivated using Magic™ DNA clean up system columns and linearised
dephosphorylated plasmids were subsequently labelled at the 5' ends with T4
polynucleotide kinase. l(ig of plasmid was incubated with 50|itCi of [y32P] ATP
(Amersham, 3000Ci/mmol), 10 units of T4 polynucleotide kinase and 1 x kinase buffer
at room temperature for 30 mins. Labelled DNA was seperated from unincorporated
label using the Magic™ DNA clean up system.
Labelled linearised plasmids were then cut with a second restriction enzyme in
order to generate two singly end labelled fragments, one of almost full length and the
other of 10-20 bp in length which would not interfere with the DNase 1 assay. The
enzymes chosen produced DNA fragments in which the region of promoter to be
analysed was located approximately 50-200 bp from the labelled end. Finally, enzyme
activity was terminated using the Magic™ DNA clean up system and the DNA
fragments were eluted in 30|ll of TE.
Another approach involved restricting the plasmid pSMl'/Q5 with EcoR I and
Hind III, separating the digestion products on a 1 % low melting point agarose gel and
purifying the desired DNA fragment of approximately 650 bp, containing rPPT-A
promoter sequence and pUC19 polylinker sequence (Section 2.2.2.3.a.). The purified
DNA was then restricted with Dde I, again the digestion products were separated on a
1% low melting point agarose gel and the desired DNA fragment of approximately
500 bp was purified. This purified DNA fragment was dephosphorylated and 5' end
labelled as described above. Finally, it was restricted with Sal I, passed over a
Magic™ DNA clean up system column and was ready for use in DNase 1 footprinting
assays.
2.2.5.3. Labelling DNA probes for exonuclease assays.
10p,g of the plasmid pSMl/Q5 was restricted with Pvu II (Section 2.2.2.2.),
digestion products were separated on a 1% low melting point agarose gel and the DNA
fragment containing rPPT-A promoter sequence plus the lac operator sequence from
Figure 3. Diagrammatic representation of the method used to generate suitable
substrates for DNase 1 footprinting assays.
The plasmid shown (substrate plasmid) represents the constructs prPPT-(3Gal3,
prPPT-[3Gal4, PrPPT-pGal6, pVL29, pSMl/Q5 and pSM17Q5, with the sites of
polylinker sequence and insert DNA sequence noted.
1. The plasmids were digested in the polylinker with the restriction enzyme Sal I.
2. The 5' ends of the resulting linearised plasmids were then dephosphorylated using
CIP.
3. Dephosphorylated, linearised plasmids were then radioactively 5' end labelled with
T4 polynucleotide kinase.
4. This was followed by digestion with a second restriction enzyme to remove 10-20
bp of DNA sequence from one end of the linearised, labelled DNA fragments. This





1. Linearise with Sal I
2. Dephosphorylate 5' ends with CIP
3. Radioactively label at 5' ends
with T4 polynucleotide kinase
4. Cut with second restriction enzyme
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pUC19 was purified (Section 2.2.2.3.a.). The resulting blunt ended fragment was then
3' end labelled using the Klenow fragment of E. coli DNA polymerase as follows.
l|lg of the DNA fragment was initially incubated with 5 units of the Klenow
fragment of E.coli DNA polymerase and 1 x Klenow buffer at room temperature for 15
mins. This produced 5' overhanging ends due to the 3' to 5' exonuclease activity of the
Klenow fragment. The resulting 5' overhanging ends were then filled in using the 5' to
3' polymerase activity of the Klenow fragment as follows. The DNA fragment was
incubated with 40(iCi of [a32P] dATP, dCTP, dGTP and dTTP (Amersham,
800Ci/mmol), 5 units of the Klenow fragment of E.coli DNA polymerase and 1 x
Klenow buffer at room temperature for 30 mins. This labelling step was followed by a
10 min chase using ImM of all four cold dNTPs. The Klenow fragment was then
inactivated by extraction with Tris-saturated phenol and the labelled fragment was
seperated from unincorporated label by centrifugation though Nu-Clean sephadex D50
disposable spun columns (IBI). The eluted labelled fragment was finally ethanol
precipitated (Section 2.2.2.4.) and was ready for use in exonuclease assays.
2.2.5.4. Labelling DNA markers.
lOOng of 123 bp ladder DNA (BRL) was 5' end labelled essentially following
the method for 5' end labelling of oligonucleotides (Section 2.2.5.1.a.), except that
Nu-Clean D50 sephadex disposable spun columns (IBI) were used to remove
unincorporated label.
2.2.6. Analysis of protein/DNA interactions.
2.2.6.1. Electrophoretic mobility shift assays.
Electrophoretic mobility shift assays, as outlined below, were based on the
method of Singh et al. (1986) with a few modifications.
A typical electrophoretic mobility shift assay contained approximately lng of
double-stranded end labelled oligonucleotide (Section 2.2.5.1.), 0.5-2.5fig (depending
on batch lot) of non-specific competitor poly [d(I-C)] (Boehinger), 10-30|lg of protein
extract and sufficient OmM or lOOmM buffer D to bring the final reaction concentration
to lOOmM salt, in a volume of 5-10|il.
Protein extracts (nuclear or whole cell, Section 2.2.4.1. and 2.2.4.2.) were
mixed with buffer D and poly [d(I-C)] and left at room temperature for up to 5 mins.
Labelled oligonucleotide probe and 2jll1 of dye mix (2% (w/v) bromophenol blue, 2%
(w/v) xylene cyanol) were then added and the reaction mixtures were incubated at
room temperature for 20 mins. Where appropriate, excess unlabelled competitor
oligonucleotide was included in the reaction mixture. Competitors were added along
with labelled oligonucleotide probe, unless stated, at 10 to 250 molar excess over 32P
labelled oligonucleotide. Reactions were then loaded onto 4% or 6% native
polyacrylamide gels (Section 2.2.1.2.a.) and protein/DNA complexes were resolved
from unbound DNA by electrophoresing at 200V for 1-2 h. Dried gels were exposed to
autoradiographic film for 1-16 h (Section 2.2.1.3.).
2.2.6.2. DNase 1 footprinting assays.
Singly end labelled DNA fragments (Section 2.2.5.2.) (lOOng per reaction)
were mixed with assay buffer (40mM Tris HC1 pH7.5, 6mM MgCl2) and brought to a
total volume of 20(_l1 with dH20. DNA fragments were then mixed with approximately
lmg of protein extract (whole cell or nuclear, Section 2.2.4.1. and 2.2.4.2.) which had
been preincubated with 5 to 30[lg of poly [d(I-C)] for 2 mins at room temperature.
Reaction mixtures were incubated at room temperature for 20 mins and were then
digested with DNase 1 enzyme (l-4|il) (Pharmacia FPLC pure, 7.5 units/jil) at 37°C
for 2 mins. The amount of DNase 1 enzyme added was predetermined in preliminary
experiments. DNase 1 enzyme activity was terminated by the addition of an equal
volume of 1 x stop buffer (lOmM Tris HC1 pH7.4, 25mM EDTA, 0.5% SDS, 50mM
NaOAc) followed by extraction with an equal volume of phenol/chloroform. Finally,
reactions were ethanol precipitated (Section 2.2.2.4.) and resuspended in 4p,l of stop
solution (95% deionised formamide, 20mM EDTA, 0.05% (w/v) bromophenol blue,
0.05% (w/v) xylene cyanol). Reactions were boiled for 2 mins then loaded onto 6%
denaturing polyacrylamide gels (170mm x 880mm x 0.4mm ) (Section 2.2.1.2.a.),
along with 32P labelled marker DNA (Section 2.2.5.4.) and a Maxam-Gilbert
sequencing reaction of the labelled fragment (Section 2.2.7.2.). Gels were
electrophoresed for approximately 16 h at 1500V and once dried, were exposed to
autoradiographic film (Section 2.2.1.3.), typically for 16 h.
2.2.6.3. Exonuclease protection assays.
The exonuclease protection assay is a method which allows for the identification
of sequence specific protein binding sites within a particular fragment of DNA. This
method makes use of immunobeads, consisting of anti-rabbit Ig coupled to anti-|3-
galactosidase, in order to concentrate specifically bound proteins. These beads are
prepared as outlined below.
a. Preparation of 10 x immunobeads.
Immunobeads carrying goat anti-rabbit Ig coupled to anti-P-galactosidase
antibodies were prepared following the method of Levens and Howley (1985).
Immunobeads (Biorad) were mixed with anti-rabbit-(3-galactosidase antibody at
a volume ratio of 11:1 in the presence of lOpg/ml BSA as a carrier to prevent non¬
specific binding. This reaction mixture was incubated at room temperature for 3 h
inverting every 20 mins and the beads were recovered by centrifugation at 3000rpm for
10 mins at room temperature in a bench top centrifuge (Chilpsin, MSE). Pelleted beads
were washed twice in 1 x binding buffer (lOx; 0.1M Tris HC1 pH7.5, 0.25M NaCl,
lOmM DTT, 75mM MgCl2), re-pelleted and finally resuspended in 10 x binding buffer
plus ImM DTT and 100pg/ml BSA to produce 10 x binding beads.
b. Exonuclease protection assay.
Exonuclease protection assays were carried as previously described (Quinn et
al., 1987).
32P-3'-end-labelled DNA fragments (Section 2.2.5.3.) (lOOng per reaction)
were immobilized on immunobeads via a lac repressor-(3-galactosidase fusion protein
as follows. DNA was mixed with O.lpg of lac repressor-P-galactosidase fusion protein
(Promega) and 1 x binding buffer in a total volume of lOpl. Reactions were left at room
temperature for 10 mins to allow the lac repressor protein to bind to the lac operon of
pUC19. A predetermined volume (typically 15-25[ll) of 10 x immunobeads (Section
2.2.6.3.a.) was then added and reactions were left at room temperature for a further 15
mins to allow the beads to bind the P-galactosidase portion of the protein. Beads were
recovered by centrifugation in a bench top eppendorf centrifuge for 30 sees then
washed in 1 x lOOmM D buffer, re-pelleted and resuspended in 10pl (per reaction) of 1
x exonuclease buffer (lOmM Tris HC1 pH8.0, 5% glycerol, 4mM MgCl2, 0.2mM
DTT).
10|ol (per reaction) of 32P-3'-end-labelled DNA linked to immunobeads was
incubated with approximately 0.2mg of protein extract (whole cell or nuclear, Sections
2.2.4.1. and 2.2.4.2.) in a final volume of 15(0.1, including lOOmM 1 x buffer D and 2-
5jog of poly [d(I-C)], at room temperature for 30 mins. Immunobead-DNA-protein
complexes were recovered by centrifugation in a bench top eppendorf centrifuge for 30
sees and resuspended in 15)0.1 of 1 x exonuclease buffer. 40 to 80 units of T7 gene 6
exonuclease enzyme (USB) was then added in order to digest the DNA from the 5' end
to the 3' end. Reactions were incubated at room temperature for 3 mins and terminated
by the addition of an equal volume of 1 x stop buffer. Reaction volumes were brought
to 30|il with dH20 and then extracted with an equal volume Tris-saturated phenol.
Finally, reactions were ethanol precipitated (Section 2.2.2.4.), resuspended in 4fil of
stop solution and electrophoresed through 6% denaturing polyacrylamide gels (300mm
x 400mm x 0.4mm) along with 32P labelled marker DNA (Section 2.2.5.4.) at 1500V
for 3-4 h. Dried gels were exposed to autoradiographic film (Section 2.2.1.3.),
typically for 16 h.
2.2.7. DNA sequencing.
2.2.7.1. Dideoxv sequencing.
Plasmid DNA was sequenced using Sequenase version 2.0 according to
manufacturers instructions (USB).
DNA samples (2-5 jig) were denatured in a final volume of 20pl containing 4|il
of 1M NaOH and incubated at room temperature for 5 mins. Denatured samples were
then ethanol precipitated in 8[il of 5M NH4AC and lOOpl of EtOH (Section 2.2.2.4.)
and resuspended in 5(il of dH20. The DNA samples were then annealed to the
appropriate primer in a final volume of lOjxl containing 2(il of 5x sequenase buffer (5x;
200mM Tris HC1 pH 7.5, lOOmM MgCl2, 250mM NaCl), 5|ll of denatured DNA and
5ng of primer. For sequencing the plasmids pSMl/Q5 and pSM17Q5 the primer
supplied with the Sequenase version 2.0 kit was used (termed -40;
5 ' GTTTTCCCAGTCACGAC 3 '). For sequencing the plasmids prPPT-(3Gal3,
prPPT-pGal4, prPPT-|3Gal6 and pVL29 a primer containing sequence from the rPPT-
A promoter, spanning nucleotides +4 to -20 relative to the major transcriptional start
site, was used (sequence; 5' TCGACTCTAGTCCCTGCTCCTGCTTCGC 3').
Reactions were boiled for 2 mins and then slowly cooled to room temperature.
Annealed DNA samples (10(ll) were then radioactively labelled with 35S dATP by
incubation with l(il of 0.1M DTT, 2|il of labelling mix (7.5|lM dCTP, 7.5|lM dGTP,
7.5(xM dTTP, diluted 1:5 in dH20), 5p.Ci of [35S] dATPaS (Amersham,
lOOOCi/mmol) and 2jil of Sequenase Version 2.0 (diluted 1:8 in enzyme dilution
buffer: lOmM Tris HC1 pH7.5, 5mM DTT, 0.5mg/ml BSA) at room temperature for 2-
5 mins. Reactions were terminated by the incubation of 3.5|il of each labelled DNA
sample with 2.5|il aliquots of all four ddNTPs (prewarmed to 37°C) followed by an
incubation at room temperature for 5 mins. 4|xl of stop solution was then added and
samples were boiled for 2 mins before loading onto 6% denaturing polyacrylamide/urea
gels (Section 2.2.1.2.b.). Gels were electrophoresed at 1500V for 3-4 h and fixed for
30 mins (5% methanol, 15% acetic acid) before drying and exposing to
autoradiographic film (Section 2.2.1.3.), typically for 16 h.
2.2.7.2. Maxam Gilbert sequencing.
Singly 32P-5'-end-labelled DNA fragments (Section 2.2.5.2.) were sequenced
using the G+A reaction in the Sigma Maxam-Gilbert kit as according to manufacturers
instructions (Sigma).
Briefly, 5-10|al of DNA was depurinated by incubation with 2(xl of pyridinium
formate at 37°C for 30 mins. Samples were dried under vacuum using a Gyrovap,
resuspended in 20|il of dH20 and dried once more. DNA was cleaved at the modified
bases by dissolving in IOOjlxI of piperidine (diluted 1:10 in dH^O), followed by an
incubation at 90°C for 30 mins. Samples were dried once more under vacuum and
resuspended in 10p.l of dH^O. Resuspended DNA samples were dried once again,
resuspended in 10|ll of dH20 and finally dried and resuspended in 5(il of stop solution.
Sequenced DNAs were boiled for 2 mins and quickly cooled in ice water before
electrophoresing on 6% denaturing polyacrylamide gels (Section 2.2.1.2.a.), along
with DNase 1 footprinting reactions (Section 2.2.6.2.).
Section 3: Analysis Of The Rat Preprotachykinin-A Promoter.
3.1. Aim of the study.
The aim of this study was to investigate how the rat preprotachykinin-A (rPPT-
A) gene is regulated at the transcriptional level.
The regulation of the initiation of mRNA synthesis involves the specific
interaction of several different types of trans-acting factors with a number of cis-acting
DNA sequence elements, including upstream activating sequences and enhancers,
located both upstream and downstream from the major transcriptional start site (Section
1.2.3.). In order to characterise regions of DNA sequence within the rPPT-A promoter
which have the potential to act as such regulatory elements, an attempt was made to
identify protein/DNA interaction sites within a 1300 bp region of the promoter.
The sequence of the region of the promoter examined, spanning nucleotides
-865 to +447, is shown in Figure 4 with the first nucleotide (+1) of the major
transcription initiation site (identified by Carter and Krause, 1990) as an adenine base.
3.2. Sequence analysis of the rPPT-A promoter.
Two previous studies have identified putative transcription factor binding sites
within the 5' flanking region of the rPPT-A promoter. Carter and Krause (1990)
sequenced 866 bp of 5' flanking sequence and, by comparison with the consensus
sequence for various transcription factors, identified several putative regulatory
elements. These include a region homologous to an estrogen response element (ERE) at
-149 to -137 (..GGTTACCGTCTCG..) (Maurer and Notides, 1987), a serum response
element (SRE) at -224 to -206 (..GATGGCGAGACCTCGACTT..) (Triesman, 1986),
cAMP response elements (CRE) at -41 to -30 (..ATCACGCCTGAG..) and -409 to -398
(..TTTGGCTGTCCT..) (Roesler et al., 1988), a CAAT box at -181 to -177
(..CCAAT..) (Santoro et al., 1988), and GC boxes at -108 to -100 (..GGGGGCGGC..)
and -270 to -261 (..GGGGCGTCAG..) ( reviewed by Dynan and Tjian, 1985; Briggs et
al., 1986). Chapman et al. (1993) extended this analysis and determined the nucleotide
sequence of 3350 bp of 5' flanking sequence. By inspection of the sequence several
putative regulatory elements were noted within the 5' flanking DNA. These sequence
elements include putative octamer binding protein binding sites at -2822 to -2815
(..ATTTGTAT..), -2782 to -2775 (..ATACAAAT..) and -662 to -655 (..ATGTAAAA..)
(reviewed by Schaffner, 1989) and putative AP-1 binding sites at -2743 to -2737
(..TGAGTCA..), -2382 to -2376 (..TGACTAA..), -341 to -335 (..TGAGTCA..) and -318
to --312 (..TGAGTAA..) (reviewed by Curran and Franza, 1988).
Figure 4. Nucleotide sequence of the rPPT-A promoter spanning nucleotides -865 to
+447.
The nucleotide sequence is numbered on the left hand side with the first nucleotide (+1)
of the major transcriptional start site as an adenine base (shown in bold type) (identified




























CTGCAGAGCT CCAAAGGTAA GCATCCAGCC TTTCTAGTCC CCCAACAAGG
CTAAAGGGGA GAGAGGCACA ATTATCCTCT TCCCACCCCT TCTGCCTTCA
GGGTGTGCCT GGGAAGAAGC TGTAGGGGAA CAAAAGATGC CTTAGAATGG
CTGATGGGTA AGTTCTACAT GAGAAAGGAG GTTTAAATTC CTCTTTCCCC
TAAATGTAAA ACAAACCTGC CTTCATCCTC TGAAGCGGGA GACCGGAAAC
ACTTTTGCAG TGCTAGAGAA ATGAGAATAT TCTGACTGAT TTGGTGGGGA
GGGGGGTTGG GGGGGTGTGT TCCAGCCCTA GATATAACAC CTCATAAACC
TTAAGACACA TAAAGTAGAA ATGAAAGGAA AACCCCGCTT GCTTCATCCC
TCTGAAGTGC TTGCTGGTGT CTTAGTATTA TTCACAAGGT TTTGCTGCTC
AAGTTATTTG GCTGTCCTCA AAGCGCAATA TTCCCTGATG CCTCTTGAGA
GAAAAGTTCC CTAAGTCCGA AGCATGAGTC ACTTCGCTCA GTTTTGATGA
GTAATCTCAG GTGTCACTGA ACCTTGTTCG GAAGAAGAGG GGAGGGGGGC
GTCAGATTTG CAGACGGAAG AAAACAGGTC TCTCTGGATT GGATGGCGAG
ACCTCGACTT CCCTAAAATT GCGTCATTTC GAACCCAATT TGGTCCAGAT
GTTATGGACT CCGACGGGTT ACCGTCTCGG AAACTCTATC ACGCAAGCAA
AAGGCGAGGG GGCGGCTAAT TAAATATTGA GCAGAAAGTC GCGTGGGGAG
AGTGTCACGT GGCTCTCCAG GCTCATCACG CCTGAGATAA ATAAGGCGAA
GCAGGAGCAG GGACTAGAGC GCACTCGGAC CAGCTCCACT CCAGCACCGC
GGCGGAGGAG AGCGAGGAGC GCCCAGCAAG TGCGCACCTG CGGAGCATCA
CCGGGTCCGA CCGCAGTGAG TACCACTCCC GCCTGCCATC TGCCGCTGCC
TGGGGCCCGT CGTGCCTTGG TCAGAGGTGG CGTCCGCCCG GGGTTTCACC
TGCAGCAGCC ACAGACCCGG AGAGAAACTG TGCAAATACC AACACCTCTC
TTTGTCTGCC TTCAGGCTTC GGAGTGTGGG TCAGTGGGTA GGGGGCTGGG
ACGTTGAGAG GCAAAGAGAG GAGGACTTGA GGCTCTTTGG CACGTCAGTA
GCCTTCTTAA AGGGTTTGGA GAAATGTTCG ACCTGGTGGG TTTTTGTTTT
TGTTTTAATC TTGGTTTAGC GAGACCTCTT CTTTCTTCCT TGTGGCATTG
AAATTCAGCT GC
3.3. Functional analysis of the rPPT-A promoter.
Understanding the transcriptional regulation of the rPPT-A promoter has been
hampered by the lack of cell lines which express the gene at high levels, either
endogenously or when transfected with plasmids containing regions of the promoter
linked to reporter genes (Wood et al., 1990; Gilchrist et al., 1991; and personal
communications, J.Quinn).
Recently, Mulderry et al. (1993) demonstrated, by microinjection, that plasmids
containing 3.3 Kb of rPPT-A 5'-flanking sequences linked to a lacZ reporter gene are
expressed in cultured DRG neurons. By 5' deletion analysis, they showed that
expression was directed by 865 bp of the promoter lying immediately upstream of the
transcriptional start site. Furthermore, inclusion of sequences downstream of the major
transcriptional start site to +526, incorporating the first intron, increased expression
two to three fold.
3.4. Strategy.
The findings above suggest that many of the elements regulating rPPT-A gene
expression in DRG neurons lie in 865 bp of sequence immediately 5' to the major
transcriptional start site and in 3' sequence encompassing the first intron.
Based on these findings it was decided, in this study, to analyse a
corresponding region of the promoter, spanning nucleotides -865 to +447 bp relative to
the major transcriptional start site, for potential cis-acting DNA sequence elements. In
order to identify sequences of DNA within the promoter important for function, a series
of assays were used dedicated to identifying protein/DNA interaction sites. These are;
1. Exonuclease protection analysis.
2. DNase 1 footprinting analysis.
3. Electrophoretic mobility shift assays.
Unfortunately, it is very difficult to obtain material of suitable quantity and
quality from DRG neurons making this tissue unsuitable for use in the types of
biochemical assays that this study requires. As there are no cell lines which express the
rPPT-A gene at high levels (Wood et al., 1990), the well characterised HeLa cell line
was used as a source of protein extract. HeLa cells have been shown to express a large
array of transcription factors and many of these, including for example AP-2 (Mitchell
et al., 1991) and Oct-1 (Wood et al., 1992), are also expressed in DRG neurons, thus
making them suitable for use in this study.
Initially, a region of the rPPT-A promoter close to the transcriptional start site
and TATA box was analysed for the presence of protein/DNA interaction sites using the
exonuclease protection assay. This was followed by DNase 1 footprinting and
electrophoretic mobility shift analysis of a larger region of the promoter.
3.5. Analysis of the rPPT-A promoter by the exonuclease protection assay.
3.5.1. The exonuclease protection assay.
The exonuclease protection assay (Quinn et al., 1987) (Section 2.2.6.3.) is a
method which allows for the enrichment, identification and characterisation of
sequence-specific DNA-binding proteins (Figure 5). The advantage of this assay over
the more commonly used DNase 1 footprinting assay is that it does not require binding
sites on the DNA to be saturated. Thus, this assay requires less protein extract than
DNase 1 footprinting assays and may detect DNA-binding proteins which are less
abundant and would not be identified by footprinting analysis .
The principles behind the exonuclease protection assay are outlined in Figure 5.
The DNA sequence of interest is cloned into polylinker sequence of the pUC19 vector
adjacent to the lac operator sequence (Oi and O3). A Pvu II fragment including the
DNA sequence of interest and the lac operator sequence is radioactively 3' end labelled.
This end labelled fragment is then incubated with a lac repressor-(3-galactosidase fusion
protein allowing the lac repressor portion of the fusion protein to bind to the operator
sequence. Immunobeads, consisting of anti-rabbit Ig coupled to anti-(3-galactosidase
antibodies, are then added to the reaction. The (3-galactosidase portion of the fusion
protein will bind to the anti-(3-galactosidase antibody. This results in a complex of DNA
linked to immunobeads via the lac repressor-(3-galactosidase fusion protein. The
complex is then incubated with protein extract in the presence of the non-specific
competitor DNA, poly(d[I-C]), to allow sequence specific proteins to bind to any
recognition sites present within the DNA. Pelleting the beads by brief centrifugation
concentrates the specifically bound protein(s), leaving un-bound proteins in the
supernatant. T7 gene 6 exonuclease enzyme, which digests the DNA in a 5' to 3'
direction, is then added to the washed pellet. In the absence of specific binding factors,
digestion proceeds along the DNA only stopping at the lac operator-lac repressor
interaction. On electrophoresis, this is revealed as two bands, one large (indicated as a)
and one small (indicated as b). However, if factor(s) are specifically bound to a
particular region of the DNA, exonuclease digestion stops at the position(s) of binding
and new band(s) (indicated as b + c) appear on electrophoresis corresponding to bound
factor(s) (indicated as Protein Binding Site). This is accompanied by a diminution of
the intensity of the lower lac operator-lac repressor band. From the position of the
protein binding site on an autoradiogram relative to size marker DNA, electrophoresed
along with the exonuclease enzyme digestion products, the location of the protein
binding site on the DNA can be estimated.
Figure 5. Schematic representation of the exonuclease assay.
A DNA fragment containing the sequence of interest, ( Y/////77/1), cloned next to
the lac operator sequence (O3 and Oi) from pUC 19 is radioactively labelled at the 3'
ends.
A lac repressor-p-galactosidase fusion protein (LRFP) (0) is added to the end-labelled
DNA fragment allowing the lac repressor portion of the fusion protein to bind to the lac
operator sequence.
Y
Immunobeads carrying anti-(3-galactosidase antibodies (0 ) are subsequently added.
The anti-(3-galactosidase antibody recognises the (3-galactosidase portion of the fusion
protein. This produces a complex of DNA linked to immunobeads via the lac repressor-
(3-galactosidase fusion protein.
The complex is then incubated with protein extract in the presence of the non-specific
DNA competitor poly(d[I-C]), in order to allow sequence specific DNA-binding
protein(s) (^SSI^) to bind to any recognition sites within the DNA.
T7 gene 6 exonuclease is then added, this enzyme digests the DNA in a 5' to 3'
direction. In the absence of specific binding factor(s), exonuclease enzyme proceeds
digestion along the DNA only stopping at the lac repressor-lac operator interaction.
This produces two DNA fragments on electrophoresis corresponding to the lac
operator-/ac repressor interactions, one large (indicated as a) and one small (indicated as
b).
If protein(s) are specifically bound to any point on the DNA fragment then they prevent
exonuclease digestion proceeding along the DNA. This results in a diminution of the
lower lac repressor-/ac operator interaction (b) and the appearance of new band(s)
(indicated as b + c) corresponding to the bound factors (Protein Binding Site).
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In order to analyse a region of the rPPT-A promoter close to the transcriptional
start site and TATA box for potential regulatory elements the constructs pSMl/Q5 and
pSMl'/Q5 were made. These constructs are derived from the plasmid pPPT (Quinn,
1992) which contains a fragment of the rPPT-A gene, spanning nucleotides -3356 to
+447 relative to the major transcriptional start site, cloned into the polylinker of the
vector pUC19.
Construction of pSMl/Q5 and pSMl'/Q5 was carried out as follows. Plasmid
pPPT was digested in the polylinker with the restriction enzymes Xba I and EcoR I and
a fragment of approximately 3900 bp, corresponding to rPPT-A sequence, was purified
from a 1% low melting point agarose gel. Purified insert DNA was then digested with
the restriction enzyme Hinf I and the desired fragment, covering nucleotides -160 to
+447 of the rPPT-A promoter, was again purified from a low melting point agarose
gel. Sticky ends were filled in with Klenow DNA polymerase.
The vector pUC19 was digested with Sma I and then dephosphorylated with
CIP. Dephosphorylated vector and filled-in insert were ligated and transformed into
competent HBlOl cells. Resulting colonies were picked and tested for inserts. Clones
containing inserts in both directions were grown-up and the sequence of the insert was
confirmed by DNA sequencing. The constructs are termed pSMl/Q5 and pSM17Q5,
and are diagramatically represented in Figure 6.
3.5.2. Identification of a protein/DNA interaction within the rPPT-A promoter by the
exonuclease protection assay.
Exonuclease protection analysis was carried out using the construct pSMl/Q5
(Figure 6) and HeLa nuclear extract.
Figure 7 shows the result of such an assay. The lac operator-/ac repressor
interaction bands (indicated as lac operator interaction) are, as expected, only present
when exonuclease enzyme was added (lanes 3 & 4). An additional strong band
(indicated as Protein/DNA interaction) is present in lane 4 when both exonuclease
enzyme and HeLa nuclear extract were included in the reaction. This band corresponds
to a protein/DNA interaction site which, from the position of size marker DNA, lies
approximately 300 bp from the end of the DNA fragment. Taking the pUC vector and
rPPT-A DNA into account, the binding site of this factor can be placed close to the
major transcriptional start site.
Thus, using the exonuclease protection assay system, a binding site for proteins
expressed in HeLa cells has been identified close to the major transcriptional start site of
the rPPT-A gene.
Figure 6. Diagrammatic representation of the constructs used for exonuclease protection
and DNase 1 footprinting assays.
A region spanning nucleotides -856 to +447 of the rPPT-A promoter (indicated as
rPPT-A) was analysed for DNA/protein interaction sites.
In order to achieve this a series of constructs were used. Constructs prPPT-pGal 3, 4
and 6 and pVL24 contain various fragments of the rPPT-A promoter linked to a lacZ
((3-galactosidase) reporter gene (Supplied by K. Chapman, Department of Medicine,
Western General Hospital, Edinburgh; Mulderry et al., 1993). These are;
1. prPPT-|3Gal 3: A 957 bp fragment spanning nucleotides -865 to +92.
2. prPPT-pGal 4: A 763 bp fragment spanning nucleotides -671 to +92.
3. pVL29: A 523 bp fragment spanning nucleotides -431 to +92.
4. prPPT-flGal 6: A 437 bp fragment spanning nucleotides -345 to +92.
pSMl/Q5 and pSM17Q5 contain a 607 bp fragment spanning nucleotides -160 to +447



















Figure 7. Identification of a protein/DNA interaction site within the rPPT-A promoter
by the exonuclease protection assay.
The construct pSMl/Q5 was digested with the restriction enzyme Pvu II and a resulting
DNA fragment, containing rPPT-A sequence and the lac operator sequence from
pUC19, was radioactively 3' end labelled. lOOng of the end-labelled DNA fragment
was digested with T7 gene 6 exonuclease, following incubation with HeLa nuclear
extract.
Lane 1 shows the position of the labelled DNA fragment which, as indicated, co-
migrates with size marker DNA at approximately 600 bp. Lane 2 demonstrates that the
addition of HeLa nuclear extract (0.2mg) had no effect on the migration of the DNA
fragment. The addition of exonuclease enzyme, (40 units) (lane 3), digested the DNA
to reveal two lac operator-lac repressor interactions (indicated as Lac operator
interaction). In the presence of HeLa nuclear extract, (0.2mg) (lane 4), exonuclease
enzyme (40 units) digested the DNA to reveal an additional band which corresponds to
a protein/DNA interaction site (indicated as Protein/DNA interaction). The approximate
position of this interaction, by alignment with size marker DNA, is 300 bp from the end
of the DNA fragment
Lane: 12 3 4
Exonuclease: - + +
HeLa: - + - +






Further exonuclease protection assays using the same construct (pSMl/Q5)
with different extracts and conditions have demonstrated the presence of several more
specific protein/DNA interaction sites, placed both 5' and 3' of the major transcriptional
start site (personal communication, J.Quinn). Additionally, a previous study using the
same assay identified multiple protein binding sites within a 3.8 kb fragment of the
promoter (Quinn, 1992).
Unfortunately, the exonuclease protection assay does not allow the exact
location of identified protein/DNA interaction sites to be determined. In order to achieve
such accurate mapping of such sites and to examine them in more detail, DNase 1
footprinting and electrophoretic mobility shift assays were subsequently carried out, as
described in the following sections.
3.6. Analysis of the rPPT-A promoter by DNase 1 footprinting and electrophoretic
mobility shift assays.
DNase 1 footprinting analysis (Section 2.2.6.2.) uses singly 5' end labelled
DNA fragments in order to identify sequence specific protein binding sites within a
particular region of DNA sequence. This particular assay, although requiring the use of
more protein extract than exonuclease protection assays, does allow the exact bases
protected by bound factors to be accurately determined.
A series of constructs, diagramatically represented in Figure 6, were used in
this study for DNase 1 footprinting assays. The construction of the plasmids pSMl/Q5
and pSMl'/Q5 is described in Section 3.5.1. Constructs prPPT-(3Gal 3, 4 and 6 and
pVL24 (a gift from K. Chapman) contain various fragments of the rPPT-A promoter
linked to a lacZ (fi-galactosidase) reporter gene. These constructs were sequenced
(Section 2.2.7.1.) and were shown to contain the following regions from the rPPT-A
promoter:
1. prPPT-pGal 3; A 957 bp fragment spanning nucleotides -865 to +92.
2. prPPT-(3Gal 4; A 763 bp fragment spanning nucleotides -671 to +92.
3. pVL29; A 523 bp fragment spanning nucleotides -431 to +92.
4. prPPT-(3Gal 6; A 437 bp fragment spanning nucleotides -345 to +92.
In order to generate suitable substrates for use in DNase 1 footprinting assays
constructs were linearised by restriction enzyme digestion in the polylinker with Sal I
and then radioactively 5' end labelled (Figure 3). Each DNA fragment was then
digested in the polylinker, with Xba\ for prPPT-pGal-3, 4 and 6 and pVL29 and with
Hind III for pSMl/Q5 and pSM17Q5. This produced two singly end labelled
fragments, one of almost full length and the other of only 10-20 bp in length which
would not interfere with the assay. Singly end labelled fragments were incubated with
protein extract (approximately 1.0 mg) in the presence of the non-specific competitor
DNA, poly(d[I-C]). This allowed sequence specific proteins to bind to any DNA
recognition sites present within the rPPT-A promoter sequence. DNase 1 enzyme was
then added at a predetermined concentration in order to introduce, on average, a single
random nick per DNA molecule. The reactions were terminated by the addition of
EDTA and SDS and reaction products were visualised by denaturing polyacrylamide
gel electrophoresis and autoradiography. Regions of DNA bound by sequence specific
proteins were identified by comparing the ladder of DNase 1 digestion products in the
presence of protein with that generated in the absence of protein. Bands missing from
the ladder resulted from bound proteins protecting the DNA from DNase 1 nicking and
darker bands, or hypersensitive sites, appeared when bound proteins altered the
conformation of the DNA to allow preferential DNase 1 nicking. The exact bases
protected by bound factors were determined by Maxam Gilbert sequence reactions of
the appropriately labelled DNA fragment (Section 2.2.7.2.) electrophoresed along with
the DNase 1 reaction products.
Electrophoretic mobility shift assays (Section 2.2.6.1.) (Singh et al., 1986)
were also used, in some cases, to analyse footprinted sequences from the rPPT-A
promoter in more detail. The electrophoretic mobility shift assay is a method used to
identify and characterise protein/DNA binding activities. It involves incubating cellular
extracts (nuclear or whole cell) with a short radioactively labelled oligonucleotide probe
containing the consensus sequence and flanking regions for the transcription factor of
interest. When reaction mixtures are run on a native polyacrylamide gel, DNA bound
by protein is seperated from free DNA and appears as a retarded band, the specificity of
which can be determined by the addition of competitor DNA.
3.6.1. Identification of potential regulatory elements within the rPPT-A promoter.
By the use of DNase 1 footprinting and electrophoretic mobility shift assays
several potential regulatory sequence elements have been identified within the rPPT-A
promoter. The sequence of each element has been underlined in Figure 8 and each
element has been numbered 1 to 19.
3.6.1.2. Element 1.
DNase 1 footprinting analysis was carried out using the construct pSMl/Q5
(Figure 6) and HeLa nuclear extract. Figures 9 A and 9B, lane 1 show the pattern of
DNase 1 digestion when no extract was present. When HeLa nuclear extract was added
to the reaction (Figure 9A, lane 2 and Figure 9B, lanes 2 and 3) a footprint, as
indicated, was clearly visible. From the Maxam and Gilbert sequence reaction in Figure
9A (lane 3), the footprint can be located to a 20 bp sequence element spanning
nucleotides -67 to -47. This footprint is termed E-box 1 as it includes an E-box
Figure 8. Nucleotide sequence of 1300bp of the rPPT-A gene indicating potential
regulatory elements.
The nucleotide sequence is numbered on the left hand side with the first nucleotide (+1)
of the major transcriptional start site as an adenine base (shown in bold type).
Underlined sequences are regions identified as protein/DNA interaction sites by
DNase 1 footprinting analysis and electrophoretic mobility shift assays. The numbers
underneath underlined sequences correspond to the following elements:
1 . Element containing an E-box motif (E-box 1).
2 . Element containing an E-box motif (E-box 2).
3 . Element displaying homology to both CRE/ATF and AP-1 consensus
sequences ('CRE').
4 . Element rich in dG and dA residues (Purine-Rich Element).
5 . Element containing an E-box motif (E-box 3).
6 . Element containing a six out of seven base pair match to an AP-1 consensus
sequence (AP-11).
7 . Element containing a perfect AP-1 consensus sequence (AP-1).
8 . Element rich in dG nucleotides (5' G-Rich).
9 . Unidentified Element 1 (U.D. 1).
10. Element rich in dA and dT nucleotides containing an octamer-like consensus
sequence (5' AT-Rich).
11. Elements which bind both single-stranded and double-stranded DNA binding
proteins (dsDBP/ssDBP).
1 2. Region located between the TATA box and transcriptional start site (Minimal
Element).
13-16. Elements displaying tissue specificity in their protein binding activity.
17. Element rich in dG nucleotides (3' G-rich).
18. Unidentified Element 2 (U.D. 2).
19. Element rich in dT nucleotides (3' T-rich).
-865 CTGCAGAGCT CCAAAGGTAA GCATCCAGCC TTTCTAGTCC CCCAACAAGG
-815 CTAAAGGGGA GAGAGGCACA ATTATCCTCT TCCCACCCCT TCTGCCTTCA
-765 GGGTGTGCCT GGGAAGAAGC TGTAGGGGAA CAAAAGATGC CTTAGAATGG
11
-715 CTGATGGGTA AGTTCTACAT GAGAAAGGAG GTTTAAATTC CTCTTTCCCC
-665 TAAATGTAAA AGAAAGGTGG CTTCATCCTC TGAAGCGGGA GACCGGAAAC
1 0
-615 ACTTTTGCAG TGCTAGAGAA ATGAGAATAT TCTGACTGAT TTGGTGGGGA
9
-565 GGGGGGTTGG GGGGGTGTGT TCCAGCCCTA GATATAACAC CTCATAAACC
8
-515 TTAAGACACA TAAAGTAGAA ATGAAAGGAA AACCCCGCTT GCTTCATCCC
-465 TCTGAAGTGC TTGCTGGTGT CTTAGTATTA TTCACAAGGT TTTGCTGCTC
-415 AAGTTATTTG GCTGTCCTCA AAGCGCAATA TTCCCTGATG CCTCTTGAGA
-365 GAAAAGTTCC CTAAGTCCGA AGCATGAGTC ACTTCGCTCA GTTTTGATGA
7 6
-315 GTAATCTCAG GTGTCACTGA ACCTTGTTCG GAAGAAGAGG GGAGGGGGGC
5 4
-265 GTCAGATTTG CAGACGGAAG AAAACAGGTC TCTCTGGATT GGATGGCGAG
-215 ACCTCGACTT CCCTAAAATT GCGTCATTTC GAACCCAATT TGGTCCAGAT
3 2
-165 GTTATGGACT CCGACGGGTT ACCGTCTCGG AAACTCTATC ACGCAAGCAA
-115 AAGGCGAGGG GGCGGCTAAT TAAATATTGA GCAGAAAGTC GCGTGGGGAG
-65 AGTGTCACGT GGCTCTCCAG GCTCATCACG CCTGAGATAA ATAAGGCGAA
1
-15 GCAGGAGCAG GGACTAGAGC GCACTCGGAC CAGCTCCACT CCAGCACCGC
1 2
+36 GGCGGAGGAG AGCGAGGAGC GCCCAGCAAG TGCGCACCTG CGGAGCATCA
13 14
+86 CCGGGTCCGA CCGCAGTGAG TACCACTCCC GCCTGCCATC TGCCGCTGCC
15 16
+136 TGGGGCCCGT CGTGCCTTGG TCAGAGGTGG CGTCCGCCCG GGGTTTCACC
+186 TGCAGCAGCC ACAGACCCGG AGAGAAACTG TGCAAATACC AACACCTCTC
+236 TTTGTCTGCC TTCAGGCTTC GGAGTGTGGG TCAGTGGGTA GGGGGCTGGG
1 7
+286 ACGTTGAGAG GCAAAGAGAG GAGGACTTGA GGCTCTTTGG CACGTCAGTA
1 8
+336 GCCTTCTTAA AGGGTTTGGA GAAATGTTCG ACCTGGTGGG TTTTTGTTTT
+386 TGTTTTAATC TTGGTTTAGC GAGACCTCTT CTTTCTTCCT TGTGGCATTG
1 9
+436 AAATTCAGCT GC
Figure 9. DNase 1 footprinting analysis of a region of the rPPT-A promoter
encompassing an E-box motif.
The construct pSMl/Q5 was singly 5' end labelled with T4 polynucleotide kinase and
lOOng of labelled probe was digested with DNase 1, in the absence or presence of
HeLa nuclear extract.
A. Lane 1 shows the pattern of digestion generated by 1.5 units of DNase 1. In
addition to DNase 1 (30 units), in lane 2 HeLa nuclear extract (lmg) was added and
lane 3 shows the G+A Maxam Gilbert sequencing reaction of the DNA probe.
A footprint was generated (lane 2) which, from the sequence in lane 3, spans
nucleotides -67 to -47 relative to the major transcriptional start site. This element is
termed E-box 1 as it contains an E-box motif (CACGTG).
B. Lane 1 shows the pattern of digestion generated by 1.5 units of DNase 1. In
addition to DNase 1 (30 units), increasing amounts of HeLa nuclear extract were added
in lanes 2 and 3 (0.5 and lmg respectively).
A footprint was generated (lanes 2 and 3) which, from comparison with 9A, spans
nucleotides -67 to -47 relative to the major transcriptional start site.
Lane 1 2 3
: I
:
Lane 1 2 3
DNasel + + +
HeLa ■ + ++
consensus sequence (CANNTG) (shown in bold type below), recognised by members of
the bHLH and bHLH/ZIP proteins (Section 1.2.3.1.1.h.):
-61 AGAGTGTCACGTGGCTCTCCA ~47
In order to further examine the interactions between the E-box 1 element and
proteins from various cell lines and tissues an oligonucleotide, termed El (Figure 10),
was made containing sequence spanning nucleotides -69 to -48 from the rPPT-A
promoter, for use in electrophoretic mobility shift assays.
Figure 11 shows the result of such an electrophoretic mobility shift assay. HeLa
nuclear extract (lanes 1-3) and CI300 (lanes 4-6), PC 12 (lanes 7-9) and AtT20 (lanes
10-12) whole cell extracts all formed complexes with the probe (indicated by an arrow),
with similar mobilities (compare lanes 1, 4, 7, and 10). These complexes were
demonstrated to be sequence specific as they were competed by specific DNA
competitor (lanes 2, 5, 8, and 11) and not by a heterologous competitor, (PPT AP-1,
Figure 10) (lanes 3, 6, 9, and 12). Non-specific complexes formed between the El
oligonucleotide and the various extracts are indicated as N.S.
Figure 12 shows that sequence specific complexes (indicated by an arrow) were
also formed between oligonucleotide E1 and proteins from rat spinal cord and caudate
nuclear extracts. These complexes display a similar mobility to the complex formed
with HeLa nuclear extract (compare lanes 1, 2 and 5).
3.6.1.3. Element 2,
DNase 1 footprinting assays carried out using the construct prPPT-(3Gal6
(Figure 6) and HeLa nuclear extract revealed a footprinted region spanning nucleotides
-177 to -155 (Figure 13, lane 2).
This footprint contains an E-box consensus sequence (CANNTG), termed E-box 2, as
shown in bold type below;
-17 7 TTTGGTCCAGATGTTATGGACTC ~155
Electrophoretic mobility shift assays, using this footprinted sequence as an
oligonucleotide probe, have demonstrated that the binding of proteins present in HeLa
cells to this element is specifically competed by related E-box containing
oligonucleotides (personal communication, J. Quinn).
3.6.1.4. Element 3.
DNase 1 footprinting assays using the construct prPPT-[3Gal6 (Figure 6) and
HeLa nuclear extract also revealed a footprint spanning nucleotides -198 to -180
(Figure 13, lane 2), as shown below;
-198 ATTGCGTCATTTCGAACCC ~180
Figure 10. Sequence of the oligonucleotides used in electrophoretic mobility shift
assays.
The sequence of the oligonucleotides used in electrophoretic mobility shift assays are
shown in their double stranded forms.
Oligonucleotides El, PPT AP-1, PPT 'CRE', 3' G-Rich, 5' AT-Rich, 3' T-Rich and
168/169 contain the following sequences from the rPPT-A promoter, relative to the
major transcriptional start site:
El;-69 to -48.
PPT AP-1;-347 to -327.
PPT 'CRE'; -200 to -186.
3' G-Rich; +264 to +291.
5' AT-Rich (782/783); -672 to -651.
3' T-Rich; +369 to +395.
168/169;-20 to+4
POB contains an element form the pro-opiomelanocortin (POMC) gene spanning
nucleotides -23 to +5 (Riegel et al., 1990).
NS (Non-specific) is a randomly computer generated sequence.
Oct contains an octamer binding protein element from the immunoglobulin heavy-chain
enhancer (Augereau and Chambon, 1986; and Staudt et al., 1988).
El 5' TCGAGGAGAGTGTCACGTGGCTCTCC
CCTCTCACAGTGCACCGAGAGGAGCT
PPT AP-1 5' TCGAAAGCATGAGTCACTTCGCTC
TCGTACTCAGTGAAGCGAGAGCT
PPT 'CRE' 5 ' TCGAAATTGCGTCATTTC
TTAACGCAGTAAAGAGCT
3' G-Rich 5 ' TCGAGGTCAGTGGGTAGGGGGCTGGGACGTTG
CCAGTCACCCATCCCCCGACCCTGCAACAGCT
5' AT-Rich 5 ' TCGATTTCCCCTAAATGTAAAACAAA
(782/783) AAAGGGGATTTACATTTTGTTTAGCT
3' T-Rich 5 ' TCGATGGTGGGTTTTTGTTTTTGTTTTAATC
ACCACCCAAAAACAAAAACAAAATTAGAGCT








Figure 11. Electrophoretic mobility shift assay using an E-box motif from the rPPT-A
promoter and extracts from HeLa. CI300. PC 12 and AtT20 cells.
A double stranded oligonucleotide (El) from the rPPT-A promoter spanning
nucleotides -69 to -48, containing an E-box motif, was 5' end labelled with T4
polynucleotide kinase. End-labelled oligonucleotide (lng) was incubated with either
HeLa nuclear extract or CI300, PC 12 or AtT20 whole cell extracts (20|ig each), in the
presence of l(ig of poly d(I-C).
Lanes 1, 4, 7 and 10 demonstrate that several complexes were formed between the
probe and HeLa, CI300, PC 12 and AtT20 extracts respectively, in the absence of
competitor DNA. One of these complexes, indicated by an arrow, was shown to be
specific as it was competed by homologous oligonucleotide, (S) (lOOng) (lanes 2, 5, 8
and 11), and not by a non-specific oligonucleotide, (NS) (lOOng) (lanes 3, 6, 9 and
12). Non-specific complexes are indicated by N.S.
Extract: HeLa CI 300 PC12 AtT20
Competitor: S N.S. S N.S. S N.S. N.S.
Figure 12. Electrophoretic mobility shift assay using an E-box motif from the rPPT-A
promoter and extracts from HeLa cells, rat spinal cord and rat caudate.
A double stranded oligonucleotide (El) from the rPPT-A promoter spanning
nucleotides -69 to -48, containing an E-box motif, was 5' end labelled with T4
polynucleotide kinase. End-labelled oligonucleotide (lng) was incubated with either
HeLa nuclear extract, rat spinal cord or caudate nuclear extracts (20pg each), in the
presence of lpg of poly d(I-C).
Lanes 1, 2, and 5 demonstrate that complexes were formed between the probe and
HeLa, rat spinal cord and rat caudate extracts respectively, in the absence of competitor
DNA. One of the complexes, indicated by an arrow, formed between the rat spinal cord
and caudate extracts was shown to be specific as it was competed by homologous
oligonucleotide, (S) (lOOng) (lanes 3 and 6), and not by a non-specific oligonucleotide,
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Figure 13. DNase 1 footprinting analysis of a region of the rPPT-A promoter
encompassing a 'CRE' and an E-box motif.
The construct prPPT-(3Gal 6 was singly 5' end labelled with T4 polynucleotide kinase
and lOOng of labelled probe was digested with DNase 1, in the absence or presence of
HeLa nuclear extract.
Lane 1 shows the pattern of digestion generated by 1.25 units of DNase 1. In addition
to DNase 1 enzyme (30 units), in lane 2 HeLa nuclear extract (lmg) was added. Lane 3
shows the G+A Maxam Gilbert sequencing reaction of the DNA probe.
Two footprints were generated in lane 2 which, from the sequence in lane 3, can be
located to nucleotides -198 to -180 and -177 to -155.
The footprinted region spanning nucleotides -198 to -180 contains a sequence
displaying homologies with both an AP-1 and a CRE/ATF consensus sequence and so
is termed 'CRE'. The footprint spanning nucleotides -177 to -155 contains an E-box

















The region shown in bold type displays homology to both a CRE/ATF (cyclic
AMP element binding protein/activating transcription factor) binding motif
(TGACGTCA) and to an AP-1 (TGA G/C TCA) consensus sequence.
As this region of the promoter has previously been suggested to represent a
functional CRE in the bovine PPT-A gene (Kageyama et al., 1991) and has previously
been noted as a potential CRE by others (Chapman et al., 1993), it is referred to here as
a 'CRE'.
3.6.1.5. Element 4.
A region containing a highly purine rich sequence was footprinted using the
construct pVL29 (Figure 6) and HeLa nuclear extract, (Figure 14, lane 2). This element
spans nucleotides -284 to -264 as shown below;
-284 AAGAAGAGGGGAGGGGGGCGT -264
It can be seen from Figure 14 that the footprint generated covering this region of
the promoter is not as strong as those generated over the regions spanning nucleotides
-324 to -308 and -345 to -330. However, an oligonucleotide containing the purine rich
footprinted region and flanking sequence will form specific complexes in
electrophoretic mobility shift assays, confirming that protein(s) will bind to this region
of the promoter in vitro (personal communication, J.Quinn).
3.6.1.6. Element 5.
DNase 1 footprinting using the construct pVL29 (Figure 6) and HeLa nuclear
extract failed to generate a footprint over a noted E-box motif within the rPPT-A
promoter (Figure 14, lane 2). This element, shown in bold type below, is termed
E-box 3:
-311 TCTCAGGTGTCA "300
However, an oligonucleotide spanning nucleotides -312 to -295, which
includes the E-box 3 motif, will form a specific complex in electrophoretic mobility
shift assays with HeLa nuclear extract (personal communication, J.Quinn). The
complex formed has been shown by cross-competition analysis to be related to other
complexes formed using E-box containing oligonucleotides. Thus, when in isolation
the E-box 3 motif will bind sequence-specific proteins.
3.6.1.7. Element 6.
DNase 1 footprinting analysis using the construct pVL29 (Figure 6) and HeLa
nuclear extract did, however, generate a footprint spanning nucleotides -324 to -308
(Figure 14, lane 2). The sequence of the footprinted region is shown below:
Figure 14. DNase 1 footprinting analysis of a region of the rPPT-A promoter
encompassing two AP-1 motifs and a purine-rich element.
The construct pVL29 was singly 5' end labelled with T4 polynucleotide kinase and
lOOng of labelled probe was digested with DNase 1, in the absence or presence of
HeLa nuclear extract.
Lane 1 shows the pattern of digestion generated by 1.25 units of DNase 1. In addition
to DNase 1 (30 units), in lane 2 HeLa nuclear extract (lmg) was added and lane 3
shows the G+A Maxam Gilbert sequencing reaction of the DNA probe.
Three footprints were generated in lane 2 which, from the sequence in lane 3, can be
located to nucleotides -345 to -330, -324 to -308 and -284 to -264.
The footprint spanning nucleotides -345 to -330 contains a perfect AP-1 consensus
sequence and is termed AP-1. The footprint spanning nucleotides -324 to -308 contains
a six out of seven base pair match to an AP-1 consensus sequence and is termed AP-1'
and finally the footprint spanning nucleotides -284 to -264 is rich in dG and dA
nucleotides and is termed a purine-rich element.
Immediately downstream of the AP-1' footprint there is an E-box motif (CAGGTG,
termed E-box 3) which is not footprinted.
Lane: 1 2 3
DNasel: + + G+A
HeLa: - +
-324 TTTTGATGAGTAATCTC ~308
This sequence element contains a region (shown in bold type) which displays a
six out of seven base pair match to an AP-1 consensus sequence (tga g/c tca) and
so is termed AP-1'.
3.6.1.8. Element 7.
DNase 1 footprinting analysis using the construct pVL29 (Figure 6) and HeLa
nuclear extract also generated a footprint spanning nucleotides -345 to -330 (Figure 14,
lane 2), as shown below:
"345 AGCATGAGTCACTTCG ~330
This footprint contains a perfect AP-1 consensus sequence (tga g/c tca)
(shown in bold type) and so is termed AP-1.
3.6.1.9. Element 8.
DNase 1 footprinting analysis was carried out using the construct prPPT-(3Gal4
(Figure 6) and HeLa nuclear extract. A footprint, spanning nucleotides -575 to -546,
was generated (Figure 15, lane 2), as shown below:
-575 ttggtggggaggggggttgggggggtgtgt ~546
This footprint is rich in dG residues and so is termed a 5' G-rich element.
3.6.1.10. Element 9.
DNase 1 footprinting analysis carried out using the construct prPPT-(3Gal4
(Figure 6) and HeLa nuclear extract also generated a footprint spanning nucleotides
-618 to -607 (Figure 15, lane 2), as shown below:
-618 aacacttttgca ~607
An oligonucleotide containing this element will form specific complexes with
HeLa nuclear extract by electrophoretic mobility shift assays (personal communication,
J. Quinn). As the identity of the proteins binding to the element have yet to be
determined it has been termed unidentified element 1 (U.D. 1).
3.6.1.11. Element 10.
Inspection of 5' flanking sequence of the rPPT-A promoter reveals the presence
of an AT-rich sequence, termed 5' AT-rich, which spans nucleotides -662 to -655 and,
interestingly, displays a six out of eight base pair match with the octamer binding
protein consensus sequence (atgcaaat), as shown below in bold type:
-665 TAAATGTAAAACAAA ~651
Figure 15. DNase 1 footprinting analysis of a region of the rPPT-A promoter
encompassing U.D.I and a G-rich sequence.
The construct prPPT-(3Gal 4 was singly 5' end labelled with T4 polynucleotide kinase
and lOOng of labelled probe was digested with DNase 1, in the absence or presence of
HeLa nuclear extract.
Lane 1 shows the pattern of digestion generated by 2.5 units of DNase 1. In addition to
DNase 1, in lane 2 HeLa nuclear extract (lmg) was added and lane 3 shows the G+A
Maxam Gilbert sequencing reaction of the DNA probe.
Two footprints were generated (lane 2) which, from the sequence reaction (lane 3),
span nucleotides -618 to -607 and -575 to -546.
The footprint spanning nucleotides -618 to -607 is termed U.D. 1 and the footprint
spanning nucleotides -575 to -546 is rich in dG nucleotides and is termed 5' G-Rich.
 
Footprinting analysis of this region of the promoter using the construct prPPT-
(3Gal3 (Figure 6) and HeLa nuclear extract failed to detect any protein binding activity
over the 5' AT-rich sequence. However, closer inspection of such footprinting assays
reveals that this region of the promoter is not cleaved by DNase 1, even in the absence
of protein. Therefore if a protein does bind over this region a footprint will not be
apparent.
The fact that 5' AT-rich sequence displays a high degree of homology with the
octamer binding protein consensus sequence suggests that proteins belonging to the
octamer binding protein family may recognise and specifically bind to this region of the
rPPT-A promoter. In order to determine if this is so an oligonucleotide was made
corresponding to the 5' AT-rich element and flanking sequences, spanning nucleotides
-672 to -651 (Figure 10, 5' AT rich), for use in electrophoretic mobility shift assays.
Figure 16, lane 1 shows that a complex, indicated by an arrow, was formed
between the 5' AT rich oligonucleotide (termed 782/783 ) and HeLa nuclear extract.
This complex was shown to be specific as it was competed by increasing
concentrations of homologous DNA competitor, (Specific) (lanes 2-4), and not by
increasing concentrations of a non-specific competitor DNA, (NS, Figure 10) (lanes
11-13). Increasing concentrations of an oligonucleotide containing the octamer binding
element from the immunoglobulin heavy-chain enhancer, (Octamer) (Augereau and
Chambon, 1986; Staudt et al., 1988) (Oct, Figure 10), also competed for complex
formation (lanes 5-7). In fact competition was complete with only a 10-fold
concentration excess of competitor (lane 5). Lane 14 shows the complex formed
between the ubiquitous Oct-1 protein from HeLa cells and the octamer containing
oligonucleotide. Comparison of lane 1 with lane 14 shows that the Oct-1 complex
migrates to a similar position as that formed with the 5' AT-rich oligonucleotide.
Therefore, it appears that the 5' AT-rich element from the rPPT-A promoter will bind
octamer binding proteins present in HeLa cells.
Electrophoretic mobility shift assays were also carried out using the octamer
binding element containing oligonucleotide (Oct) as a probe. Figure 17, lane 1 shows
the position of the complex, indicated by an arrow, formed between the octamer
oligonucleotide and Oct-1 from HeLa nuclear extract. The formation of this complex
was competed by increasing concentrations of both homologous oligonucleotide,
(Specific) (lanes 2-4), and 5' AT-rich oligonucleotide, (5') (lanes 5-7), but not by a
non-specific oligonucleotide, (lanes 11 and 12). In Figure 18 it is shown that the 5'
AT-rich oligonucleotide will also compete for complex formation between the octamer
oligonucleotide and proteins present in CI300 whole cell extract. Lane 1 shows the
position of the complex, indicated by an arrow, formed between Oct-1 from HeLa
nuclear extract and the octamer containing oligonucleotide. This complex migrates in a
Figure 16. Electrophoretic mobility shift assay using the rPPT-A 5' AT-rich element
and extract from HeLa cells.
A double stranded oligonucleotide (termed 782/783) containing the rPPT-A 5' AT-rich
element, spanning nucleotides -672 to -651 relative to the major transcriptional start
site, was 5' end labelled with T4 polynucleotide kinase. End-labelled oligonucleotide
(lng) was incubated with HeLa nuclear extract (20fig), in the presence of ljig of poly
d(I-C).
Several complexes were formed between the probe and HeLa cell extract, in the
absence of competitor DNA (lane 1). One of these complexes, indicated as an arrow,
was shown to be specific as it was competed by increasing concentrations (10, 100 and
200ng) of homologous oligonucleotide (Specific) (lanes 2-4). Complex formation was
also competed by increasing concentrations (10, 100 and 200ng) of oligonucleotides
containing either the immunoglobulin octamer binding element, (Octamer) (lanes 5-7),
or a 3' T-rich sequence from the rPPT-A promoter (lanes 8-10). Increasing
concentrations (10, 100 and 200ng) of non-specific oligonucleotide (lanes 11-13) failed
to compete for complex formation.
Lane 14 shows a specific complex (indicated as an arrow) formed between the
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Figure 17. Electrophoretic mobility shift assay using the immunoglobulin octamer
binding element and extract from HeLa cells.
A double stranded oligonucleotide containing the immunoglobulin octamer binding
element was 5' end labelled with T4 polynucleotide kinase. End-labelled
oligonucleotide (lng) was incubated with HeLa nuclear extract (20|J,g), in the presence
of ljig of poly d(I-C).
Several complexes were formed between the probe and HeLa cell extract, in the
absence of competitor DNA (lane 1). One of these complexes, indicated by an arrow,
was shown to be specific as it was competed by increasing concentrations (10, 100 and
200ng) of homologous oligonucleotide (Specific) (lanes 2-4). Increasing concentrations
(10, 100 and 200ng) of oligonucleotides containing either 5' AT-rich (5', lanes 5-7) or
3' T-Rich (3', lanes 8-10) sequences from the rPPT-A promoter also competed for
complex formation. Increasing concentrations (100 and 200ng) of a non-specific
oligonucleotide (lanes 11 and 12) failed to compete for complex formation.
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9 B-""
1 23 4 56 7 89101112
Figure 18. Electrophoretic mobility shift assay using the immunoglobulin octamer
binding element and extract from CI300 and HeLa cells.
A double stranded oligonucleotide containing the immunoglobulin octamer binding
element was 5' end labelled with T4 polynucleotide kinase. End-labelled
oligonucleotide (lng) was incubated with either HeLa nuclear extract (20|Xg) or CI300
whole cell extract (20|ig), in the presence of l[lg of poly d(I-C).
Lane 1 contains HeLa cell extract and lanes 2-8 contain CI300 cell extract. Several
complexes were formed between the probe and HeLa cell extract (lane 1) and between
the probe and CI300 cell extract (lane 2), in the absence of competitor DNA. One of the
complexes formed with CI300 cell extract, indicated by an arrow, was shown to be
specific as it was competed by increasing concentrations (10 and lOOng) of
homologous oligonucleotide (Specific) (lanes 3 and 4). Increasing concentrations (10
and lOOng) of an oligonucleotide containing a 5' AT-rich sequence from the rPPT-A
promoter, (T-Rich) (lanes 5 and 6), also competed for complex formation and
increasing concentrations (10 and lOOng) of a non-specific oligonucleotide, (N.S.)
(lanes 7 and 8), failed to compete.
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similar position to that formed between CI300 cell extract and the same oligonucleotide
(lane 2). The formation of the complex generated by CI300 cell extract was competed
by increasing concentrations of both homologous, (Specific) (lanes 3 and 4), and 5'
AT-rich, (T-Rich) (lanes 5 and 6), competitor oligonucleotides. Increasing
concentrations of non-specific oligonucleotide, (N.S.) (lanes 7 and 8), failed to
compete for complex formation.
Therefore, a region of the rPPT-A promoter containing a six out of eight base
pair match to the octamer binding protein consensus sequence has affinity for octamer
binding proteins present in both HeLa nuclear and CI300 whole cell extracts.
3.6.1.12. Element 11.
It has previously been shown (Quinn and McAllister, 1993) that one of the
DNA strands from an element within the rPPT-A promoter, spanning nucleotides -761
to -741, binds a single-stranded sequence-specific DNA binding protein. By
electrophoretic mobility shift assays it was demonstrated that this protein is present in
extracts prepared from a series of adult rat tissues (brain, cerebellum, spinal cord and
spleen) and in cultured adult rat DRG, but that it is absent from a series of neuronal and
non-neuronal derived cell lines (Quinn and McAllister, 1993). A mechanism for
binding of this protein to single-stranded DNA was proposed based on the fact that the
region binding the single-stranded DNA binding protein can be modelled as the loop of
a putative stem-loop structure. Further analysis was carried using an oligonucleotide,
spanning nucleotides -790 to -738, which contains the entire sequence of the putative
stem-loop structure. This longer oligonucleotide, in addition to binding single-stranded
DNA binding proteins present in rat tissue extract, was also found to bind proteins
from tissue culture cell lines when in the double-stranded form. Binding to the double-
stranded form was not observed with rat tissue extract (McAllister et al., 1993).
In order to investigate the binding of proteins from HeLa nuclear extract to this
region of the promoter, DNase 1 footprinting analysis was carried out using the
construct prPPT-PGal3 (Figure 6). Figure 19, lane 2 shows that HeLa nuclear extract
generated a footprint (indicated as footprint 1) spanning nucleotides -779 to -755, as
shown below;
~779 CCCTTCTGCCTTCAGGGTGTGCCTG ~755
Interestingly, when a 30 fold excess of the oligonucleotide spanning nucleotides
-790 to -738 was preincubated with the HeLa extract (lane 3), a different footprinting
pattern was generated (indicated as footprint 2) which spans nucleotides -759 to -731,
as shown below:
-759 GCCTGGGAAGAAGCTGTAGGGGAACAAAA ~731
Figure 19. DNase 1 footprinting analysis of a region of the rPPT-A promoter which
binds both single-stranded and double-stranded DNA binding proteins.
The construct prPPT-pGal3 was singly 5' end labelled with T4 polynucleotide kinase
and lOOng of labelled probe was digested with DNase 1, in the absence or presence of
HeLa nuclear extract.
Lane 1 shows the pattern of DNA digestion generated by 1.5 units of DNase 1. In
addition to DNase 1 (30 units), HeLa nuclear extract (lmg) was added in lanes 2 and 3.
In lane 3 an oligonucleotide (3|i,g), spanning nucleotides -790 to -738 of the rPPT-A
promoter, was preincubated with the HeLa nuclear extract. Lane 4 shows the G+A
Maxam Gilbert sequencing reaction of the DNA probe.
A footprinted region was generated by HeLa nuclear extract (lane 2) which, from the
sequence in lane 4, spans nucleotides -779 to -755, indicated as footprint 1. The
presence of the oligonucleotide in lane 3 resulted in the generation of a new footprint
spanning nucleotides -759 to -731, indicated as footprint 2.
These two footprints cover a region of the rPPT-A promoter which has previously been
shown to bind both single-stranded and double-stranded DNA binding proteins and has
also been proposed to form a stem-loop structure (Quinn and McAllister, 1993;






A region of the rPPT-A promoter, located between the TATA box and the major
transcriptional start site, termed the minimal promoter element, displays sequence
homology with a similarly positioned element from the pituitary-specific pro¬
opiomelanocortin (POMC) gene promoter. The POMC element spans nucleotides -3 to
-15 and specifically binds a factor termed PO-B which acts as a transcriptional
activator, facilitating POMC gene expression (Riegel et al, 1990). A comparison of the
sequences around the POMC and rPPT-A elements is shown below;
PPT -26 AA-tAagGcGAAGcAgGaG-CAGGGAC ~2
POMC ~23 AAgaAgaGaGAAG-A-GtGaCAGGGAC +2
The two elements show 65% sequence homology suggesting that they may bind
similar or related proteins.
In order to further analyse the rPPT-A minimal promoter element and to
investigate any potential relationships with the POMC element an oligonucleotide
(termed 168/169, Figure 10) was made, spanning nucleotides -20 to +4 of the rPPT-A
promoter, for use in electrophoretic mobility shift assays. Figure 20, lane 1 shows that
a complex (indicated by an arrow) was formed between the oligonucleotide 168/169
and HeLa nuclear extract. This complex was shown to be specific as it was competed
by increasing concentrations of homologous DNA competitor, (Specific) (lanes 2-4),
and not by increasing concentrations of a heterologous DNA competitor, (Octamer,
lanes 5-7).
In order to investigate the possible relationship between PO-B and the protein(s)
binding to the rPPT-A minimal promoter element, electrophoretic mobility shift assays
were carried out using an oligonucleotide corresponding to nucleotides -23 to +5 of the
POMC promoter, (a gift from A.Riegel, Department of Pharmacology, Georgetown
University, Washington DC ) (termed POB, Figure 10). Figure 21, lane 1 shows a
complex (indicated by an arrow) formed between the POB probe and HeLa nuclear
extract. This complex was specifically competed by increasing concentrations of
homologous competitor, (Specific) (lanes 2-4), but not by increasing concentrations of
the oligonucleotide 168/169 (lanes 5-7). This suggests that the proteins binding to the
POMC and rPPT-A elements are not related. Further support for this observation
comes from the finding that the complexes formed between oligonucleotides 168/169
and POB and various protein extracts have different mobilities. Figure 22 shows the
complexes (indicated as arrow 3) formed between the POB probe and HeLa nuclear
extract in lane 1, CI300 whole cell extract in lane 2 and AtT20 whole cell extract in lane
3. Lanes 4-6 show the complexes (indicated as arrow 2) formed between these same
Figure 20. Electrophoretic mobility shift assay using the rPPT-A minimal element and
extract from HeLa cells.
A double stranded oligonucleotide (168/169) containing rPPT-A sequence, spanning
nucleotides -20 to +4 relative to the major transcriptional start site, was 5' end labelled
with T4 polynucleotide kinase. End-labelled oligonucleotide (lng) was incubated with
HeLa nuclear extract (20pg), in the presence of l|lg of poly d(I-C).
Complexes were formed between the probe and HeLa cell extract (lane 1), in the
absence of competitor DNA. One of these complexes, indicated as an arrow, was
shown to be specific as it was competed by increasing concentrations (25, 50 and
lOOng) of homologous oligonucleotide (Specific) (lanes 2-4). Increasing concentrations
(25, 50 and lOOng) of an oligonucleotide containing the immunoglobulin octamer
binding element, (Octamer) (lanes 5-7), failed to compete for complex formation.
Competitor: Specific Octamer
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Figure 21. Electrophoretic mobility shift assay using an element from the POMC
promoter and extract from HeLa cells.
A double stranded oligonucleotide containing an element from the POMC promoter,
termed POB, spanning nucleotides -23 to +5 relative to the major transcriptional start
site was 5' end labelled with T4 polynucleotide kinase. End-labelled oligonucleotide
(lng) was incubated with HeLa nuclear extract (20pg), in the presence of lp,g of poly
d(I-C).
Complexes were formed between the probe and HeLa cell extract, in the absence of
competitor DNA (lane 1). One of these complexes, indicated as an arrow, was shown
to be specific as it was competed by increasing concentrations (25, 50 and lOOng) of
homologous oligonucleotide (Specific) (lanes 2-4). Increasing concentrations (25, 50
and lOOng) of an oligonucleotide (168/169) containing sequence from the rPPT-A
promoter (lanes 5-7) failed to compete for complex formation.
Competitor: Specific 168/169
Figure 22 Electrophoretic mobility shift assay using either the rPPT-A minimal
promoter element, an element from the POMC promoter or the immunoglobulin
octamer binding element and extract from HeLa. CI300 and AtT20 cells.
Double stranded oligonucleotides containing either rPPT-A sequence spanning
nucleotides -20 to +4 (168/169), an element from the POMC promoter spanning
nucleotides -23 to +5 (POB) or the immunoglobulin octamer binding element (Oct)
were 5' end labelled with T4 polynucleotide kinase. End-labelled oligonucleotides
(lng) were incubated with either HeLa nuclear extract, CI300 or AtT20 whole cell
extracts (20)lg each), in the presence of l(lg of poly d(I-C).
Complexes were formed between the POB probe and HeLa nuclear extract, C1300
whole cell extract and AtT20 whole cell extract (lanes 1-3 respectively). Arrow 3
indicates the position of the specific complexes, as determined from previous
electrophoretic mobility shift assays (Figure 21). Complexes were also formed between
the 168/169 probe and HeLa nuclear extract, CI300 whole cell extract and AtT20
whole cell extract (lanes 4-6 respectively). Arrow 2 indicates the position of specific
complexes, as determined from previous electrophoretic mobility shift assays (Figure
20). In Lane 7 the specific complex (as determined in previous electrophoretic mobility
shift assays Figure 16, lane 14) formed between HeLa nuclear extract and the Oct probe
is indicated by arrow 1.






















extracts and the rPPT-A 168/169 probe. The complex (indicated as arrow 1) generated
by the ubiquitous Oct-1 protein present in HeLa nuclear extract and an octamer
containing oligonucleotide (Oct, Figure 10) is indicated in lane 7. From this figure it is
clear that the complexes formed between the probes from the POMC promoter and the
rPPT-A promoter have very different mobilities, suggesting that distinct proteins bind
to these two promoter elements.
Interestingly, DNase 1 footprinting analysis carried out using the construct
pSMl/Q5 (Figure 6) and HeLa nuclear extract also revealed protein binding activity
within this region of the rPPT-A promoter (i.e. between the TATA box and the
transcriptional start site). Figure 23 (lanes 2 and 3) shows that in addition to a strong
footprint covering nucleotides -67 to -47 (E-box 1, element 1), HeLa nuclear extract
generated a footprint (indicated by arrows) covering nucleotides -16 and -17, shown
below in bold type:
-20 GCGAAGC ~14
In addition to the footprint, HeLa nuclear extract also generated a hypersensitive
site covering a dC nucleotide at position -19. This nucleotide was not cleaved by DNase
1 in the absence of protein, but was cleaved in the presence of protein (compare lane 1
with lanes 2 and 3).
Footprints generated over this region of the rPPT-A promoter were only
occasionally observed. This finding was reflected in electrophoretic mobility shift
assays. Complexes formed between the 168/169 oligonucleotide and protein extracts
were not routinely observed, in some cases the specific shift was very weak or not
present at all. This suggests that the protein/DNA interaction(s) in this region of the
promoter are in some way unstable, perhaps due to the lability of the protein(s)
responsible for complex formation.
3.6.1.14. Elements 13 to 16.
By use of the exonuclease protection assay multiple and specific DNA-protein
interaction sites have previously been identified within a 3.8 kb DNA fragment of the
rPPT-A promoter (Quinn, 1992). One of the sites of interaction was mapped to a region
3' of the transcriptional start site, approximately at the intron 1/exon 1 boundary. The
proteins binding to this site displayed neuronal specificity in their tissue distribution.
Proteins from rat cerebellar, hippocampal, spinal cord and PC 12 whole cell extracts
displayed binding activity, whereas binding was not observed by proteins present in rat
spleen extract or in the non-neuronal derived cell lines HeLa and 293 (Quinn, 1992).
In order to further investigate this apparently neuronal specific protein/DNA
interaction site, DNase 1 footprinting assays were carried out using a DNA fragment
Figure 23. DNase 1 footprinting analysis of a region of the rPPT-A promoter located
between the TATA box and transcriptional start site.
The construct pSMl/Q5 was singly 5' end labelled with T4 polynucleotide kinase and
lOOng of labelled probe was digested with DNase 1, in the absence or presence of
HeLa nuclear extract.
Lane 1 shows the pattern of digestion generated by 1.5 units of DNase 1. In addition to
DNase 1 (30 units), increasing amounts of HeLa nuclear extract (0.5 and lmg) were
added in lanes 2 and 3.
Two footprinted regions were generated by HeLa nuclear extract (lanes 2 and 3). The
lower footprint corresponds to the E-box 1 element spanning nucleotides -67 to -47.
The upper footprint, indicated by arrows, spans nucleotides -16 and -17 (dAs) and




from the rPPT-A promoter, derived from the construct pSMl'/Q5, with HeLa and rat
cerebellar nuclear extracts.
A suitable substrate for DNase 1 footprinting assays was generated by digestion
of the construct pSMl'/Q5 (Figure 6) in the polylinker with the restriction enzymes
EcoRl and Hindlll. This generated a DNA fragment of approximately 650 bp,
containing sequence spanning nucleotides -160 to +447 from the rPPT-A promoter.
This DNA fragment was purified from a low melting point agarose gel and then
digested with the restriction enzyme Dde I. A resulting DNA fragment of approximately
500 bp, termed pSMV/Q5/Dde I (Figure 6), which contains nucleotides -35 to +447
from the rPPT-A promoter, was purified and subsequently used in DNase 1
footprinting assays.
Figure 24 shows the result of a DNase 1 footprinting assay using
pSMY/Q5/Dde I with HeLa and rat cerebellar nuclear extracts. In lane 1 the pattern of
DNase 1 digestion in the absence of protein extract is shown. In addition to DNase 1,
HeLa and rat cerebellar (indicated as Cer.) extracts were added in lanes 2 and 3
respectively. It is clear that the two extracts generated different patterns of footprints.
The cerebellar generated footprints have been termed elements 13 and 16 and the HeLa
generated footprints have been termed elements 14 and 15.
Element 13.
Cerebellar nuclear extract (Figure 24, lane 3) generated a footprint spanning
nucleotides +55 to +89, as shown below:
+55 CGCCCAGCAAGTGCGCACCTGCGGAGCATCACCGG +89
(Nucleotide +89 is a hypersensitive site.)
This element contains two E-box motifs (consensus sequence CANNTG), as
shown in bold type. The CAAGTG motif is termed E-box 4 and the CACCTG motif is
termed E-box 5.
Element 16.
Cerebellar extract (Figure 24, lane 3) also generated a footprint spanning
nucleotides +116 to +130, as shown below:
+116 GCCTGCCATCTGCCG +13°
This elements also contains an E-box motif (shown in bold type), termed E-box 6.
Figure 24. DNase 1 footprinting analysis of a region of the rPPT-A promoter which
shows tissue specificity in its protein binding activity.
The construct pSMl/Q5 was digested with the restriction enzymes EcoR I, Hind III and
Dde I to produce a DNA fragment of approximately 500 bp in length. This fragment
was singly 5' end labelled with T4 polynucleotide kinase and lOOng was digested with
DNase 1, in the absence or presence of either HeLa or rat cerebellar nuclear extracts.
Lane 1 shows the pattern of digestion generated by 2.5 units of DNase 1. In addition to
DNase 1 (30 units in lane 2 and 15 units in lane 3), HeLa (lmg) and rat cerebellar
extract (Cer.) (lmg) were added in lanes 2 and 3 respectively . Lane 4 shows the G+A
Maxam Gilbert sequencing reaction of the DNA probe.
The neuronal and non-neuronal derived extracts generated different patterns of
protection over this region of the promoter.
Two footprints were generated by HeLa nuclear extract (lane 2) which, from the
sequence in lane 4, span nucleotides +74 to +94 and +98 to +107. The footprint
spanning nucleotides +74 to +94 is contained within exon 1 and the footprint spanning
nucleotides +98 to +107 is located over the intron 1/exon 1 boundary. When this
footprint is extended to nucleotide +108 it displays a five out of seven base pair match
to an AP-1 consensus sequence and so is termed HeLa AP-1.
Two footprints were also generated by rat cerebellar extract (lane 3) which, from the
sequence in lane 4, span nucleotides +55 to +89 and +116 to +130, as indicated. The
footprint spanning nucleotides +55 to +89 is located in exon 1 and the footprint
spanning nucleotides +116 to +130 is located in intron 1. Two E-box motifs, termed E-
box 4 and 5 are contained within the footprint spanning nucleotides +55 to +89 and one
E-box motif, termed E-box 6, is contained within the footprint spanning nucleotides
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When HeLa extract (lane 2) was added a footprint was generated covering
nucleotides +74 to +94, as shown below:
+74 TGCGGAGCATCACCGGGTCCG +94
Element 15.
HeLa nuclear extract also generated a footprint spanning nucleotides +98 to
+107, as shown below:
+98 GCAGTGAGTA +107
When the sequence of this footprint is extended to nucleotide +108 (C), a region
of sequence, termed HeLa AP-1, is revealed which displays a five out of seven base
pair match to an AP-1 consensus sequence (TGA G/C TCA).
Therefore, the neuronal and non-neuronal derived protein extracts protected
distinct yet overlapping sequences in a region of the rPPT-A promoter spanning
nucleotides +55 to +130. These results provide support for the finding by Quinn
(1992) of tissue specific binding in this region and additionally allow the sites of
protein/DNA interaction to be more accurately mapped.
The protected elements are located both in exon 1, intron 1 and over the intron
1/exon 1 boundary. Two of the protected regions, the neuronal generated footprint
from +55 to +89 and the non-neuronal derived footprint from +74 to +94, overlap and
are contained in exon 1. Intron 1 starts at +101 therefore placing the second HeLa cell-
generated footprint, from +98 to +107, over the intron 1/exon 1 boundary. Finally the
second footprint generated by cerebellar extract covering nucleotides +116 to +130 is
placed in intron 1.
3.6.1.15. Element 17.
DNase 1 footprinting was carried out using the construct pSMl'/Q5 (Figure 6)
with HeLa, rat cerebellum and total rat brain nuclear extracts (Figure 25). A footprint,
located 3' of the major transcriptional start site, was generated spanning nucleotides
+268 to +290, as shown below;
+268
AGTGGGTAGGGGGCTGGGACGTT +29°
This element is rich in dG nucleotides and so is termed a 3' G-rich element. It
can be seen from Figure 25 that HeLa nuclear extract (lane 2) generated a very strong
footprint covering this G-rich element and that rat cerebellar extract, (indicated as Cer.)
(lane 3), generated a slightly weaker footprint while rat total brain extract, (indicated as
Brn.) (lane 4), did not appear to generate any footprint over this region.
Figure 25. DNase 1 footprinting analysis of a region of the rPPT-A promoter
encompassing U.D. 2 and a G-rich sequence.
The construct pSMl'/Q5 was singly 5' end labelled with T4 polynucleotide kinase and
lOOng of labelled probe was digested with DNase 1, in the absence or presence of
either HeLa, rat cerebellar or total rat brain nuclear extracts.
Lane 1 shows the pattern of digestion generated by 1.5 units of DNase 1. In addition to
DNase 1 (30 units), HeLa nuclear extract (lmg) was added in lane 2, rat cerebellar
extract, (Cer.) (lmg), in lane 3 and rat brain extract, (Brn) (lmg), in lane 4. Lane 5
shows the G+A Maxam Gilbert sequencing reaction of the DNA probe.
Two footprints were generated by the extracts (lanes 2 to 4) which, from the sequence
in lane 5, span nucleotides +317 to +341 and +268 to +290.
The footprint generated by HeLa nuclear extract (lane 2), spanning nucleotides +317 to
+341, was much weaker than those generated by cerebellar (lane 3) or brain (lane 4)
extracts. All three extracts additionally generated hypersensitive sites, (indicated as
HS), covering nucleotides +331 and +334. This footprinted region is termed U.D. 2.
A footprint was also generated by HeLa nuclear extract (lane 2) and rat cerebellar
extract (lane 3), as indicated, spanning nucleotides +268 to +290. The total rat brain
extract (lane 4) did not appear to generate any footprint over this region. This
footprinted region covers a sequence rich in dG nucleotides and therefore is termed 3'
G-rich.
Lane 12345
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In order to further analyse the binding of proteins to this 3' G-rich element an
oligonucleotide, spanning nucleotides +264 to +291, containing the footprinted region
and flanking sequence (3' G-rich, Figure 10) was made for use in electrophoretic
mobility shift assays. Figure 26, lane 1 shows that a complex, indicated as an arrow,
was formed between the 3' G-rich oligonucleotide and HeLa nuclear extract. This
complex was shown to be specific as it was competed by increasing concentrations of
homologous competitor, (Specific) (Figure 26, lanes 2-4 and Figure 27, lanes 1-3), but
not by the heterologous competitor oligonucleotides, PPT AP-1 (Figure 10) in Figure
27, lanes 4-6 and 3' T-Rich (Figure 10) in Figure 26, lanes 5-7. For comparison, a
specific complex formed between HeLa nuclear extract and an oligonucleotide, (PPT
'CRE', Figure 10), containing the 'CRE' element (element 3), spanning nucleotides
-200 to -186, is shown in Figure 27, lane 7.
Attempts to carry out electrophoretic mobility shift assays using rat cerebellar
and total brain extracts were not successful. This is consistent with the DNase 1
footprinting analysis in which weaker binding was displayed by these extracts (Figure
25, lanes 3 and 4).
3.6.1.16. Element 18.
DNase 1 footprinting analysis was carried out using the construct pSM17Q5
(Figure 6) with HeLa, total rat brain and rat cerebellar nuclear extracts. All three
extracts generated footprints spanning nucleotides +317 to +341, (Figure 25, lanes 2-
4), as shown below:
+317 GCTCTTTGGCACGTCAGTAGCCTTC +341
The pattern of footprinting generated by the different extracts show some
differences. HeLa nuclear extract (lane 2) appeared to generate a weaker footprint than
rat cerebellar, (indicated as Cer.) (lane 3), or brain extract, (indicated as Brn) (lane 4).
It can be seen from Figure 25 that this footprint actually appears to consist of
two halves. One half covers nucleotides +317 to +332 and the second half covers
nucleotides +334 to +341. In addition to the footprints, all three extracts generated a
hypersensitive site (indicated as H.S.) covering a dG nucleotide at position +333
(shown in bold type above). This nucleotides was not cleaved by DNase 1 in the
absence of protein (lane 1) but was cleaved in the presence of protein extract (lanes 2-
4).
Inspection of the sequence reveals that the first half of the footprint contains a
region which displays a six out of eight base pair match to a CRE/ATF binding motif
(TGACGTCA), as shown in bold type below:
+317 GCTCTTTGGCACGTCAGTAGCCTTC +3A1
Figure 26. Electrophoretic mobility shift assay using the rPPT-A 3' G-rich element and
extract from HeLa cells.
A double stranded oligonucleotide containing the rPPT-A 3' G-rich element, spanning
nucleotides +264 to +291 relative to the major transcriptional start site, was 5' end
labelled with T4 polynucleotide kinase. End-labelled oligonucleotide (lng) was
incubated with HeLa nuclear extract (20|lg), in the presence of 2.5|lg of poly d(I-C).
Several complexes were formed between the probe and HeLa nuclear extract (lane 1).
One of these complexes, indicated as an arrow, was shown to be specific as it was
competed by increasing concentrations (25, 50 and lOOng) of homologous
oligonucleotide (Specific) (lanes 2-4). Increasing concentrations (25, 50 and lOOng) of
an oligonucleotide containing a 3' T-rich sequence from the rPPT-A promoter, (T-Rich)
(lanes 5-7), failed to compete for complex formation.
Specific T-R ic h
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Figure 27. Electrophoretic mobility shift assay using the rPPT-A 3' G-rich element and
extract from HeLa cells.
Double stranded oligonucleotides containing either the rPPT-A 3' G-rich element,
spanning nucleotides +264 to +291, or the PPT 'CRE' element, spanning nucleotides
-200 to -186, relative to the major transcriptional start site were 5' end labelled with T4
polynucleotide kinase. End-labelled oligonucleotides (lng) were incubated with HeLa
nuclear extract (20|ig), in the presence of lfig of poly d(I-C) for 'CRE' and 2.5(j,g of
poly d(I-C) for 3' G-rich.
Several complexes were formed between the 3' G-rich oligonucleotide and HeLa
nuclear extract. One of the complexes was shown to be specific as it was competed by
increasing concentrations (25, 50 and lOOng) of homologous oligonucleotide (Specific)
(lanes 1-3). Increasing concentrations (25, 50 and lOOng) of an oligonucleotide
containing an AP-1 element from the rPPT-A promoter, (API) (lanes 4-6), failed to
compete for complex formation. Lane 7 shows the complex formed between the 'CRE'
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Electrophoretic mobility shift assays will be required in order to determine if
this element does indeed bind a member of the CREB/ATF family of proteins.
As the identity of the proteins binding to the element have yet to be determined it
has been termed unidentified element 2 (U.D. 2).
3.6.1.17. Element 19.
DNase 1 footprinting analysis was carried out using the construct pSMl'/Q5
(Figure 6) with HeLa, total rat brain and rat cerebellar nuclear extracts. Figure 28
shows that the pattern of footprinting over this region of the rPPT-A promoter appears
to vary with different extracts.
Footprints were generated by the HeLa (lane 2) and total rat brain extracts
(indicated as Brn., lane 4) but not by rat cerebellar extract (indicated as Cer., lane 3).
The footprint generated by HeLa nuclear extract spans nucleotides +372 to
+390 and the brain generated footprint spans nucleotides +372 to +405, as shown
below:
+ 372 TGGGTTTTTGTTTTTGTTTTAATCTTGGTTTAGC +405
HeLa 1
Brain 1
Additionally, HeLa extract generated a hypersensitive site (indicated as H.S.) at
nucleotide +381, (G) (shown in bold type), which was not generated by either of the
brain derived extracts.
The sequence element footprinted by HeLa and total rat brain extracts is rich in
dT nucleotides and so is termed a 3' T-rich element. In order to further characterise the
binding of proteins from HeLa nuclear extract to this 3' T-rich element, electrophoretic
mobility shift assays were carried out using an oligonucleotide containing the HeLa
footprinted sequence and flanking regions, (3' T-rich, Figure 10). Figure 29, lane 1
shows that a complex (indicated by an arrow) was formed between the 3' T-rich
oligonucleotide and HeLa nuclear extract. This complex was shown to be specific as it
was competed by increasing concentrations of homologous DNA competitor, (Specific)
(lanes 2 and 3), and not by increasing concentrations of a heterologous DNA
competitor, (3' G-rich) (lanes 4-6).
When the sequence of the HeLa generated 3' T-rich footprint is compared to the
5' AT-rich sequence (element 8), in the reverse orientation, a significant degree of
sequence homology ( 79%) is revealed:
Figure 28. DNase 1 footprinting analysis of a region of the rPPT-A promoter
encompassing a T-rich sequence.
The construct pSMl'/Q5 was singly 5' end labelled with T4 polynucleotide kinase and
lOOng of labelled probe was digested with DNase 1, in the absence or presence of
either HeLa, rat cerebellar or total rat brain nuclear extracts.
Lane 1 shows the pattern of DNA digestion generated by 1.5 units of DNase 1. In
addition to DNase 1 (30 units), HeLa nuclear extract (lmg) was added in lane 2, rat
cerebellar extract (Cer.) in lane 3 and total rat brain nuclear extract (Brn) (lmg) in lane
4. Lane 5 shows the G+A Maxam Gilbert sequencing reaction of the DNA probe.
Footprints were generated by the HeLa extract (lane 2) and total rat brain extract (lane
4) which, from the sequence reaction (lane 5), span nucleotides +372 to +390 and
+372 to +405 respectively. Rat cerebellar extract (lane 3) failed to generate any
footprints over this region of the promoter. The sequence of the footprints are rich in
dT nucleotides and are therefore termed 3' T-rich.
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Figure 29. Electrophoretic mobility shift assay using the rPPT-A 3' T-rich element and
extract from FleLa cells.
A double stranded oligonucleotide containing the rPPT-A 3' T-rich element, spanning
nucleotides +369 to +395 relative to the major transcriptional start site, was 5' end
labelled with T4 polynucleotide kinase. End-labelled oligonucleotide (lng) was
incubated with HeLa nuclear extract (20|lg), in the presence of 2.5p.g of poly d(I-C).
Multiple complexes were formed between the probe and HeLa cell extract, in the
absence of competitor DNA (lane 1). One of these complexes, indicated as an arrow,
was shown to be specific as it was competed by increasing concentrations (100 and
250ng) of homologous oligonucleotide (Specific) (lanes 2 and 3). Increasing
concentrations (100, 250, and 500ng) of an oligonucleotide containing the
immunoglobulin octamer binding element, (Octamer) (lanes 7-9), also competed for
complex formation and increasing concentrations (100, 250, and 500ng) of an
oligonucleotide containing a 3' G-rich sequence from the rPPT-A promoter, (G-rich)
(lanes 4-6), failed to compete.
Competitor: Specific G-Rich Octamer
1 23456789
73
-664 TTTacaTTTTGTTT ~651 (reverse)
+377 TTTtgtTTTTGTTT +389
This degree of sequence homology suggests that the two elements may bind
similar or related proteins. Support for this suggestion comes from the finding that
increasing concentrations of the 3' T-rich oligonucleotide competes for complex
formation between the 5' AT-rich element and HeLa nuclear extract (Figure 16, lanes 8-
10).
As the 5' AT-rich element has been shown to display affinity for octamer
binding proteins (Section 3.6.1.11.), it was decided to determine if this is also the case
for the 3' T-rich sequence. Figure 29, lanes 7-9 demonstrates that formation of a
specific complex (indicated by an arrow) between the 3' T-rich oligonucleotide and
HeLa nuclear extract was competed by increasing concentrations of an octamer binding
element containing oligonucleotide (Oct, Figure 10). Electrophoretic mobility shift
assays were also carried out using the octamer binding element containing
oligonucleotide as a probe. Figure 30, lane 1 shows the position of the complex,
indicated by an arrow, formed between the octamer oligonucleotide and Oct-1 from
HeLa nuclear extract. The formation of this complex was competed by increasing
concentrations of both homologous oligonucleotide, (Specific) (lanes 2-4), and 3' T-
rich oligonucleotide, (T-rich) (lanes 5-7), but not by a non-specific oligonucleotide,
(lanes 8 and 9).
Figure 17 demonstrates competition for formation of the specific complex
(indicated by an arrow) between Oct-1 from HeLa cells and the octamer containing
oligonucleotide by both the 5' AT-rich (lanes 5-7) and the 3' T-rich (8-10) elements. It
appears from this figure that the 3' T-rich oligonucleotide has less affinity for Oct-1
than the 5' AT-rich element. Competition was complete at a 100-fold concentration
excess of 5' AT-rich oligonucleotide (lane 6) but even a 200-fold concentration excess
of the 3' T-rich oligonucleotide (lane 10) failed to compete the shift fully. This
decreased affinity for Oct-1 complex formation by the 3' T-rich element compared to
the 5' AT-rich element is not surprising based on the fact that the 3' T-rich sequence is
more divergent from the octamer binding protein consensus sequence.
Figure 30. Electrophoretic mobility shift assay using the immunoglobulin octamer
binding element and extract from HeLa cells.
A double stranded oligonucleotide containing the immunoglobulin octamer binding
element was 5' end labelled with T4 polynucleotide kinase. End-labelled
oligonucleotide (lng) was incubated with HeLa nuclear extract (20|ig), in the presence
of l(ig of poly d(I-C).
Multiple complexes were formed between the probe and HeLa cell extract, in the
absence of competitor DNA (lane 1). One of these complexes, indicated as an arrow,
was shown to be specific as it was competed by increasing concentrations (10, 25 and
lOOng) of homologous oligonucleotide (Specific) (lanes 2-4). Increasing concentrations
(10, 25 and 50ng) of an oligonucleotide containing a 3' T-rich sequence from the rPPT-
A promoter, (T-rich) (lanes 5-7), also competed for complex formation and increasing








3.7. Discussion. ' '
The aim of this study was to investigate how the rPPT-A gene is regulated at the
transcriptional level. To this end, this study set out to identify potential regulatory
elements within a 1300 bp region of the promoter, encompassing sequences both 5'
and 3' of the major transcriptional start site, by the use of exonuclease protection
analysis, DNase 1 footprinting analysis and electrophoretic mobility shift assays.
3.7.1. Exonuclease protection analysis.
By the exonuclease protection assay (Quinn et al., 1987), using the construct
pSMl/Q5 and HeLa nuclear extract, a protein binding site was identified within the
rPPT-A promoter which was estimated to lie in close proximity to the transcriptional
start site (Figure 7).
The rPPT-A gene is expressed endogenously in DRG neurons and expression of
constructs containing regions from the rPPT-A promoter has also been demonstrated, by
microinjection, in DRG neurons (Hokfelt et al., 1975; Otsuka et al., 1982; Price, 1985;
Tuchscherer and Seybold, 1985; Henken et al., 1990; Mulderry et al., 1993). Flowever,
there is a lack of established cell lines which express the gene endogenously at high levels
or show significant expression of transiently transfected reporter constructs (Gilchrist et
al., 1991; personal communication J. Quinn). This lack of expression in tissue culture cell
lines may be due to either the presence of a repressor or the absence of a specific activator
in such cells. If a repressor is present, its mechanism of action may be to bind to a
particular sequence within the rPPT-A promoter. As it has been shown that 5' deletion of
the promoter fails to relieve repression and that individual elements identified as protein
binding sites, when in isolation, will drive expression of reporter genes in transfected
tissue culture cells (personal communication, J.Quinn), it is postulated that such a repressor
sequence element may lie close to the transcriptional start site. The site identified by
exonuclease protection analysis may therefore represent such a repressor/DNA interaction.
3.7.2. DNase 1 footprinting and electrophoretic mobility shift assays.
Exonuclease protection analysis does not allow the exact location of identified
protein/DNA interaction sites to be determined. In order to achieve this, DNase 1
footprinting analysis was carried out using a series of constructs containing various
fragments from the rPPT-A promoter cloned into plasmid vectors (Figure 6).
Electrophoretic mobility shift assays were also carried out in order to further
characterise some of the identified elements.
By the use of DNase 1 footprinting analysis and electrophoretic mobility shift
assays multiple protein/DNA interaction sites have been identified within a 1300 bp
region of the promoter. The nucleotide sequence of the region of the promoter analysed
is given in Figure 8 with identified protein/DNA interaction sites, numbered 1 to 19,
underlined.
For the purposes of this discussion, the potential regulatory elements identified
within the rPPT-A promoter have been divided into several groups based on their
nature and their position within the promoter. These groups are:
a. E-Box motifs.
b. AP-1 and CRE elements.
c. Purine-rich and G-rich elements.
d. AT- and T-rich elements.
e. Unidentified elements 1 and 2.
f. Region binding single-stranded and double-stranded DNA binding proteins.
g. Minimal promoter element.
h. Region displaying differential protein binding activity.
3.7.2.1. Potential regulatory elements within the rPPT-A promoter.
3.7.2.1.1 E-box motifs.
Six E-box motifs (consensus sequence CANNTG) have been identified, by
DNase 1 footprinting and/or electrophoretic mobility shift assays, within a region of the
rPPT-A promoter spanning approximately 450 bp of sequence. A diagrammatic
representation of how these motifs are arranged on the promoter is shown in Figure 31.
Three of the motifs, termed E-box 1, E-box 2 and E-box 3, are located 5' of the
transcriptional start site and the other three, termed E-box 4, E-box 5 and E-box 6, are
located 3' of the major transcriptional start site .
The consensus sequence CANNTG is recognised by members of the bHLH and
bHLH-Zip families of transcription factors (Murre et al., 1989a; Davis et al., 1990;
Fisher et al., 1991) (Section 1.2.3.1.1.h). These proteins bind their target DNA site as
dimers and can be divided into three classes (Murre et al., 1989b). Class A proteins
include the ubiquitously expressed bHLH proteins (termed E proteins), such as El2,
E47 and E2A (Murre et al., 1989b), class B proteins can form heterodimers with class
A proteins and include the tissue specific bHLH proteins, such as the myogenic
proteins MyoD (Davis et al., 1987), Myf 5 (Braun et al., 1989) and myogenin (Wright
et al., 1989) and class C proteins include members of the Myc protein family (DePinho
et al., 1987), Max proteins (Blackwood an Eisenman, 1991), Mad (for Max
dimerization) (Ayer et al., 1993), Mxi 1 (for Max interactor 1) (Zervos et al., 1993) and
the transcription factors USF (Carthew et al., 1985; Sawadogo and Roeder, 1985),
Figure 31. Location of identified E-box motifs within the rPPT-A promoter.
A diagrammatic representation of the rPPT-A promoter, spanning nucleotides -330 to
+200 relative to the major transcriptional start site, is shown. Six identified E-box
motifs (consensus sequence CANNTG), numbered E-box 1 to 6, are shown along with
the position of the first nucleotide of each motif. The majority of the E-box motifs were
identified by DNase 1 footprinting analysis with the exception of E-box 3 which was
identified by electrophoretic mobility shift assays.
E-box 1 is contained within a footprinted element spanning nucleotides -67 to -47.
E-box 2 is contained within a footprinted element spanning nucleotides -177 to -155.
E box-3 spans nucleotides -308 to -303.
E-box 4 and E-box 5 are both contained within a footprinted element spanning
nucleotides +55 to +89.










TFE-3 (Beckmann et al., 1990), TFEB (Carr and Sharp, 1990) and AP-4 (Hu et al.,
1990).
One cell may contain several bHLH proteins recognising the same six base pair
E-box consensus sequence, therefore mechanisms must exist which allow the proteins
to achieve some degree of specificity in their action. One way in which specificity of
action may be achieved is by different homo- and heterodimeric protein complexes
preferentially recognising different sequences both inside and outside core E-box motif
(Blackwell and Weintraub, 1990; Blackwell et al., 1990; Sun and Baltimore, 1991;
Wright et al., 1991; Fisher and Goding, 1992; Hu et al., 1992; Kato et al., 1992;
Blackwell et al., 1993; Fisher et al., 1993). Interestingly, the six E-box motifs
identified within the rPPT-A promoter all contain different core motifs and flanking
sequences (Figure 32) suggesting that they may each bind different protein complexes.
a. E-box motifs located 5' of the transcriptional start site.
E-box 1 (element 1) corresponds to the core consensus sequence CACGTG
(shown in bold type below) and is contained within the HeLa generated footprint
spanning nucleotides -67 to -47 (Figures 9 A and 9B):
~67 AGAGTGTCACGTGGCTCTCCA "47
Electrophoretic mobility shift assays (Figures 11 and 12) demonstrated that
proteins from various cellular and tissue extracts will form specific complexes with an
oligonucleotide termed El, containing this footprinted element and flanking sequences.
These findings suggest that protein(s) present in a wide variety of tissues will
potentially bind to this region of the rPPT-A promoter.
The core consensus sequence CACGTG is recognised by the class C bHLH-Zip
proteins. It has subsequently been demonstrated, by electrophoretic mobility shift
assays, that bacterially expressed Max, which belongs to the class C proteins, will
specifically bind to the El oligonucleotide (J.Paterson et al., submitted). Max
homodimers and heterodimers, formed by association of Max with the different Myc
proteins and the Max interactor proteins Mad and Mxil, can all potentially bind to this
same consensus sequence (Blackwood and Eisenman, 1991; Pendergast et al., 1991;
Blackwood et al., 1992a and 1992b; Kato et al., 1992; Littlewood et al., 1992; Ayer et
al., 1993; Zervos et al., 1993). Of all the potential dimeric complexes, Max-Max, Myc-
Max, Mad-Max and Mxil-Max, which may bind to this sequence, only Myc-Max
heterodimers are thought to be capable of activating transcription (Amati et al., 1992,
1993; Kato et al., 1992; Kretzner et al., 1992).
As Max is a constitutively, ubiquitously expressed protein (Blackwood an
Eisenman, 1991) it is possible that in DRG neurons it will specifically dimerise with
CANNTG
E-box 1 ~66 GAGTGT CACGTG GCTCTC ~49
E-box 2 ~176 TTGGTC CAGATG TTATGG ~159
E-box 3 ~314 TAATCT CAGGTG TCACTG ~297
E-box4 +56 GCCCAG CAAGTG CGCACC +73
E-box 5 +64 AGTGCG CACCTG CGGAGC +81
E-box 6 +116 GCCTGC CATCTG CCGCTG +133
Figure 32. Sequence comparison of six E-box motifs identified within the rPPT-A
promoter.
The sequence of six E-box motifs (E-box 1 to 6) identified within the rPPT-A
promoter, by DNase 1 footprinting analysis and electrophoretic mobility shift assays,
plus six base pairs of 5' and 3' flanking sequence are shown.
The consensus sequence for an E-box motif is shown as CANNTG.
Myc family members or Max interactor proteins, present in such tissue, and that the
resulting heterodimeric complexes will bind to the E-box 1 motif to regulate rPPT-A
gene expression.
Another factor of particular interest which also recognises the core consensus
sequence CACGTG is the transcription factor USF. USF was initially identified as a
cellular factor which activates the Ad-MF promoter by binding to an E-box motif
which, like E-box 1, is located at position -60 relative to the major transcriptional start
site (Sawadago and Roeder, 1985). It has subsequently been demonstrated that a factor
which shares immunological relationships with USF, termed TFII-I, binds co¬
operatively with USF to both the high-affinity USF site (E-box) and to two initiator
elements (Inr 1 and Inr 2), distinct in sequence from the E-box motif, located near the
transcriptional initiation site of the Ad-ML promoter (Roy et al., 1991). Du et al. (1993)
havesubsequently shown that USF, in addition to stimulating transcription initiation
through the Ad-MF E-box site, is capable of stimulating the basal activity of both HIV-
1 and Ad-ML core promoters, lacking E-box sites, through Inr elements. It was
suggested from these results that many bHLH regulatory proteins may interact with
both classical E-box sites and with Inr elements. As a region of sequence located
between the TATA box transcriptional start site of the rPPT-A promoter has been
identified as a potential regulatory element, by electrophoretic mobility shift assays and
DNase 1 footprinting analysis (Section 3.6.1.13.), it is possible that bHLH factors,
such as USF or TFII-I, bind to both this element and to the E-box 1 motif to regulate
transcription.
E-box 2 (element 2) is contained within the HeLa generated footprinted region
spanning nucleotides -177 to -155 (Figure 13) and consists of the asymmetrical
consensus sequence CAGATG as shown in bold type below:
-177 TTTGGTCCAGATGTTATGGACTC ~155
The identity of the protein(s) from HeLa cells which bind to this footprinted
sequence is unknown. However, binding by proteins from HeLa cells to an
oligonucleotide containing the E-box 2 motif and flanking sequences is specifically
competed by related E-box containing oligonucleotides in electrophoretic mobility shift
assays (personal communication, J. Quinn). This suggests, therefore, that the footprint
is generated by protein(s) specifically recognising the E-box 2 motif.
The sequence CAGATG is found within the promoter regions of several peptide
hormone genes, including the rat glucagon promoter where it is critical for the specific
expression of glucagon in alpha cells of the pancreatic islets (Phillipe et al., 1988).
DNase 1 footprinting assays using the construct pVL29 and HeLa nuclear
extract (Figure 14) failed to generate any footprint covering a noted E-box consensus
sequence. This sequence, termed E-box 3 (element 5), is located immediately
downstream of the AP-1' footprint (element 6), and contains the core motif CAGGTG,
as shown below in bold type:
-311 TCTCAGGTGTCA -300
It has however been shown that an oligonucleotide containing the E-box 3 motif
and flanking sequence will form a specific complex by electrophoretic mobility shift
assays using HeLa cell extract. Additionally, the complex is competed by other E-box
containing oligonucleotides suggesting that proteins will specifically recognise and bind
to the E-box motif (personal communication, J.Quinn).
The reason for the lack of a footprint covering the E-box 3 site is unknown.
Perhaps, in HeLa cells, binding to the E-box 3 site is sterically hindered by proteins
which specifically recognise neighbouring AP-1 and AP-1' sites. Such interactions
between factors binding to specific regulatory elements have been demonstrated for
various gene promoters. For example, synergism has been reported between bHLH
proteins and octamer binding proteins in the calcitonin/calcitonin gene-related peptide
(CT/CGRP) promoter (Tverberg and Russo, 1993). In this study, an 18 bp sequence
element, essential for cell-specific expression of the gene in rat thyroid C-cell lines, was
shown to contain an overlapping E-box motif and octamer binding protein consensus
sequence (GGCAGCTGTGCAAATCCT). It was subsequently demonstrated, by
functional analysis and electrophoretic mobility shift assays, that both sites are
synergistically involved in controlling cell-specific expression of the CT/CGRP gene
(Tverberg and Russo, 1993). In another study, Yoon and Chikaraishi (1992)
demonstrated the presence of a minimal enhancer element from the rat tyrosine
hydroxylase promoter which is composed of an AP-1 motif and an adjacent E-box
motif (TGATTCAGAGGCAGGTGCCTGTGA). It was demonstrated that an interaction
between the AP-1 and E-box motifs is necessary for cell-specific tyrosine hydroxylase
expression (Yoon and Chikaraishi, 1992).
Therefore, it is possible that there is an interaction between the different factors
which can bind to the E-box 3 and AP-1 motifs, from the rPPT-A promoter, and that
such interactions are important for regulating gene expression. It is possible that other
cell or tissue types express proteins with a higher affinity for the E-box motif or that the
expression of the proteins which recognise the different motifs can be altered in
response to certain extracellular stimuli, thus potentially allowing for tissue-specific and
stimulus-dependent gene expression.
b. E-box motifs located 3' of the transcriptional start site.
DNase 1 footprinting analysis (Figure 24) identified two sequence elements,
located 3' of the major transcriptional start site, which contain three E-box motifs and
are bound by proteins present in rat cerebellar nuclear extract. HeLa nuclear extract, in
the same assays, also generated two footprints, however these are distinct from the
cerebellar generated footprints and do not include E-box motifs. The E-box motifs
contained within the cerebellar generated footprints are termed E-box 4, E-box 5 and E-
box 6.
E-box 4 (CAAGTG) and E-box 5 (CACCTG) (shown below in bold type) are
both contained within a footprinted element (element 13) spanning nucleotides +55 to
+89:
+55 CGCCCAGCAAGTGCGCACCTGCGGAGCATCACCGG +89
and E-box 6 (CATCTG) is contained within a footprinted element (element 16) spanning
nucleotides +116 to +130:
+116 GCCTGCCATCTGCCG +13°
Although both contain E-box motifs, it is possible that the two footprints are
generated by proteins recognising and binding to distinct DNA sequence motifs present
within the two elements. Additionally, if the E-box motifs are specifically recognised
by bHLH protein complexes it seems unlikely that both E-box 4 and E-box 5 will be
bound simultaneously as they are so close to each other. The E-box 6 sequence
CATCTG is present in two elements, termed Nir and Far boxes, from the rat insulin I
gene promoter essential for enhancer activity (Moss et al., 1988) and additionally is
present in an element, termed insulin control element (ICE), from the rat insulin II gene
promoter where it is bound by a positive acting factor specific to (3-cells (Whelan et al.,
1990). The identity of the factors which do bind to these two footprinted sequences and
whether they specifically recognise the E-box motifs, may be further investigated by the
use of electrophoretic mobility shift assays.
As this region of the promoter appears to display differential protein binding
characteristics, depending on whether the extracts used are of neuronal or non-neuronal
origin, it is possible that the DNA binding proteins responsible for generating the
footprints are expressed in a cell- or tissue-specific manner. There are many known
transcription factors which are specifically expressed in certain cell or tissue types. An
example of such proteins are the class B myogenic bHLH proteins, such MyoD (Davis
et al., 1987), Myf 5 (Braun et al., 1989) and myogenin (Wright et al., 1989), which
have been shown to be specifically associated with the regulation of muscle-specific
genes (Lassar et al., 1991). Other bHLH proteins have been shown to be display a
neuronal-specific pattern of expression. These include the proteins encoded by genes of
the achaete-scute complex of Drosophila and their rat homologues, MASH-1 and
MASH-2 (mammalian achaete-scute homologues), which have been shown to play an
important role in neuronal determination (Cabrera et al., 1987; Johnson et al., 1990,
1992; Guillemot et al., 1993).
Thus, in summary six E-box motifs have been identified within a region of the
rPPT-A promoter spanning approximately 450 bp. Figure 32 demonstrates that all six
motifs contain different sequences both within and flanking the six base pair consensus
sequence, suggesting that each may bind different combinations of bHLH proteins.
Several genes contain multiple E-box motifs within their promoter regions,
including the mouse desmin gene (Li and Capetanaki, 1993) and the acetylcholine
receptor 8-subunit gene (Simon and Burden, 1993), where each motif has been
suggested to play a distinct role in regulating gene expression. Based on the fact that the
six motifs identified within the rPPT-A promoter are predicted to preferentially bind
different protein complexes and that they are located within distinct regions of the
promoter, it is possible that they also have a variety of different roles to play in
regulating gene expression.
The exact nature of the proteins binding to these motifs and their individual
roles in regulating rPPT-A gene expression are unknown. DRG neurons have been
shown to display high level of expression of the bHLH protein NSCL, cloned from a
mouse cDNA library based on its homology to the hemopoietic bHLH protein SCL
(Begley et al., 1992). NSCL has been shown to be expressed in the developing
nervous system (thus neurological SCL) where it is thought to play a role in neuronal
development (Begley et al., 1992). Therefore, it is possible that protein(s) similar or
related to NSCL regulate rPPT-A gene expression in DRG neurons by binding to one
or a combination of the identified E-box motifs within the promoter. Additionally, it has
been shown that the expression of the bHLH protein MASH-1 is upregulated by NGF
in PC12 cells (Johnson et al., 1990, 1992). As the levels of rPPT-A mRNA have been
shown to be upregulated by NGF in adult rat DRG (Lindsay and Harmar, 1989), it is
tempting to postulate that one or a combination of the identified E box motifs within the
rPPT-A promoter may be important for conferring the transcriptional response to NGF
in DRG neurons.
3.7.2.1.2. AP-1 and CRE elements.
DNase 1 footprinting analysis identified five elements within the rPPT-A
promoter which contain regions of sequence displaying homologies to an AP-1
consensus sequence (TGA G/C TCA) and/or a CRE/ATF (cyclic AMP element binding
protein/activating transcription factor) binding motif (TGACGTCA).
a. AP-1 elements.
Three sequence elements, termed AP-1, AP-T and HeLa AP-1, were identified
within the rPPT-A promoter. These are all bound by proteins present in HeLa cell
extract and contain regions displaying homology to an AP-1 consensus sequence (TGA
G/C TCA). Additionally, an element was identified which displays homologies to both
an AP-1 consensus sequence and a CRE/ATF motif. This element has been termed
'CRE' and will be discussed in Section b (CRE elements).
The consensus sequence TGA G/C TCA is recognised by the transcription factor
AP-1. This factor is a dimeric complex consisting of proteins belonging to the bZIP
family of DNA-binding proteins (Section 1.2.3.1.1.g.). These proteins include all of
the members of the fos and jun gene families discovered to date, such as c-fos (Curran
and Teich, 1982; Curran et al., 1984; Curran et al., 1985), c-jun (Angel et al., 1987;
Bohmann et al., 1987; Maki et al., 1987), fra-1 (Cohen and Curran, 1988; Cohen et
al., 1989), fra-2 (Matsui et al., 1990; Nishina et al., 1990; Yoshida et al., 1991), fosB
(Zerial et al., 1989), junB (Ryder et al., 1988) and junD (Hirai et al., 1989; Ryder et
al., 1989). The proteins encoded by the jun genes can bind DNA as homodimers or can
heterodimerise with Fos proteins. Therefore a large number of regulatory protein
complexes can be generated among family members all of which are likely to possess
different DNA-binding and transcriptional activities (Halazonetis et al., 1988;
Nakabeppu et al., 1988; Rauscher et al., 1988; Kovary and Bravo, 1991).
An element, footprinted by HeLa cell extract, was identified within the rPPT-A
promoter spanning nucleotides -345 to -330 (Figure 14) (element 7), as shown below:
~345 AGCATGAGTCACTTCG -330
This footprint contains a region (shown in bold type), termed AP-1, which
displays a perfect match to an AP-1 consensus sequence.
It appears, by electrophoretic mobility shift assays, that this element does
represent a bona fide AP-1 site. Specific complexes formed between this element and
extract from HeLa cells are recognised by antibodies directed against c-Fos and
additionally the element will bind partially purified Fos and Jun proteins from HeLa cell
extract (personal communication, J. Quinn).
An additional footprint, spanning nucleotides -324 to -308 (element 6) (Figure
14), was identified within the rPPT-A promoter which contains a region of sequence,
termed AP-1', displaying a six out of seven base pair match to an AP-1 consensus
sequence, as shown below in bold type:
-324 TTTTGATGAGTAATCTC ~308
Although this element does not contain a perfect AP-1 consensus sequence,
several studies have shown that such sites will bind AP-1 complexes. For example,
Bohmann et al. (1987) demonstrated that the binding of purified AP-1 and c-Jun to an
AP-1 recognition site from the Saccharomyces cerevisiae his3 promoter was not
affected after the introduction of certain point mutations into the recognition sequence.
Additionally, a motif from the rat tyrosine hydroxylase promoter (TGATTCA), which
also contains a six out of seven base pair match to an AP-1 consensus sequence, has
been shown to represent a bona fide AP-1 motif (Yoon and Chikaraishi, 1992).
Subsequent studies have shown that the rPPT-A AP-1' sequence element, in a
similar manner to the AP-1 element at -340, will bind partially purified Fos and Jun
proteins from HeLa cells in electrophoretic mobility shift assays and that it will bind
proteins recognised by antibodies against c-Fos (personal communication, J. Quinn).
Therefore, based on these studies, this element does seem to represent an AP-1 site.
Finally, an element, footprinted using HeLa nuclear extract and located 3' of the
transcriptional start site, was found to contain a region of sequence displaying a five out
of seven base pair match to an AP-1 consensus sequence (Figure 24). This element
(element 15), termed HeLa AP-1, spans nucleotides +98 to +107 and when nucleotide
+ 108 is included a five out of seven base pair match (shown in bold type below)
becomes apparent:
+98 GCAGTGAGTAC +108
It is not known if this element does represents an AP-1 site, however, as
demonstrated for the AP-1" element, sites which are not perfect AP-1 consensus
sequences will bind AP-1 protein complexes. Electrophoretic mobility shift assays may
provide further information concerning the binding characteristics of this element and
whether or not it binds members of the fos or jun gene families.
Therefore, three potential AP-1 binding sites have been identified within the
rPPT-A promoter. Additionally, an element has been identified which displays
homologies with both an AP-1 consensus sequence and a CRE/ATF motif, this element
is discussed in more detail in Section b (CRE elements). The role that each of these
sites has to play in the regulation of rPPT-A gene expression is unknown. As the fos
and jun gene families have been shown to exhibit cell type, stimulus, and temporal
specificity of expression (reviewed by Morgan and Curran, 1991), it is possible that
these sites are involved in mediating both tissue-specific and stimulus-dependent gene
expression. Of particular interest is the fact that the expression of the c-fos and c-jun
genes have been shown to be induced in response to NGF in PC 12 cells (Curran and
Morgan, 1985; Greenberg et al., 1985; Kruijer et al., 1985; Milbrandt, 1986) and it has
also been shown that the levels Fos, Jun and Fra proteins vary in PC 12 cells in
response to NGF (Quinn, 1991). As the levels of rPPT-A mRNA have been shown to
increase in adult rat DRG neurons in response to NGF treatment (Lindsay and Harmar,
1989), it is possible that this alteration in expression levels is in part mediated by
factors binding to one or a combination of the identified AP-1 elements within the
promoter.
b. CRE elements.
Two footprinted sequence elements, termed 'CRE' and U.D. 1, both displaying
homologies to a CRE/ATF motif (TGACGTCA), have been identified within the rPPT-A
promoter.
The consensus sequence TGACGTCA is recognised by proteins belonging to the
CREB/ATF family such as CREB, CRE-BP1 and the ATFs (Hai et al., 1989;
Maekawa et al., 1989; reviewed in Habener, 1990; Foulkes et al., 1991). Like the
members of the fos and jun gene families, these factors belong to the bZIP family of
DNA-binding proteins and they also bind their DNA target sites as dimers, with
multiple homo- and heterodimeric complexes forming between the different family
members (Section 1.2.3.1.1.g.). CREB is believed to mediate transcriptional signals
directed by the cAMP and calcium second-messenger pathways (Yamamoto et al.,
1988; Dash etal, 1991; Sheng et al., 1991).
DNase 1 footprinting analysis (Figure 13) identified an element, bound by
proteins present in HeLa cells, which has previously been noted as a potential CRE
from sequence analysis of the rPPT-A promoter (Chapman et al., 1993). This element
(shown in bold type below) is contained within a footprint (element 3) which spans
nucleotides -198 to -180:
~198 ATTGCGTCATTTCGAACCC ~180
It can be seen that this element actually displays homologies with both an AP-1
consensus sequence (TGA G/C TCA) and with a CRE/ATF motif (TGACGTCA).
However, based on the fact that this region has previously been noted as a potential
CRE (Chapman et al., 1993) and that the corresponding region from the bovine
promoter has been shown to act as a functional CRE (Kageyama et al., 1991), for the
purposes of this study it is termed a 'CRE'.
Studies have shown that, when used as an oligonucleotide in electrophoretic
mobility shift assays, this element will compete for complex formation between HeLa
cell extract and oligonucleotides containing AP-1 and/or CRE/ATF elements (Morrison
et al., 1994 in press). Functional assays have also shown that this element possesses
properties resembling both AP-1 and CRE elements (Morrison et al., 1994 in press).
Attempts to identify the proteins from HeLa cells which will interact with this element
have demonstrated that it is not bound by proteins recognised by antibodies directed
against the proteins Fos, Fra-1, CREB or ATF (Morrison et al., 1994 in press).
However, as several CREB-related genes have been cloned (Hai et al., 1989; Maekawa
etal., 1989; reviewed in Habener, 1990; Foulkes etal, 1991) and multiple fos and jun
gene families exist, it is possible that the protein(s) which do bind to this sequence
element are distinct from those recognised by the Fos, Fra-1, ATF and CREB
antibodies.
DNase 1 footprinting analysis (Figure 25) identified an additional element
(element 18), termed unidentified element 2 (U.D. 2), which contains a region of
sequence displaying homologies to a CRE/ATF motif (as shown in bold type below).
This footprint is located 3' of the transcriptional start site and spans nucleotides +317 to
+341:
+317 GCTCTTTGGCACGTCAGTAGCCTTC +341
This element was footprinted using HeLa, rat brain and rat cerebellar nuclear
extracts (Figure 25), although proteins present in HeLa nuclear extract did not appear to
bind as avidly as proteins present in rat brain or cerebellar extracts.
It is not known if a member of the CREB/ATF family of transcription factors
will specifically bind to this sequence element. Interestingly, the footprint actually
appears to consist of two halves, one extending from nucleotides +317 to +332, thus
including the CRE-like region, and the other extending from nucleotides +334 to +341,
with a hypersensitive site separating the two halves at nucleotide +333 (G) (underlined
above). It has yet to be determined how this pattern of footprinting is generated. One
possible explanation is that a CRE-like protein complex may recognise one half of the
element and that other factor(s) may recognise the second half. Electrophoretic mobility
shift assays should help to determine the nature of the proteins binding to this region of
the promoter and to determine whether any belong to the CREB/ATF family of
proteins.
Therefore, multiple potential regulatory elements have been identified within the
rPPT-A promoter which may be bound by AP-1 or CREB/ATF protein complexes. The
number of different dimeric protein complexes which can potentially bind to each
element is very large. In addition to AP-1 and CREB/ATF proteins forming homo- and
heterodimers within their own families, they can additionally heterodimerise with
members of the opposite family to produce protein complexes displaying novel binding
and transcriptional activities (Ivashkiv et al., 1990; Jones, 1990; Hai and Curran,
1991). Yet a further degree of diversity arises from the fact that proteins belonging to
the C/EBP family of bZIP proteins can bind to CRE/ATF elements, both as
homodimers (Bakker and Parker, 1991; Park et al., 1993) and as heterodimers formed
by association with CREB/ATF proteins (Park et al., 1993; Vallejo et al., 1993).
Additionally, heterodimerisation has been reported between bZIP transcription factors
and proteins belonging to distinct classes of DNA-binding proteins. For example, the
bHLH protein MyoD has been shown to heterodimerise with the c-Jun protein (Bengal
et al., 1992; Fi et al., 1992). The fact that such a large number of protein complexes
can potentially bind to the AP-1 and CRE elements identified within the rPPT-A
promoter suggests that they may have a wide range of roles to play in the regulation of
gene expression.
3.7.2.1.3. Purine-rich and G-rich elements.
a. Purine-rich element.
DNase 1 footprinting analysis identified an element (element 4), spanning
nucleotides -284 to -264, protected from DNase 1 digestion by proteins present in
HeFa nuclear extract (Figure 14). This element, as shown below, is rich in purine
nucleotides on one strand with the complementary strand thereby being rich in
pyrimidine nucleotides :
~284 AAGAAGAGGGGAGGGGGGCGT ~264
Homopurine-homopyrimidine sequences are often found in the promoter
regions of actively transcribed eukaryotic genes (Nickol and Felsenfeld, 1983; Elgin,
1984). They have been shown to be sensitive to single-stranded nucleases such as SI
(Farsen and Weintraub, 1982; Nickol and Felsenfeld, 1983; Elgin, 1984) and have
been proposed to play a role in transcriptional control. Such elements are present in the
promoter regions of many genes including the human U1 gene family (Fltun et al.,
1984) and the human c-myc gene (Siebenlist et al., 1984; Hay et al., 1987; Davis et al.,
1989; Postel et al., 1989) where they have been termed CT elements. CT elements have
been shown to adopt an altered structure under certain conditions including high pH
and negative supercoiling (Lyamichev et al., 1985, 1986; Hanvey et al., 1988; Htun
and Dahlberg, 1988; Johnston, 1988; Kinniburgh, 1989). This unusual structure is
termed H-DNA and contains both triple-stranded and single-stranded regions. It has
been suggested that proteins binding to these stretches of polypurine/polypyrimidine
sequences may regulate gene expression by producing a nuclease-sensitive
conformation in vivo and so altering DNA structure.
It is thought that a large family of CT element binding proteins exist displaying
overlapping affinities for different elements and possessing the ability to modulate gene
expression. Factors which specifically bind to CT elements have been described by a
number of groups. Such factors include NSEP-1 (nuclease-sensitive element protein-1)
(Kolluri and Kinniburgh, 1991) which has been shown, by electrophoretic mobility
shift assays using various oligonucleotides, to bind both duplex CT elements and the
CT-rich single strands of such elements in a sequence specific manner (Kolluri et al.,
1992).
Two other groups have identified factors which bind to CT elements from the
human c-myc promoters. The human c-myc gene is transcriptionaly controlled,
principally, by two tandem promoters PI and P2 with the downstream promoter, P2,
being predominant (Spencer and Groudine, 1990; reviewed in Marcu et al., 1992).
DesJardins and Hay (1993) identified and characterised components regulating
transcription from the two human c-myc promoters. The regulators upstream of the PI
promoter were shown to consist of five tandem repeats of CT elements, loosely
following the consensus CCTCCCCA, and the regulators upstream of the P2 promoter
were shown to include a sequence element which, in the opposite orientation,
resembles the CT elements of PI.
The CT elements from the c-myc promoters have been shown to be specifically
bound by a variety of potential regulatory proteins. These include the heterogeneous
ribonucleoprotein particle protein K (hnRNPK) (Takimoto et al., 1993) and the Zn2+
finger proteins ZF87/MAZ and Spl (DesJardins and Hay, 1993).
Spl was originally identified in HeLa cells on the basis of its ability to activate
the SV40 early promoter (Dyann and Tjian, 1983a). Subsequently it was shown that
Spl recognises and binds selectively to a GC-rich sequence or GC-box, GGGCGG,
present as six tandem copies in the SV40 early promoter (Dynan and Tjian, 1983b). It
is now known that Spl can activate transcription from a variety of viral and cellular
genes which have one or more GC-box recognition sequences within their 5' flanking
sequences (Dynan et al., 1985; Jones and Tjian, 1985; Dynan et al., 1986; Geiser et
al., 1993; Jeang et al., 1993). Following the purification of Spl (Briggs et al., 1986) a
partial cDNA encoding Spl was cloned from a HeLa cDNA library (Kadonaga et al.,
1987). It was shown that Spl contains three Zn2+ finger motifs homologous to those
of the general transcription factor TFIIIA (Brown et al., 1985; Miller et al., 1985) and
that it requires Zn2+ for sequence-specific binding to DNA (Kadonaga et al., 1987).
It has been shown that not all GC-boxes bind Spl equally well and sequences
outside the core hexanucleotide appear to modulate the efficiency of binding. Kadogna
et al. (1986) and Jones et al. (1986) compared 36 different Spl binding sites and
revealed a range of binding affinities differing by at least 10- to 20- fold, with
individual binding sites displaying a remarkable degree of sequence variation. A
consensus sequence for Spl binding has nevertheless been compiled as shown below:
G/T G/A GGCG G/T G/A G/A C/T
o 7When this consensus sequence is compared with the footprinted purine-rich




Interestingly, an oligonucleotide containing the footprinted CT element from the
rPPT-A promoter will form specific complexes with HeLa nuclear extract, by
electrophoretic mobility shift assay, and it has been demonstrated that an
oligonucleotide containing a c-myc CT element will specifically compete for complex
formation (personal communication, J. Quinn). This suggests that a protein(s) similar
to or identical to those binding to the c-myc promoters, such as Spl, also binds to the
rPPT-A promoter to regulate gene expression
b. G-rich elements.
DNase 1 footprinting assays identified an element (element 8) rich in dG
residues, and thus termed a 5' G-rich element, protected from DNase 1 digestion by
proteins present in HeLa nuclear extract (Figure 15). This element spans nucleotides
-575 to -546, as shown below:
-575 TTGGTGGGGAGGGGGGTTGGGGGGGTGTGT ~546
A region 3' of the transcriptional start site, also rich in dG residues (element
17), was identified by DNase 1 footprinting analysis using HeLa, rat cerebellum and rat
nuclear extract (Figure 25). This element is termed a 3' G-rich element and spans
nucleotides +268 to +290, as shown below:
+ 268 AGTGGGTAGGGGGCTGGGACGTT +290
The protein(s) binding to this element appear, by DNase 1 footprinting analysis,
to differ in their relative abundance between different tissues. Proteins present in HeLa
cell extract appeared to generate a stronger footprint than those present in rat cerebellar
extract and the rat brain extract did not appear to generate any footprint.
When aligned, there is a region of 92% sequence homology between the 3' and 5' G-
rich elements as shown below;
-572 GTGGGgAGGGGG ~561
+269 GTGGGtAGGGGG +28°
Interestingly there is also a degree of sequence homology between the 5' and 3'




This homology suggests that all three elements may be bound by similar or
related proteins. Oligonucleotides corresponding to all three footprinted elements will
form specific complexes with proteins from HeLa nuclear extract in electrophoretic
mobility shift assays (Figures 26 and 27 and personal communication, J. Quinn).
Cross-competition studies, using electrophoretic mobility shift assays, may be used in
order to determine whether they do indeed bind similar or related proteins.
Potential transcription factors which recognise G-rich sequences and therefore
may regulate rPPT-A gene expression by binding to the 5' and 3' G-rich elements
include the transcription factor Spl. As was the case for the purine-rich element
(Section a), both of the G-rich elements display an eight out of ten base pair match to





This suggests that the protein(s) binding to both the purine- and the G-rich
elements may be related to the transcription factor Spl. Interestingly, it has been shown
that when different elements within the same DNA molecule are simultaneously bound
by Spl then the different Spl molecules can interact with one another by looping out
the intervening DNA (Su et al., 1991). Therefore, it is possible that if these three
identified elements do indeed bind Spl then they may communicate in a similar manner.
In order to determine if Spl will bind to any of these identified rPPT-A elements,
oligonucleotides containing Spl sites and anti-Spl antisera may be used in
electrophoretic mobility shift assays using the purine- or G-rich rPPT-A elements as
oligonucleotide probes.
Another factor that recognises sequences rich in dG nucleotides is the HSH
transcription factor AP-2 (Section 1.2.3.1.1.i.). AP-2 was first identified and purified
from HeLa cells as a 50-52 KDa binding activity recognising sequences common to the
enhancer elements of SV40 and the human metallothionein-IlA (IiMT-IIa) genes
(Haslinger and Karin, 1985; Imagawa et al., 1987; Mitchell et al., 1987). It was
subsequently demonstrated that AP-2 is able to stimulate transcription in a binding site-
dependent manner both in vitro (Mitchell et ai, 1987) and in vivo (Williams et al.,
1988; Williams and Tjian, 1991). Binding sites for AP-2 have been found in the
promoter regions of a number of cellular genes including proenkephalin (Comb et al.,
1986), growth hormone (Imagawa et al., 1987), c-myc (Imagawa et al., 1987) and
acetyl-CoA carboxylase (ACC) (Park and Kim, 1993). From comparison of twelve
such binding sites a consensus sequence of CCCCAGGC was determined by Mitchell et
al. (1987), although individual sites may vary substantially from the consensus.
A cDNA encoding human AP-2 was cloned by Williams et al (1988) and using
a series of cDNA mutants, Williams and Tjian (1991) analysed the DNA-binding and
transcriptional activation properties of the AP-2 protein. By methylation interference
and missing contact probe assays they determined a consensus sequence for AP-2
binding to DNA which is slightly different from the originally formulated sequence
(Mitchell et al., 1987): GN4GGG.
The expression of AP-2 mRNA and protein shows a cell type specific
expression pattern, being absent from the human hepatoma cell line HepG2 but present
in HeLa cells (Williams et al., 1988) and in DRG neurons (Mitchell et al., 1991).
Expression is induced by retinoic acid treatment (Williams et al., 1988) and in response
to adjuvant mediated inflammation (Donaldson et al., 1993). The DNA-binding activity
of AP-2 can be blocked by SV40 large T antigen (Mitchell et al., 1987) and is
stimulated by both TPA and cAMP (Imagawa et al., 1987; Roesler et al., 1988; Park
and Kim, 1993). Thus, AP-2 can potentially act to modulate transcription from a
number of genes in response to various different stimuli.
It is possible that AP-2 binds to the purine- and/or G-rich elements identified
within the rPPT-A promoter as all three elements contain regions of sequence matching
the consensus sequence for AP-2, GN4GGG (Williams and Tjian, 1991), and
additionally all three elements were footprinted using HeLa nuclear extract where AP-2
has been shown to be expressed (Williams et al., 1988). Since AP-2 mRNA has been
detected in DRG neurons (Mitchell et al., 1991) and it has been shown that the levels of
both AP-2 and rPPT-A mRNA increase in DRG neurons in response to adjuvant
mediated inflammation in vivo (Donaldson et al., 1992, 1993), it has been suggested
that AP-2 may mediate the induction of rPPT-A gene expression in DRG neurons
during the early inflammatory process (Donaldson et al., 1993). Therefore, it is
possible that AP-2 binds to one or a combination of the purine- or G-rich elements
identified within the rPPT-A promoter to mediate the transcriptional response to
induced inflammation.
Other characterised transcription factors which recognise G-rich elements
includeamember of the Zn2+ finger class of transcription factors (Section
1.2.3.1. I.e.), NGF-IA ( or Egr-1 . : early growth response
gene ). This factor bindsto the consensus sequence GCGGGGGGG and mediatesgrowth
factor and TPA activation of transcription (Chavier et al., 1988; Christy et al., 1988;
Sukhatme et al., 1988). Additionally, a protein has been described which binds to a G-
rich EGF response element present in the gastrin promoter (gERE),
GGGGCGGGGTGGGGGG (Merchant et al. (1991). Although this gERE contains an Spl
consensus site, the specific DNA binding protein bound by the gERE in GH4 cells was
found to be distinct from previously described G-rich binding transcription factors, Sp-
1, AP-2, NGF-IA and NGF-IB (Merchant et al., 1991), suggesting that it is bound by
a so far uncharacterised DNA-binding protein.
BGP1 (beta globin protein 1) is another factor which has been shown to bind
DNA sequences rich in dG residues. The 5' flanking region of the chicken (3-globin
gene contains a DNase 1 hypersensitive domain spanning nucleotides -60 to -260
(Lewis et al., 1988). This domain contains a (dG)- homopolymer sequence of 16 bp
termed a G-string (Nickol and Felsenfeld, 1983) which, in supercoiled plasmids, can
assume one or more non-B DNA conformations (Kohwi-Shigematsu and Kohwi 1985;
Kohwi and Kohwi-Shigematsu 1988; Kohwi 1989). The G-string is bound by the
Zn2+-dependent protein BGP1 from erythroid cells (Lewis et al., 1988) with the
minimum binding site requiring seven dG residues (Clark et al., 1990). There is a core
consensus for the transcription factor Spl at the terminal of the G-string and although a
monoclonal antibody directed against BGP1 cross-reacts weakly with Spl and both
Spl and BGP1 require Zn2+ for their DNA binding activity, the two proteins have been
shown to differ in their DNA binding specificites, chromatographic properties and
molecular weights (Lewis et al., 1988). The biological function of this G-string within
the (3-globin promoter is not clear but it has been suggested that, on binding to DNA,
BGP1 may effect nucleosome positioning near the promoter (Clark et al. 1990). Others
have suggested (Larsen and Weintraub 1982; Kohwi and Kohwi-Shigematsu 1988;
Kohwi, 1989) that the interconversion of the G-string between B- and non-B-form
DNA may also play an important role in the control of transcription, either directly or
indirectly through alteration in nucleosome positioning or conformation (Kefalas et al.,
1988).
Thus, a large number of proteins exist which specifically recognise and bind to
different G-rich elements from various gene promoters to mediate both stimulus-
dependent and cell-specific regulation of gene expression. This, taken together with the
fact that the specific DNA recognition sequence for a given transcription factor can be
highly degenerate, raises the possibility that any one of the proteins described above, or
as yet unidentified proteins, may specifically recognise and bind to the rPPT-A purine-
and/or G-rich sequence elements to regulate gene expression. Further studies using
electrophoretic mobility shift assays, in conjunction with specific anti-sera against
candidate DNA binding proteins and oligonucleotides corresponding to the various
binding elements, will enable the identity of the factor(s) binding the rPPT-A elements
to be determined more accurately.
3.7.2.1.4. AT- and T-rich elements.
Two related sequence elements, one AT-rich (element 10) and located 5' of the
major transcriptional start site and the other T-rich (element 19) and located 3' of the
major transcriptional start site, have been identified within the rPPT-A promoter.
The 3' T-rich sequence (element 19) spans nucleotides +372 to +405, as shown below,
and was identified by DNase 1 footprinting analysis using HeLa, rat brain and rat
cerebellar nuclear extracts (Figure 28):
+ 372 TGGGTTTTTGTTTTTGTTTTAATCTTGGTTTAGC +405
The proteins binding to this sequence element appear, by DNase 1 footprinting
analysis, to display specificity in their tissue distribution. Proteins present in rat
cerebellar extract failed to generate any footprint over this region and proteins from
HeLa and rat brain extracts generated differing patterns of footprinting. HeLa extract
generated a footprint covering nucleotides +372 to +390 and produced a hypersensitive
site at nucleotide +381 (dG nucleotide, shown in bold type above). The brain generated
footprint is extended further in a 3' direction, to nucleotide +405, and does not contain
any hypersensitive sites.
The 5' AT-rich sequence (element 10) spans nucleotides -662 to -655, as
shown below in bold type:
-665 TAAATGTAAAACAAA ~651
This element is located in a region of the rPPT-A promoter not cleaved by
DNase 1 even in the absence of protein extract. However, it was noted that it displays a
six out of eight base pair match to the octamer binding protein consensus sequence
(ATGCAAT). Subsequently, it was demonstrated, by electrophoretic mobility shift
assays, that an oligonucleotide probe containing the 5' AT-rich element and flanking
sequences will form sequence specific complexes with proteins present in HeLa and
CI300 cells (Figures 16-18). Interestingly, these specific complexes were shown to
migrate to a similar position as a complex formed between Oct-1 and an octamer
containing oligonucleotide (Figure 16) and, additionally, the 5' AT-rich and octamer
oligonucleotides were found to cross-compete for specific complex formation (Figure
16-18). These results then suggest that the 5' AT-rich element may bind a member(s) of
the octamer binding protein family.
The 5' AT-rich sequence element was noted as sharing a significant degree of
sequence homology (79%) with the 3' T-rich element, on the complementary strand.
Consequently oligonucleotides containing the two elements were found to cross-
compete for complex formation in electrophoretic mobility shift assays (Figure 16).
This suggests that the two elements may bind similar or related proteins. Consistent
with this sequence homology and cross-competition, the 3' T-rich element was also
found to display affinity for octamer binding proteins. Formation of a specific complex
between the 3' T-rich oligonucleotide and HeLa nuclear extract was competed by
increasing concentrations of the octamer oligonucleotide (Figure 29). Additionally the
3' T-rich oligonucleotide was shown to compete for complex formation between the
octamer containing oligonucleotide and Oct-1 present in HeLa nuclear extract (Figure
17 and 30). Competition for Oct-1 complex formation required a higher concentration
of the 3' T-rich oligonucleotide than was required for competition using the 5' AT-rich
oligonucleotide (Figure 17). This may be expected based on the fact that the 3' T-rich
sequence displays less sequence homology with the octamer binding protein consensus
sequence than the 5' AT-rich sequence does.
Therefore, it is possible that both the 5' AT-rich and the 3' T-rich rPPT-A
elements regulate rPPT-A gene expression by binding member(s) of the octamer
binding protein family (Section 1.2.3.1.1.d.). The identity of the particular octamer
binding proteins which interact with these elements remains unknown. However, the
fact that the 3' T-rich element displays tissue specificity in the proteins it binds, by
DNase 1 footprinting analysis, suggests that ubiquitous Oct-1 is not the only factor
interacting with this region of the promoter. Different octamer binding proteins have
been shown to display varying and overlapping tissue distributions and additionally the
expression of many has been shown to be regulated throughout development and in
response to various extracellular stimuli (He et al., 1989). Therefore, the particular set
of octamer binding proteins present in a given cell at any one time and in response to
extracellular stimuli will vary, thus potentially allowing for tissue-specific and stimulus-
dependent gene regulation.
Although the rPPT-A gene is expressed in a few non-neuronal cells, including
the intestine, stomach, thyroid and retina, its expression is mainly restricted to specific
populations of neuronal cells of the central and peripheral nervous systems and in
particular to a subset of primary sensory neurons of the DRG (Nawa et al., 1983,
1984; Krause et al., 1987, 1989; Carter and Krause, 1990; Harmar et al., 1990;
Bannon et al., 1992). Adult rat DRG sensory neurons are known to express a number
of POU-domain proteins, including Oct-1, N-Oct-2, Brn-3 and a number of Brn-3-
related factors (Wood et al., 1992). Therefore one of these proteins may be a candidate
for regulating rPPT-A gene expression in sensory neurons via the identified octamer-
like elements. Interestingly, in DRG sensory neurons the levels of N-Oct-2 and its
mRNA were found to be upregulated by NGF treatment (Wood et al., 1992). As the
levels of rPPT-A transcripts in adult DRG neurons have been shown to both depend on
NGF availability (Henken et al., 1990) and to increase with NGF treatment (Lindsay
and Harmar, 1989), it is tempting to postulate that N-Oct 2 may bind to one or both of
the identified octamer-like elements within the rPPT-A promoter to regulate gene
expression and to mediate the transcriptional response to NGF.
In order to determine the identity of the octamer binding proteins which will
bind to the identified rPPT-A elements, electrophoretic mobility shift assays may be
carried out using either purified octamer binding proteins or specific anti-sera directed
against the individual POU-domain proteins. In order to determine if the elements are
involved in mediating the transcriptional response to NGF various functional assays
may be carried out, including the transfection of plasmids containing the elements
linked to reporter genes into clonal cell lines and DRG neurons in culture followed by
treatment with NGF.
3.7.2.1.5. Unidentified elements 1 and 2.
DNase 1 footprinting analysis identified two potential regulatory sequence
elements, U.D. 1 (element 9) and U.D. 2 (element 18), located 5' and 3' of the rPPT-A
promoter transcriptional start site respectively.
U.D. 1 was identified by DNase 1 footprinting assays using HeLa nuclear
extract (Figure 15) and spans nucleotides -618 to -607, as shown below:
-618 AACACTTTTGCA ~607
U.D. 2 was identified by DNase 1 footprinting assays using HeLa, rat brain
and rat cerebellar nuclear extracts (Figure 25) and spans nucleotides +317 to +341, as
shown below:
+317 GCTCTTTGGCACGTCAGTAGCCTTC +341
The proteins binding to this element appear, by DNase 1 footprinting analysis,
to vary in their abundance between different tissues as proteins present in HeLa nuclear
extract generated a weaker footprint than those present in rat total brain or cerebellar
extracts.
When aligned, the U.D. 1 and U.D. 2 elements display an 80% sequence
homology, as shown below:
~616 CaCTTTtGCA ~607
+318 CtCTTTgGCA +327
In addition to this high degree of sequence homology, the two elements are
placed a similar context within the promoter i.e. between a G-rich element and a T- or
AT-rich element (Figure 37). Therefore, it is possible that the two elements may bind
similar or related proteins. Electrophoretic mobility shift assays will be required to be
carried out in order to further investigate the potential relationship between the two
elements.
As mentioned in Section 3.7.2.1.2.b. the U.D. 2 element contains a region of
sequence which displays a six out of eight base pair match to a CRE/ATF motif, as
shown in bold type below:
+317 GCTCTTTGGCACGTCAGTAGCCTTC +341
Interestingly, the footprint appears to actually consist of two halves, with the
CRE/ATF-like motif being contained within the first half and being separated from the
second half by a hypersensitive site corresponding to nucleotide +333 (G) (underlined
above).
Unlike U.D. 2, sequences contained within the U.D. 1 element do not appear to
display any homologies with a CRE/ATF motif. Therefore, if the two elements do bind
similar or related proteins it seems unlikely that they will belong to the CREB/ATF
family of transcription factors.
Further studies are required in order to determine the exact nature of the proteins
binding to these two elements and how they are related to each other. These studies
may include electrophoretic mobility shift assays using the two elements as probes in
conjunction with various competitor oligonucleotides containing the consensus
sequence for known transcription factors and specific anti-sera directed against various
known transcription factors.
3.7.2.1.6. Region binding single-stranded and double-stranded DNA binding proteins.
DNase 1 footprinting analysis, using HeLa nuclear extract, detected protein
binding activity (element 11) in a region of the rPPT-A promoter previously reported to
bind a sequence-specific single-stranded DNA binding protein (Quinn and McAllister,
1993).
In their study, Quinn and McAllister postulated that a region from the rPPT-A
promoter, spanning nucleotides -761 to -741, may play a role in the regulation of gene
expression. This stemmed from the fact that this region of the promoter shares a
significant degree of homology with an element from the rat type II Na2+ channel
promoter, thought to be important for mediating cell-specific gene expression (Maue et
al., 1990). By electrophoretic mobility shift assays, it was demonstrated that proteins
present in rat DRG, spinal cord, caudate and spleen extracts bound specifically to a
single-stranded form of an oligonucleotide containing sequence from this region of the
rPPT-A promoter (Figure 33, SS Element). Binding, however, was not detected by
Figure 33. Nucleotide sequence of a region of the rPPT-A promoter which is proposed to
form a stem-loop structure, binds single-stranded DNA binding proteins and is footprinted
using HeLa nuclear extract.
The sequences of a region of the rPPT-A promoter proposed to form a stem-loop
structure and the loop of such a structure are shown.
Shown below these is the sequence of a footprint (footprint 1) generated by HeLa nuclear
extract within this region of the promoter. Footprint 2 was generated when an
oligonucleotide corresponding to the stem-loop structure was used as a competitor in
DNase 1 footprinting assays.
The sequence of the region of the rPPT-A promoter demonstrated to specifically bind
single-stranded DNA binding proteins (SS element) is also shown.
Stem-Loop:~779CCCTTCTGCCTTCAGGGTGTGCCTGGGAAGAAGCTGTAGGGG~738 Loop:"766AGGGTGTGCCTGGGAA~751 Footprint1:-778CCCTTCTGCCTTCAGGGTGTGCCTG~755 Footprint2:~759GCCTGGGAAGAAGCTGTAGGGGAACAAAA~731 SSElement:-765GGGTGTGCCTGGGAAGAAGCTGTAGGG-752
proteins present in rat testis extract, HeLa nuclear extract and a number of other clonal
cell lines (Quinn and McAllister, 1993).
The DNA sequence of this element was subsequently shown to share
homologies with other single-stranded elements from various promoters including an
element, termed M3, from the adipsin gene (Wilkison et al., 1990) and a proximal
repressor element (PRE) from the growth hormone promoter (Pan et al., 1990). This
led to the suggestion that the protein(s) which specifically recognise and bind to the
single-stranded form of this DNA element may act to regulate rPPT-A gene
transcription (Quinn and McAllister, 1993).
Surprisingly, a significant degree of homology was also revealed between the
rPPT-A single-stranded DNA element and an RNA stem-loop-structure, termed TAR
element, located at the 5' end of all HIV-1 transcripts (Rosen et al., 1985). This
element is bound by the potent activator of viral gene transcription, Tat (Ayra et al.,
1985; Sodroski et al., 1985). TAR has been shown to be capable of forming a stem-
loop structure (Muesing et al., 1987) and this structure has been shown to be crucial for
transactivation by Tat (Feng and Holland, 1988). Quinn and McAllister (1993)
suggested that a putative stem-loop structure may also form within the rPPT-A
promoter, with the sequences shown to bind a single-stranded DNA binding protein
forming the loop of such a putative structure. It was suggested if such a stem-loop
structure does occur in vivo then proteins with high affinity for the single-stranded
form of the DNA would bind preferentially to the loop and perhaps act to stabilise the
structure.
Subsequent electrophoretic mobility shift assays have been carried out using an
oligonucleotide which spans nucleotides -790 to -738 and so includes the entire putative
stem-loop structure, from nucleotides -779 to -738 (Figure 33, Stem-Loop) (personal
communication, J.Quinn). These assays reveal a further degree of complexity in the
nature of protein/DNA interactions within this region of the promoter. As was found
for the shorter oligonucleotide, proteins from rat tissue extracts were found to
preferentially bind to a single-stranded form of the oligonucleotide for which proteins
from HeLa nuclear extract and a number of other cell lines displayed no affinity.
However, in contrast to the shorter oligonucleotide, the presence of the additional
nucleotides appeared to allow proteins from HeLa nuclear extract and a number of other
cell lines and tissues to bind specifically to the double-stranded form of the
oligonucleotide (personal communication, J. Quinn).
In order to further investigate the binding of proteins from HeLa cells to this
region of the promoter, DNase 1 footprinting analysis was carried out (Figure 19). A
footprint (Figure 19, Footprint 1) was generated by proteins present in HeLa nuclear
extract spanning nucleotides -779 to -755, as shown below;
~779 CCCTTCTGCCTTCAGGGTGTGCCTG ~755
Preincubation of HeLa nuclear extract with the oligonucleotide spanning the
entire putative stem-loop structure appeared to compete off the complex binding to this
site and to allow the binding of another factor to a distinct yet overlapping sequence
(corresponding to Footprint 2, Figure 19), as shown below:
"759 GCCTGGGAAGAAGCTGTAGGGGAACAAAA "731
When these two footprinted regions are aligned with the proposed stem-loop
sequence (Figure 33), it can be seen that footprint 1 appears to cover the 5' end of the
structure and footprint 2 appears to cover the 3' end and adjacent sequence. This seems
to indicate that at least two complexes can bind to this region of the rPPT-A promoter
and that the binding of one appears to prevent the binding of the other. Interestingly,
most of the sequence protected in footprint 2 is contained within the competitor stem-
loop oligonucleotide suggesting that the binding of protein(s) element may be mediated
by nucleotides -737 to -731.
It can be seen from Figure 33 that both footprint 1 and footprint 2 contain
regions of sequence contained within the element shown to bind single-stranded DNA
binding proteins. Thus, it appears that distinct yet overlapping regions from the rPPT-A
promoter can bind both single-stranded and double-stranded DNA binding proteins.
Although the majority of reported eukaryotic sequence-specific DNA binding
proteins recognise native double-stranded sequences, there have been reports of
proteins which recognise the single-stranded form of DNA and are involved in the
regulation of transcription. Such proteins include muscle factor 3 (MF3) which interacts
with the single-stranded forms of DNA sequence elements important for regulating
muscle gene expression (Santoro et al., 1991) and the estrogen receptor (ER) which,
by way of a DNA binding stimulating factor (DBSF), preferentially binds to the single-
stranded form of its response element (Lannigan and Notides, 1989; Mukherjee and
Chambon, 1990). Other factors include the sterol-regulatory element binding protein
(SRE-BP) (Stark et al., 1992). SRE-BP can bind specifically to both double- and
single-stranded forms of its response element in the low density lipoprotein (LDL)
receptor promoter with the sequence specificites for single-and double-stranded binding
shown, by electrophoretic mobility shift assay, to be distinct yet overlapping (Stark et
al., 1992; Yokoyama et al., 1993). Two distinct factors, termed PRE-binding nuclear
protein (PREB) and single-stranded PREB (ssPREB), bind the double- and the single-
stranded forms of the growth hormone promoter repressor element (PRE) respectively
(Pan et al., 1990). These two factors have been shown to display distinct patterns of
expression (Pan et al., 1990). PREB has been shown, by electrophoretic mobility shift
assays, to be specifically expressed in non-pituitary cell-lines while ssPRE was
detected in all cell lines tested (Pan et al., 1990).
Regulatory sequence elements which can adopt a single-stranded structure
include CT elements (Section 3.7.2.1.3.a.). The rPPT-A footprinted sequence,
footprint 1, does contain a high degree of dC and dT nucleotides, particularly at its 5'
end, and footprint 2 contains a high degree of dG and dA nucleotides. Therefore, it is
possible that factors which have been shown to specifically recognise and bind to such
elements, including Spl, may bind to this region of the rPPT-A promoter to regulate
gene expression.
Therefore, it appears that a wide range of proteins exist with the ability to
recognise and bind to the single-stranded forms of DNA sequence elements.
Additionally, many of these elements are also recognised in the double-stranded form,
both by the same and distinct proteins which often display distinct yet overlapping
sequence specificity and patterns of expression.
The exact nature of the proteins binding to both the single- and double-stranded
forms of DNA from the rPPT-A promoter and their roles in regulating gene expression
are yet to be determined. It is possible that the abundance of such proteins may differ
between different cell types and in response to extracellular stimuli, thus potentially
allowing for tissue-specific and stimulus-dependent gene regulation. For example,
protein(s) specific to a particular set of tissues (e.g. DRG neurons) may recognise and
bind to the single-stranded form of the putative stem-loop structure and other proteins,
expressed in a distinct set of tissues (e.g. spleen), may preferentially recognise the
double-stranded form thus imposing a different form of regulation on the promoter.
Electrophoretic mobility shift assays may be carried out in order to identify the
factors which can bind to this region of the rPPT-A promoter and to determine whether
they recognise the double-stranded, single-stranded or both forms of the DNA
sequence
3.7.2.1.7. Minimal promoter element.
A region of the rPPT-A promoter, located between the TATA box and the major
transcriptional start site, termed the minimal promoter element was noted as sharing a
significant degree of sequence homology with a similarly placed element from the pro¬
opiomelanocortin (POMC) promoter (Section 3.6.1.13.). The POMC element has been
shown to be bound by a novel trans-acting factor, termed PO-B (Riegel et al., 1990).
Although the binding site for PO-B is located close to the binding site for the general
transcription factor TFIID (Section 1.2.2.2.a.), it has been shown that both factors are
unrelated in their binding, fractionation and transcriptional stimulatory properties
(Riegel et al., 1990).
PO-B has been shown to be required for maximal efficiency of the POMC
promoter both in vivo and in vitro and in association with the functional TATA box is
capable of directing transcriptional initiation (Riegel etal., 1990). Interestingly, it has
been shown that factors with PO-B like binding activity are present in a number of cell
lines in which POMC is not normally expressed (Reigel et al., 1990), suggesting that
PO-B may have a function in the regulation of other eukaryotic genes. This finding
taken together with the fact that rPPT-A promoter sequence, between the TATA box
and transcriptional start site, shares a significant degree of homology with the PO-B
binding region suggested that PO-B, or a related factor, may bind to the rPPT-A
minimal promoter element.
In order to investigate any possible relationships between the factors which bind
to the POMC and rPPT-A promoters, electrophoretic mobility shift assays were carried
out using oligonucleotides containing sequences either from the rPPT-A promoter,
spanning nucleotides -20 to +4 (termed 168/169), or from the POMC promoter,
spanning nucleotides -23 to +5. The results from such assays demonstrated that
although protein(s) will specifically bind to the rPPT-A minimal promoter element
(Figure 20), they do not appear to be related to PO-B. Specific complexes formed
between the two oligonucleotides and various cellular extracts were shown to display
very different mobilities (Figure 22) and the two oligonucleotides failed to show any
cross-competition for complex formation with HeLa nuclear extract (Figure 21).
DNase 1 footprinting analysis using HeLa nuclear extract subsequently
identified a protein binding site (element 12) located between the TATA box and
transcriptional start site of the rPPT-A promoter (Figure 23). A footprint was
generated, as shown below in bold type, which covers two dA nucleotides at positions
-16 and -17 and a hypersensitive site was generated which corresponds to a dC
nucleotide at position -19:
-20 GCGAAGC ~14
This footprint is contained within the sequence of the oligonucleotide (168/169)
used for the electrophoretic mobility shift assays described above. Therefore the results
from both assays, taken together, demonstrate the presence of a potential regulatory
element within the rPPT-A promoter, spanning nucleotides -20 and +4, as shown
below:
-20 GCGAAGCAGGAGCAGGGACTAGAG +4
The identity of the protein(s) which bind to the rPPT-A minimal promoter
element have yet to be determined. The core promoters of genes transcribed by RNA
polymerase II commonly contain a TATA element (Section 1.2.2.) and/or an initiator
(Inr) element (Grosschedl and Birnstiel, 1980; Smale and Baltimore, 1989) (Section
1.2.2.4.)- Both of these elements are important for promoter function and specifically
interact with sequence-specific transcription factors. Directly acting transcriptional
repressor proteins have also been shown to bind to the minimal promoter regions of
several genes. Thus, it is possible that a factor(s) which specifically recognises TATA,
Inr or repressor elements is responsible for generating the observed binding activity
over the rPPT-A minimal promoter element.
a. General transcription factors.
It is unlikely that the TATA-box binding protein, TBP (Section 1.2.2.2.a.), is
responsible for generating the observed binding activity, as the TATA box from the
rPPT-A promoter (identified by Carter and Krause, 1990) spans nucleotides -22 to -28
and therefore lies immediately 3' of the identified protein binding site. Other general
transcription factors (Section 1.2.2.2.) are also unlikely to be responsible as none have
been shown to display sequence-specific binding to DNA in the vicinity of the
transcriptional start site.
b. Initiator elements.
Inr elements (Section 1.2.2.4.) are found in the vicinity of the transcriptional
start site of several eukaryotic genes. Multiple types of Inr elements have been shown
exist, serving a variety functions and interacting with a wide range of factors including
USF and TFII-I (Roy etai, 1991; Du et al„ 1993), YY1 (Seto et al., 1991; Shi et al,
1991) and the Inr-binding protein of SV40 (IBP-s) (Wiley et al., 1993).
A weak consensus sequence, as shown below, has been derived for Inr
elements (Corden et al., 1980):
5'-PyPyCAPyPyPyPyPy-3'
When the sequence of the rPPT-A minimal promoter element is shown on the
complementary strand, two overlapping regions (shown below in bold type) are




It is not known if the rPPT-A minimal promoter element represents such an Inr
element. However, it does posses a high degree of sequence similarity with the
consensus sequence and it is interesting to note that both the AdML and the rPPT-A
promoters posses similarly located E-box motifs (i.e. at positions -60) and Inr-like
elements close to their transcriptional start sites (Sawadago and Roeder, 1985; Roy et
al., 1991; Du et al., 1993) (Section 3.7.2.1.1.a.). The sequence of the Inr element ^
from the AdML promoter located close to its transcriptional start site is shown below:
~3 CTCACTCTCTTC +9
When this is aligned with the minimal promoter element from the rPPT-A
promoter a degree of homology (62 %) is revealed:
"3 CTCa-CtCTctTC +9
_2° CGCTTCGTCCTCgtCcCTgaTCTC +4
The AdML Inr elements are bound by the same bHLH proteins which bind to
its E-box motif at -60, raising the possibility that similar factors may bind to the E-box
1 motif and the minimal promoter element from the rPPT-A promoter. Further studies
are required in order to determine the nature of the protein(s) binding to the rPPT-A
minimal promoter element, to determine if they are related to other Inr or E-box binding
proteins and to determine if they share any functional properties with other well
characterised Inr elements.
c. Transcriptional repressor proteins.
It is possible that, as was found for the PO-B binding region of the POMC
promoter (Riegel et al., 1990), a factor other than an Inr element binding protein binds
to rPPT-A minimal promoter region.
Some of the factors which are involved in mediating the repression of
transcription initiation bind to sequences around the transcriptional start site. Directly
acting repressors which alter the interaction of RNA polymerase II or the general
transcription factors with promoters have been commonly observed in prokaryotic gene
regulation (reviewed by Adhya 1989). This mechanism is also thought to account for
the autoregulation of certain viruses such as regulation of SV40 gene expression by the
SV40 T antigen (Rio and Tjian, 1983). Gomez-Cuadrado et al. (1992) reported the
isolation of a DNA-binding protein from mature chicken erythrocytes, termed cIBR
(chicken Inr binding protein). cIBR recognises sequences spanning the transcriptional
start site of the histone H5 gene but was shown to be functionally unrelated to Inr
binding proteins (Gomez-Cuadrado et al., 1992). It was demonstrated that the binding
of cIBR could repress transcription from the H5 promoter in vitro and this was thought
to be achieved through direct interference with general transcription factors, other than
TFIID (Gomez-Cuadrado et al., 1992).
Other identified transcriptional repressor proteins proposed to mediate their
action through direct communication with general transcription factors, at minimal
promoter elements, include the p53 gene product. The p53 protein has been shown to
act as an activator of gene expression through the binding of specific regulatory
sequences termed p53 response elements (Farmer et al., 1992; Zambetti et al., 1992). ^
p53 has also been shown to negatively regulate a number of genes that lack a p53
response element including the c-fos and c-jun genes and the p53 gene itself (Ginsberg
et al., 1991; Santhanam et al., 1991). Seto et al. (1992) demonstrated that p53 can
inhibit transcription from minimal promoters in a HeLa nuclear extract and that it can
bind to human TFIID. From these findings it was suggested that p53 mediates
transcriptional repression by binding to TFIID and interfering with transcriptional
initiation. Mack et al. (1993) subsequently demonstrated that p53 specifically represses
the activity of promoters whose initiation is dependent on the presence of a TATA box.
The repression observed was again consistent with a direct interaction of p53 with the
TATA-dependent basal machinery.
Thus, multiple different factors, including TFIID, Inr binding factors and
repressor proteins, have been shown to bind sequences around the TATA box and
transcriptional start site of genes transcribed by RNA polymerase II. The identity and
the function of the factor(s) interacting with the rPPT-A minimal promoter element is as
yet unknown. However, it would be attractive to postulate that the factor(s) binding to
this region may in some way interact with the basal transcriptional machinery to repress
transcription. This would be consistent with results demonstrating that the rPPT-A
promoter is not expressed, either endogenously or by transfection, in tissue culture
cells and that 5' deletion of the promoter fails to relieve this repression (J. Quinn,
personal communication). If a factor(s) is present in such cells which can bind to the
minimal promoter element and prevent the initiation of transcription by the basal
transcriptional machinery, then a lack of gene expression in these cells would be
expected. If this hypothesis is correct then one would expect that cells or tissues which
do express the rPPT-A gene, by transfection or endogenously, either do not express the
repressor or express it in a modified form.
Further studies are required in order to identify both the nature and the
expression pattern of the factor(s) which interact with this region of the promoter.
Functional studies will then allow the validity of the above hypothesis to be tested.
3.7.2.1.8. Region displaying differential protein binding activity.
By DNase 1 footprinting analysis (Figure 24) extracts form rat cerebellar tissue
and HeLa cells have been shown to protect distinct yet overlapping sequences from the
rPPT-A promoter, in a region located 3' of the major transcriptional start site, spanning
nucleotides +55 to +130.
Proteins present in HeLa nuclear extracted generated two footprints in this
region, one is located in exon 1 (element 14) and spans nucleotides +74 to +94:
+74 TGCGGAGCATCACCGGGTCCG +94
and the other is located over the intron 1/exon 1 boundary (element 15) and spans
nucleotides +98 to +107:
+98 GCAGTGAGTA +107
The identity of the factors from HeLa cells which bind to these two sequence
elements are unknown. However, a region of sequence contained within the footprint
covering the intron 1/exon 1 boundary, when extended to nucleotide +108 (C),
displays a five out of seven base pair match to an AP-1 consensus sequence (TGA G/C
TCA), as shown in bold type above. This then raises the possibility that an AP-1
complex may bind to this site to regulate transcription (Section 3.7.2.1.2.a.).
Electrophoretic mobility shift assays using the two footprinted elements as
oligonucleotide probes and various competitor oligonucleotides may provide further
information concerning their binding characteristics.
Rat cerebellar extract also generated two footprints over this region of the
promoter. One of the sequences bound by cerebellar proteins, contained within exon 1,
overlaps one of the elements (element 14) bound by HeLa extract at its 5' end, but is
extended further in a 3' direction. This element (element 13) spans nucleotides +55 to
+88, with a hypersensitive site present at nucleotide +89:
+55 CGCCCAGCAAGTGCGCACCTGCGGAGCATCACCGG +89
The second cerebellar generated footprint (element 16) is distinct from either of
the HeLa generated footprints and is contained within intron 1, spanning nucleotides
+ 116 to+130:
+116 GCCTGCCATCTGCCG +130
Interestingly, both of the cerebellar generated footprints contain E-box motifs,
shown in bold type (Section 3.7.2.1.l.b.). Electrophoretic mobility shift assays may
help to determine the nature of the proteins binding to these footprints and to determine
whether proteins specifically recognise the E-box motifs or if other sequences within
the footprints are specifically recognised by distinct proteins.
A neuronal-specific protein/DNA interaction, within the rPPT-A promoter, has
previously been reported by use of the exonuclease protection assay (Quinn, 1992). It
was found that proteins present in rat cerebellar, hippocampal and spinal cord extracts
and in extract from PC 12 cells generated a specific protein/DNA interaction which was
not observed by proteins present in rat spleen extract or the non-neuronal derived cell
lines HeLa and 293 (Quinn, 1992). This apparently neuronal specific interaction was
mapped to a region 3' of the transcriptional start site, approximately at the intron 1/exon
1 boundary (Quinn, 1992). The DNase 1 footprinting data above is consistent with this
finding of a 3' neuronal specific protein/DNA interaction, as cerebellar extract was
found to generate a distinct pattern of binding from that generated by HeLa extract. ^
Additionally, DNase 1 footprinting has allowed the sites of protein/DNA interactions to
be mapped more accurately. However, where as exonuclease protection analysis
suggested a lack of binding by proteins present in HeLa cell extract to this 3' region
(Quinn, 1992), DNase 1 footprinting analysis has demonstrated that two sequence
elements are bound by HeLa cell extract. The reasons for the discrepancy between the
two different assays are unknown. However, they are very different assays and employ
different approaches in the identification of protein/DNA interactions. Electrophoretic
mobility shift assays using the identified elements as oligonucleotide probes and
extracts of both neuronal and non-neuronal origin may provide further information
regarding the binding characteristics of proteins to this region of the promoter.
The results from this study therefore suggest that a 3' region of the rPPT-A
promoter, spanning nucleotides +55 to +130, displays tissue-specificity in its
protein/DNA interactions. A hypothetical model to explain the observed binding pattern
supposes that the expression of the transcription factors which recognise the regulatory
elements, identified within this region of the rPPT-A promoter, varies between HeLa
and rat cerebellar extracts or that the factors which bind to these elements are expressed
in a tissue-specific manner. In this way rat cerebellar extract may contain factor(s)
which preferentially recognise a particular motif or set of motifs and HeLa cells may
express a different set of factors which recognise a distinct set of motifs.
Further studies, including electrophoretic mobility shift assays, should help to
further characterise the binding of proteins from different cell and tissue extracts to this
region of the promoter.
3.7.3. Arrangement of potential regulatory elements within the rPPT-A promoter.
Multiple potential regulatory elements have been identified within a 1300 bp
region of the rPPT-A promoter, spanning nucleotides -865 to +447.
A diagrammatic representation of how these elements are arranged within the
rPPT-A promoter is shown in Figure 34.
From this figure it appears that several domains, consisting of related elements,
can be defined within the promoter. These include a region located 5' of the
transcriptional start site, spanning nucleotides -40 to -360bp, termed the proximal
region, and a flanking region consisting of the AT-, T-, G-rich and U.D. elements,
located both 5' and 3' of the transcriptional start site.
3.7.3.1. Proximal region.
Multiple putative transcription factor binding sites have been identified within a
region of the rPPT-A promoter, spanning 320bp, located 5' of the transcriptional start
Figure 34. Arrangement of identified potential regulatory elements within a 1300 bp
region of the rPPT-A promoter.
A diagrammatic representation of the rPPT-A promoter with identified protein/DNA
interaction sites is shown. Most of these sites were characterised by DNase 1














Regions which binds both single-stranded (ss) and double-
stranded (ds) DNA binding proteins (DBP). Span nucleotides
-778 to -731.
Region rich in dA and dT nucleotides containing an octamer-like
consensus sequence (identified by electrophoretic mobility shift
assays). Spans nucleotides -662 to -655.
Unidentified Element 1. Spans nucleotides -618 to -607.
Regions rich in dG nucleotides. Span nucleotides -575 to -546.
Region containing a perfect AP-1 consensus sequence. Spans
nucleotides -345 to -330.
Region containing a six out of seven base pair match to an AP-1
consensus sequence. Spans nucleotides -324 to -308.
Regions containing E-box consensus sequences.
E-box 3 spans nucleotides -308 to -303 (identified by
electrophoretic mobility shift assays), E-box 2 spans nucleotides
-177 to -155 and E-box 1 spans nucleotides -67 to -47.
Region rich in dG and dA nucleotides. Spans nucleotides -284
to -264.
Region displaying homology to both CRE/ATF and AP-1
consensus sequences. Spans nucleotides -198 to -180.
Region located between the TATA box and the transcriptional
start site. Spans nucleotides -20 to -14.
Region displaying tissue specificity in its protein binding
activity. Spans nucleotides +55 to +130.
Unidentified Element 2. Spans nucleotides +317 to +341.
Region rich in dT nucleotides. The HeLa generated footprint
spans nucleotides +372 to +390 and the total rat brain generated






















site. A diagrammatic representation of how these sites are arranged on the promoter is ^
shown in Figure 35.
The AP-l/AP-l'/E-box 3 and 'CRE'/E-box 2 elements appear to represent two
domains within the promoter, each spanning approximately 50 bp and separated by
approximately 100 bp. Both domains contain E-box motifs and sequences displaying
homologies with both AP-1 and/or a CRE/ATF consensus sequences, (AP-1, AP-1'
and 'CRE'). The close proximity of the two domains to each other and the possible
overlap of proteins binding to sites within the domains raises the possibility that they
may synergise with one another to regulate gene expression.
The footprinted region located between these two domains, on the
complementary strand, resembles a CT element and finally there is a third E-box motif,
termed E-box 1, located approximately 60 bp upstream of the transcriptional start site.
Support for these elements having a functional significance in the regulation of
rPPT-A gene expression comes from a comparison of the rat and bovine PPT-A
promoter sequences. When the 5' flanking regions of the rat and bovine PPT-A genes
are compared a significant degree of homology (82%) is revealed within 346 bp of
sequence, immediately upstream of the transcriptional start site, with considerable
divergence further upstream (Carter & Krause, 1990; Gilchrist et al., 1991). When the
potential regulatory elements identified from the rat promoter, contained within this
homologous region, are aligned with the corresponding regions of the bovine promoter
a highly significant degree of homology is revealed (Figure 36). The homology
between the E-box-1 and E-box-2 motifs, the 'CRE' elements, and the AP-1 and AP-1'
motifs is 100%, with the homology between the E-box-3 motifs being 83% and
between the CT elements being 77%.
Such a high degree of sequence conservation between 5' flanking regions of the
rat and bovine PPT-A promoters suggests that this region of the rPPT-A promoter may
play an important role in transcriptional regulatory mechanisms.
3 J.3.2. Flanking regions.
Several related elements have been identified within the rPPT-A promoter which
are located in regions placed both 5' and 3' of the major transcriptional start site. These
have been termed 5' and 3' G-rich elements, 5' AT- and 3' T-rich elements and
Unidentified (U.D.) elements 1 and 2. A diagrammatic representation of how these
elements are arranged on the promoter is shown in Figure 37. From this figure it
appears that they can be grouped into two domains, one 5' and the other 3' of the major
transcriptional start site. Each domain spans approximately 120 bp and contains a G-
rich sequence and a T or AT-rich sequence, separated by a U.D. element. The sequence
homologies displayed between the 5' and 3' G-rich elements, the 5' AT and 3' T-rich
Figure 35. Arrangement of identified potential regulatory elements within a region of
the rPPT-A promoter spanning 320bp 5' of the transcriptional start site.
DNase 1 footprinting analysis was carried out, using the constructs prPPT-(3Gal6,
pVL29 and SM1/Q5 with HeLa nuclear extract, over a region of the rPPT-A promoter
spanning nucleotides -40 to -360, relative to the major transcriptional start site. A
number of protein bound sequence elements were identified termed AP-1, AP-1', E-
box 1 to 3, Purine-Rich and "CRE".
A diagrammatic representation of the rPPT-A promoter, spanning 360 bp of sequence
immediately 5' of the major transcriptional start site, is given with identified
protein/DNA interaction sites within a region spanning nucleotides -360 to +447
shown. The AP-l/AP-l'/E-box 3 and 'CRE'/E-box 2 elements appear to represent two







Region containing a perfect AP-1 consensus sequence. Spans
nucleotides -345 to -330.
Region containing a six out of seven base pair match to an AP-1
consensus sequence. Spans nucleotides -324 to -308.
Regions containing E-box consensus sequences.
E-box 3 spans nucleotides -308 to -303 (identified by electrophoretic
mobility shift assays), E-box 2 spans nucleotides -177 to -155 and
E-box 1 spans nucleotides -67 to -47.
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Figure 36. A sequence comparison of protein/DNA interaction sites identified within a
5' flanking region of the rat PPT-A promoter with the corresponding regions from the
bovine promoter.
A region from the rat PPT-A gene spanning 320bp, 5' of the major transcriptional start
site, was analysed for protein/DNA interaction sites by DNase 1 footprinting and
electrophoretic mobility shift assays. Several potential regulatory elements were
identified which display homologies to the DNA consensus sequences for various
transcription factors (shown in bold type).
The identified protein/DNA interaction sites from the rat gene have been compared with
the corresponding regions from the bovine PPT-A gene. This comparison reveals a
high degree of sequence conservation between the two species.
l.E-box 1.
Rat ~61 AGaGtGTCACGTGGcTCtCC ~47
Bovine "67 AGcGcGTCACGTGGgTCcCG ~47
2. E-box 2.
Rat -177 TTtGGTCCAGATGTTATGgaCTC "
Bovine ~177 TTgGGTCCAGATGTTATGcgCAC "
3. E-box 3
Rat "308 cAGGTG -303
Bovine ~308 tAGGTG "303
4. 'CRE'
Rat ~198 ATTGCGTCATTTCGAACCC "18°
Bovine ~198 ATTGCGTCATTTCGAACCC ~180
5. Purine-rich element
Rat -284 AAGAAgagGGGagGGGGGCG ~264
Bovine "284 AAGAAagaGGGgaGGGGGCG ~264
6. AP-1 elements
Rat ~324 tTTTGATGAGTAATCTC ~308
Bovine ~324 cTTTGATGAGTAATCTT ~308
Rat ~345 aGcATGAGTCACTTcG ~330
Bovine ~345 gGaATGAGTCACTTtG ~330
Figure 37. Arrangement of G-rich. T and AT-rich and unidentified elements 1 and 2
within the rPPT-A promoter.
DNase 1 footprinting analysis of the rPPT-A promoter was carried using the constructs
prPPT-pGal4 and pSMl'/Q5 with HeLa, rat brain and rat cerebellar nuclear extracts. A
number of sequence elements bound by proteins were identified. These have been
termed 5' and 3' G-rich elements, 5' AT-rich and 3' T-rich elements and unidentified
elements 1 and 2.
A diagrammatic representation of the rPPT-A promoter, spanning nucleotides -865 to
+447, including the sites of protein/DNA interactions is given. These elements appear
to represent two domains, one 5' and the other 3' of the major transcriptional start site,
each spanning approximately 120 bp of sequence.
dAT Region rich in dA and dT nucleotides which spans nucleotides -662 to -655 and
contains an octamer-like consensus sequence (identified by electrophoretic
mobility shift assays).
U. D. Unidentified Elements
U.D. 1 spans nucleotides -618 to -607.
U.D. 2 spans nucleotides +317 to +341.
dG Regions rich in dG nucleotides which span nucleotides -575 to -546 and +268
to +290.
dT Region rich in dT nucleotides. The HeLa generated footprint spans nucleotides
















elements and both U.D. elements (Sections 3.7.2. -1.3.b., -1.4. and -1.5.) suggests ^
that similar or related proteins may bind to the 5' and 3' domains and that they may, in
some way, synergise with each other to regulate rPPT-A gene expression. Both G-rich
elements may potentially be bound by the transcription factor Spl (Section
3.7.2.1.3.b.) and as it has been shown that different DNA elements bound by Spl
molecules may interact by looping out the intervening DNA (Su et al., 1991), it is
possible that the rPPT-A 5' and 3' G-rich elements may communicate in such a
manner. Additionally, different elements within the 5' and 3' domains may also
synergise with one another as, for example, there have been reports in the literature of a
functional synergism between the transcription factors Spl and Oct-1 involving
cooperativity in binding (Janson and Pettersson, 1990). As the AT- and T-rich sites,
identified within the rPPT-A promoter, may potentially be bound by a member(s) of the
octamer binding protein family, including Oct-1, it is possible that they may interact
with the G-rich sites in such a manner.
Section 4: Regulation Of Octamer Binding Proteins By Nerve Growth Factor.
4,1, Introduction.
Octamer binding proteins are a subset of a larger family of homoebox proteins
which, in addition to a homeodomain sequence, contain an adjacent conserved
sequence, termed a POU-specific domain (Section 1.2.3.1.1.d.). Members of the
octamer binding protein family recognise and bind to the octameric DNA consensus
sequence ATTTGCAT, first recognised in the histone H2B (Harvey et al., 1982) and
heavy and kappa light chain immunoglobulin genes (Falkner and Zachau, 1984). The
octamer motif has subsequently been identified as a regulatory sequence motif for a
number of ubiquitous and cell specific cellular and viral genes (reviewed in Kemler and
Schaffner, 1990). It has been shown that the consensus sequence is highly degenerate
(Baumruker et al., 1988) with flanking sequences also being important for mediating
protein/DNA interactions.
Numerous POU-domain genes have been identified in mammals and it is likely
that many more remain to be discovered. The proteins encoded by the genes isolated so
far have been postulated to serve a number of different functions and each show
varying and overlapping tissue distributions (He et al., 1989). Each POU-domain
protein has been assigned a specific Oct number, although the terminology is very
confusing and it appears that similar proteins may be referred to by several different
names. The POU-domain proteins discovered to date include the ubiquitously
expressed Oct-1 protein (Sturm et al., 1988), the B-cell specific Oct-2 protein (Clerc et
al., 1988; Ko et al., 1988; Muller-Immergluck et al., 1988; Scheidereit et al., 1988),
Oct-3 which is developmentally regulated during mouse embryogenesis (Okamoto et
al., 1990), Oct-4 which is expressed in male and female primordial germ cells and is
specific for the female germline at later stages of germ cell development (Scholer et al.,
1989, 1990), Oct-5 which is detected in unfertilised oocytes and also in embryonic
stem cells (Scholer et al., 1989) and Oct-6 which is expressed in embryonic stem cells,
glial progenitor cells and in a restricted set of neurons in the CNS (Suziki et al., 1990).
A number of nervous-tissue specific octamer binding proteins have also been
identified, such as Brain-1 (Brn-1), Brain-2 (Brn-2), Brain-3a, 3b and 3c (Brn-3a, 3b
and 3c), Brain-4 (Brn-4) and Testes-1 (Tst-1), which show distinct patterns of
expression in the developing mammalian central nervous system (He et al., 1989; Hara
et al., 1992; Theil et al., 1993; Xiang etal., 1993). Additionally, POU-domain proteins
differentially expressed in human glioblastoma and neuroblastoma cell lines have been
identified and are termed N-Oct 2a and p, N-Oct 3, N-Oct 4 and N-Oct 5a/5b
(Schreiber et al., 1990).
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Alternate splicing of primary transcripts generates further heterogeneity among
POU-domain proteins. For example, the human Oct-1 primary transcript is alternatively
spliced to generate an NH2- and COOH-terminal truncated form of Oct-1, termed Oct-
lb (Das and Herr, 1993). In transient transfection assays Oct-lb displays an enhanced
ability to activate the human histone H2B promoter than the larger Oct-1 protein (Das
and Herr, 1993). There are also alternative Oct-2 transcripts, termed Oct-2a, Oct-2b
(Schreiber et al., 1988), Oct 2c and Oct-2d (Mini-Oct) (Stoykova et al., 1992). POU-
domain proteins are also thought to be both positively and negatively regulated through
protein-protein interactions (Section 1.2.3.1.1.d.).
Lindsay and Harmar (1989) have shown that the levels of rPPT-A transcripts in
adult DRG neurons in culture increase with nerve growth factor (NGF), a trophic
molecule essential for the survival of sympathetic and sensory neurons. Subsequently,
by in situ hybridisation, Henken et al. (1990) showed that levels of rPPT-A transcripts
in adult DRG neurons may depend on the availability of NGF. Therefore, it seems
possible that some of the transcription factors regulating expression of the rPPT-A gene
may also be regulated by NGF. One such candidate is the AP-1 complex which has
already been shown to vary in composition in PC 12 cells with NGF treatment (Curran
and Morgan, 1985; Greenberg et al., 1985; Kruijer et al., 1985; Milbrandt, 1986;
Quinn, 1991). Another potential candidate for an NGF regulated transcription factor is
a member of the octamer binding protein family.
Evidence exists which suggests that there may be a link between octamer
binding proteins and NGF in the regulation of HSV immediate early gene expression.
The first stage of the lytic cycle following HSV infection involves the transcription of
the immediate early (IE) genes, ICPO, ICP4, ICP22, ICP27 and ICP47, whose
products are essential for subsequent stages of viral gene expression (Preston, 1979;
Watson & Clements, 1980). HSV can establish latent infection in sensory neurons
(reviewed by Roizman & Sears, 1986) and in situ hybridisation studies have reported
that none of the five IE gene mRNAs are detected in latently infected ganglia (Stevens et
al., 1987). The maintenance of HSV latency in in vitro systems has been shown to
require NGF. If anti-NGF antibodies are added to primary cultures of rat sympathetic
neurons, the virus reactivates and cells begin producing viral antigens (Wilcox and
Johnson, 1987, 1988).
Transcription of immediate early genes involves the interaction of various
cellular transcription factors, notably Spl and Oct-1, with sites on IE gene promoters
(Jones and Tjian, 1985; O'Hare and Goding, 1988). Oct-1 interacts, in combination
with the HSV encoded protein VP 16, with the octamer-like TAATGARAT motif on
immediate early promoters (O'Hare & Goding, 1988). The failure of immediate early
gene expression in latently infected neuronal cells has been proposed to be due to a
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difference in the nature or type of transcription factors in such cells. CI300 mouse
neuroblastoma cells have been used as a model system for studying the interaction of
HSV with neuronal derived cells (Kemp and Latchman, 1989; Kemp et al. 1990) and it
has been demonstrated that there is a difference in the nature of octamer binding
proteins in such cells. CI300 cells were found to express an additional octamer binding
protein, absent from non-neuronal cells, and this protein was proposed to mediate the
repression of IE promoters in neuronal cells (Kemp et al., 1990). As NGF is required
to maintain latency, another mechanism for altering transcription from IE promoters
may be NGF modulation of some of the transcription factors involved in IE gene
transcription. A potential candidate for such modulation may be a member of the
octamer binding protein family.
If NGF does indeed regulate the nature of octamer binding proteins then this
phenomena may be important for mediating the effects of NGF on rPPT-A gene
expression through octamer binding elements located within the promoter.
4.2. Aim of the study.
The aim of this study was to investigate the potential regulation by NGF of
octamer binding proteins which in turn may regulate the rPPT-A promoter.
4.3. Strategy.
In order to investigate the possible regulation of octamer binding proteins by
NGF, electrophoretic mobility shift assays were carried using out as described in
Sections 2.2.6.1. and 3.6. Unfortunately, it is difficult to generate sufficient protein
extract of suitable quality from primary cultures of DRG neurons for this type of study
to be carried out. Therefore, this study has made use of the CI300 mouse
neuroblastoma cell line (Augusti-Tocco and Sato, 1969) which has been previously
been used in other studies as a model system for cells of neuronal origin (Kemp et al.,
1990).
4.4. Results.
The DNA consensus sequence for the octamer binding protein from the
immunoglobulin heavy-chain enhancer, (Augereau and Chambon, 1986; Staudt et al.,
1988) (Figure 38, Oct), was used to identify specific octamer binding protein
complexes in CI300 cells by electrophoretic mobility shift assay.
Figure 39, lanes 1-5 demonstrate the presence of three complexes formed
between CI300 cells and the Oct oligonucleotide. The two lower complexes were
competed by increasing concentrations of a non-specific oligonucleotide, (NS, Figure





Figure 38. Sequence of the oligonucleotides used in electrophoretic mobility shift
assays.
The sequence of the oligonucleotides, Oct (or Specific, S) and NS, used in
electrophoretic mobility shift assays are shown.
Oct contains an octamer binding protein element from the immunoglobulin heavy-chain
enhancer (Augereau and Chambon, 1986; and Staudt et al., 1988).
NS (Non-specific) is a randomly computer generated sequence.
Figure 39. Electrophoretic mobility shift assay using the immunoglobulin octamer
binding element and extract from CI300 cells and CI300 cells exposed to NGF for
24 h.
A double stranded oligonucleotide containing the immunoglobulin octamer binding
element (Oct) was 5' end labelled with T4 polynucleotide kinase. End-labelled
oligonucleotide (lng) was incubated with either extract from CI300 cells (20|lg) or
with extract from CI300 cells exposed to NGF for 24 h (20|ig), in the presence of l|ig
of poly d(I-C).
Several complexes were formed between the probe and CI300 cell extract, in the
absence of competitor DNA (lane 1). The two lower complexes, indicated as NS, were
shown to represent non-specific binding complexes as they were competed by
increasing concentrations (10, 50, 100 and 150ng) of non-specific oligonucleotide
(NS) (lanes 2-5). The upper complex migrates to a similar position as the Oct-1
complex from HeLa cell extract (see Figure 42) and so is indicated by an arrow to
represent Oct-1.
Extract from C1300 cells exposed to NGF for 24 h (lanes 6-10) generated, in addition
to the Oct-1 complex, a complex termed C1300-Oct (indicated by an arrow). Increasing
concentrations (10, 50, 100 and 250ng) of non-specific oligonucleotide, (NS) (lanes 7-
10), competed away only the non-specific binding complexes, thus allowing the
C1300-Oct complex to be observed more clearly.
Extract: C1300 C1300 + NGF
12345 6 789 10
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N.S.). The slower migrating complex was not competed by the NS oligonucleotide and
is indicated by an arrow to be the ubiquitous octamer binding protein, Oct-1, as its
migration is in the same position as the Oct-1 complex from HeLa cells (Figure 41, lane
7). Lanes 6-10 show that on exposure of CI300 cells to NGF for 24 h a new complex,
C1300-Oct (indicated by an arrow), was observed. The C1300-Oct complex was
observed more clearly when increasing concentrations of the NS oligonucleotide were
added (lanes 7-10).
The specificity of the induced C1300-Oct complex was demonstrated by
competition with homologous (S) and heterologous (NS) oligonucleotides (Figures 40
and 41). In these and following assays, cell extracts were preincubated with l|ig of
poly[d(I-C)] and non-specific oligonucleotide (50ng) in order to remove non-specific
complexes and to allow the induced complex to be seen more clearly. Increasing
concentrations of homologous competitor (S) were added to extract from CI300 cells
exposed to NGF for 24 h, (Figure 40, lanes 2-5 and Figure 41, lanes 5-6). This
resulted in competition of both the Oct-1 complex and the C1300-Oct complex
(indicated by arrows). Increasing concentrations of heterologous competitor, (NS)
(Figure 40, lanes 7-10, and Figure 41, lanes 2-3), failed to compete for formation of
either the Oct-1 complex or the C1300-Oct complex. The complex generated by
ubiquitous Oct-1 from HeLa nuclear extract is shown in Figure 41, lane 7 to
demonstrate that it migrates to the same position as the complex generated by Oct-1
from CI300 whole cell extract.
In order to determine the time course over which the C1300-Oct complex was
induced, an electrophoretic mobility shift assay was carried out using extracts from
CI300 cells which had been treated with NGF for increasing amounts of time. Figure
42, lane 1 shows the ubiquitous Oct-1 complex (indicated by an arrow) generated by
HeLa cell extract. Lane 2 contains CI300 cell extract and lanes 3-5 contain extracts
from CI300 cells treated with NGF for 1, 3 and 24h respectively. As expected, Oct-1
was constitutively present in all of the C1300 cell extracts. The C1300-Oct complex
(indicated by an arrow) appeared as a faint complex after exposure to NGF for 3 h (lane
4) and was clearly observed at 24 h post-induction (lane 5).
Previous reports have indicated that CI300 cells constitutively express two
specific octamer binding proteins (Kemp et al., 1990). In order to demonstrate that the
finding of an NGF inducible protein in CI300 cells was not unique to one particular
isolate of cells, a different source of CI300 cells, from a different clone, was obtained.
Figure 43 shows that the results are reproducible. Oct-1 (indicated by an arrow) was
constitutively present in C1300 cells (lanes 1, 2, 5, 6 and 9-11). The C1300-Oct
complex (indicated as an arrow) appeared after exposure to NGF, in this case for 48
and 72 h (lanes 5, 6 and 9-11). The increase in abundance of the C1300-Oct complex at
Figure 40. Electrophoretic mobility shift assay using the immunoglobulin octamer
binding element and extract from CI300 cells exposed to NGF for 24 h.
A double stranded oligonucleotide containing the immunoglobulin octamer binding
element (Oct) was 5' end labelled with T4 polynucleotide kinase. End-labelled
oligonucleotide (lng) was incubated with extract from CI300 cells exposed to NGF for
24 h (20|ag), in the presence of l(lg of poly d(I-C) and 50ng of non-specific
oligonucleotide.
Several complexes were formed between the probe and CI300 cell extract, in the
absence of competitor DNA (lanes 1 and 6). Two complexes, indicated as Oct-1 and
C1300-Oct, were shown to be specific as they were competed by increasing
concentrations (10, 25, 50 and lOOng) of homologous oligonucleotide competitor (S)
(lanes 2-5). Increasing concentrations (10, 50, 100 and 150ng) of a heterologous
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Figure 41. Electrophoretic mobility shift assay using the immunoglobulin octamer
binding element and extract from HeLa cells and CI300 cells exposed to NGF for 24 h.
A double stranded oligonucleotide containing the immunoglobulin octamer binding
element (Oct) was 5' end labelled with T4 polynucleotide kinase. End-labelled
oligonucleotide (lng) was incubated with either HeLa nuclear extract or extract from
CI300 cells exposed to NGF for 24 h (20|lg), in the presence of l|ig of poly d(I-C)
and 50ng of non-specific oligonucleotide.
In lane 7 the Oct-1 complex formed between the probe and HeLa nuclear extract is
indicated by an arrow. Lanes 1-6 contain CI300 extract treated with NGF for 24 h.
Several complexes were formed between the probe and CI300 cell extract, in the
absence of competitor DNA (lanes 1 and 4). Two complexes, indicated as Oct-1 and
C1300-Oct, were shown to be specific as they were not competed by increasing
concentrations (25 and 50ng) of a heterologous oligonucleotide, (NS) (lanes 2 and 3),
but they were competed by increasing concentrations (25 and 50ng) of homologous
oligonucleotide (S) (lanes 5 and 6).
Extract: C1300 + NGF He La
NS
Competitor:
12 3 4 5 6 7
Figure 42. Electrophoretic mobility shift assay using the immunoglobulin octamer
binding element and extract from HeLa cells and CI300 cells exposed to NGF for 1.3
or 24 h.
A double stranded oligonucleotide containing the immunoglobulin octamer binding
element (Oct) was 5' end labelled with T4 polynucleotide kinase. End-labelled
oligonucleotide (lng) was incubated with either HeLa nuclear extract (20|ig) or with
extract from CI300 cells exposed to NGF for 1, 3 and 24 h (20|ig), in the presence of
l|ig of poly d(I-C) and 50ng of non-specific oligonucleotide.
Lane 1 shows the Oct-1 complex (indicated by an arrow) formed between the probe and
HeLa nuclear extract, in the absence of competitor DNA. Lane 2 contains extract from
C1300 cells and lanes 3-5 contain extract from CI300 cells treated with NGF for 1, 3
and 24 h respectively. The C1300-Oct complex (indicated by an arrow) appeared as a
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Figure 43. Electrophoretic mobility shift assay using the immunoglobulin octamer
binding element and extract from CI300 cells and CI300 cells exposed to NGF for 48
or 72 h.
A double stranded oligonucleotide containing the immunoglobulin octamer binding
element (Oct) was 5' end labelled with T4 polynucleotide kinase. End-labelled
oligonucleotide (lng) was incubated with either extract from CI300 cells (20|ig) or
with extract from CI300 cells (20|ig) exposed to NGF for 48 and 72 h (provided by
J.Morrow), in the presence of ljig of poly d(I-C) and 50ng of non-specific
oligonucleotide.
In lanes 1-4 the probe was incubated with extract from CI300 cells, in lanes 5-8 with
extract from CI300 cells exposed to NGF for 48 h and in lanes 9-11 with extract from
CI300 cells exposed to NGF for 72 h. A complex corresponding to Oct-1 (indicated as
an arrow) was formed by all cell extracts which was competed by lOOng of a
homologous oligonucleotide, (S) (lanes 3, 4, 7 and 8), but not by lOOng of a
heterologous competitor (NS) (lanes 1, 2, 5, 6, 10 and 11). Only cells treated with
NGF formed the C1300-Oct complex (indicated as an arrow). The C1300-Oct complex
was competed by lOOng of a homologous oligonucleotide, (S) (lanes 7 and 8), but not
by lOOng of a heterologous competitor (NS) (lanes 5, 6, 10 and 11).
C1300 + NGF (hrs): 0 48 72
NS- NS . S Nq






1234 5678 9 10 11
1 1 0
48 and 72 h post-induction was such that it obscured the Oct-1 complex. The specificity
of the complexes formed was again demonstrated by competition of Oct-1 and CI300-
Oct with homologous (S) competitor (lanes 3, 4, 7 and 8) but not by heterologous (NS)
competitor (lanes 1, 2, 5, 6, 10 and 11).
4.5. Discussion.
The results from this study demonstrate, by electrophoretic mobility shift
assays, that on exposure of CI300 mouse neuroblastoma cells to NGF a DNA-binding
protein recognising the octamer binding protein consensus sequence is induced.
The protein which appears after exposure of C1300 cells to NGF is termed
C1300-Oct and was shown to be absent, or only minimally present, prior to induction
(Figure 39). The C1300-Oct protein was shown to appear after treatment of the cells
with NGF for 3 h (Figure 42) and progressively increases in abundance with exposure
for 24, 48, and 72 h (Figure 42 and Figure 43).
Thus, this study demonstrates that CI300 cells constitutively express only one
octamer binding protein, identified as Oct-1 from its migration in electrophoretic
mobility shift assays to the same position as Oct-1 from HeLa cells (Figure 41). These
findings are in contrast to those of Kemp et al (1990) where two distinct octamer
binding proteins were shown to be constitutively present in CI300 cells. In order to
rule out the possibility that the findings from this study were unique to one particular
isolate of cells, a different source were used in a similar assay and a consistent result
was produced (Figure 43).
It has been shown that CI300 cells display specific binding of NGF to their
surface membranes (Revoltella et al., 1974; Greene and Shooter, 1980) and changes in
the differentiation state of CI300 cells, as determined by histochemical staining for
acetylcholinesterase expression, have been reported in response to NGF treatment
(Brodeur and Goldstein, 1976). Therefore, a change in the expression of particular
transcription factors, such as octamer binding proteins, may be expected in CI300 cells
in response to NGF treatment.
The identity of the NGF-inducible octamer binding protein, identified in this
study, is presently unknown. It is distinct from the ubiquitous Oct-1 protein, as
demonstrated by their different migrations in electrophoretic mobility shift assays,
however it does display a similar migration to that of purified Oct-2 protein (personal
communication, J. Quinn). Interestingly, the neuronal specific octamer binding proteins
N-Oct 2a and P (Schreiber et al., 1990) also display similar mobilities to C1300-Oct,
suggesting that C1300-Oct may be similar or related to these proteins. Support for this
suggestion comes from a study by Wood et al. (1992), showing that NGF upregulates
the expression of a neuronal form of Oct-2 in DRG neurons.
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Determination of the exact nature and expression pattern of the C1300-Oct
protein will require further studies to be carried out using specific anti-sera directed
against various members of the octamer binding protein family, including Oct-2, in
order to determine if any will cross-react with C1300-Oct.
Regulation by NGF has been reported previously for a number of transcription
factors. These include NGFI-A and NGFI-B which were both originally isolated based
on their rapid induction by nerve growth factor in the rat pheochromocytoma cell line,
PC 12 (Milbrandt, 1987, 1988). The products of the proto-oncogenes, c-fos and c-jun,
have also been shown to be induced rapidly and transiently in response to NGF in
PC12 cells (Curran and Morgan, 1985; Greenberg et al., 1985; Kruijer et al., 1985;
Milbrandt, 1986). The genes encoding these factors are implicated in mediating the
'early response' to NGF, they are induced to maximal levels within 30 to 60 mins and
return to basal levels within about 4 h, and thus are termed immediate early genes. In
contrast to these immediate early gene products, C1300-Oct is not detected by
electrophoretic mobility shift assay until 3 h post-induction and is present long after the
initial stimulus. Therefore, whereas the immediate early gene products are proposed to
initiate an early cascade of gene activation in mediating the response to NGF, the
C1300-Oct protein may act to mediate some of the long term responses to NGF.
It has been shown that the immediate early gene induction by NGF is not
specific to NGF. Epidermal growth factor (EGF) and NGF have both been shown to
induce the same set of immediate early genes in PC 12 cells (Greenberg et al., 1985;
Bartel et al., 1989), yet they promote distinct biological effects. EGF promoted effects
are primarily proliferative, while NGF is a differentiative factor. Selectivity in the action
of NGF has been proposed to occur at several steps in the signalling cascade, including
at the receptor level and at later gene activities (reviewed by Chao, 1992). A number of
specific genes primarily encoding structural proteins and enzymes which reflect a
neuronal phenotype have been found to be induced in the long term by NGF (reviewed
by Chao, 1992) and may provide some selectivity for NGF action. It is possible,
therefore, that C1300-Oct is responsible for mediating some of these later steps in the
response to NGF by regulating transcription from such neuronal phenotype-
determining genes.
Interestingly, two potential octamer binding elements have been identified
within the rPPT-A promoter (Sections 3.7.2.1.4.). The identity of the factor(s) which
will bind to these elements is unknown but, as the levels of rPPT-A transcripts in adult
sensory neurons have been shown to depend on NGF availability (Lindsay and
Harmar, 1989; Henken et al., 1990), it is possible that NGF-inducible octamer binding
proteins, including C1300-Oct, may be involved in the regulation of rPPT-A gene
expression. Electrophoretic mobility shift assays, using the two octamer-like elements
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from the rPPT-A promoter as oligonucleotide probes and extract from CI300 cells and
C1300 cells treated with NGF, should be carried out in order to determine if NGF
treatment alters the pattern of proteins which will bind to the two elements.
Section Summary and Future Directions.
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6.1. Summary.
The work presented in this thesis describes the identification of multiple
potential regulatory elements within a region of the rPPT-A promoter, spanning
nucleotides -865 to +447, previously shown to be sufficient for expression of a
reporter gene in microinjected DRG neurons (Mulderry et al., 1993).
By the identification of these elements, this study has implicated the
involvement of several families of transcription factors in the regulation of rPPT-A gene
expression. The majority of the elements were identified using HeLa cell extract and it
is expected that DRG neurons, where the rPPT-A gene is expressed endogenously at
high levels, will express a distinct array of transcription factors belonging to these
different families of DNA-binding proteins. Therefore, while some of the identified
elements may be recognised by proteins present in DRG neurons, it is possible that
such tissue will also express proteins which recognise a distinct set of elements from
those recognised by HeLa cell proteins. Such differential binding by proteins from
different cell or tissue sources to regulatory elements within the rPPT-A promoter may
potentially allow for tissue-specific gene regulation. Evidence to support such tissue-
specific binding comes from the finding, in this study, that some of the elements within
the rPPT-A promoter, located 3' of the transcriptional start site, differ in their binding
characteristics depending on whether extracts of neuronal or non-neuronal tissue are
used. Other elements which may play a role in mediating tissue-specific expression of
the rPPT-A gene include a CCAAT element, spanning nucleotides -181 to -177,
previously noted by sequence analysis (Carter and Krause, 1990). DNase 1
footprinting analysis, utilised in this study, was unable to detect binding over this
sequence element by proteins expressed in HeLa cells. CCAAT elements are present in
a large number of cellular promoters (Christy et al., 1989; Friedman et al., 1989;
Crossley and Brownlee, 1990) and are bound by CAAT box/enhancer binding proteins
(C/EBPs). These proteins belong to a large family of bZIP proteins and have been
shown to display a wide and varied pattern of expression (Landschulz et al., 1989; Cao
et al., 1991; Williams et al., 1991). It is possible, therefore, that DRG neurons express
a distinct set of C/EBPs from those found in HeLa cells and that these will display a
different pattern of binding to regulatory elements within the rPPT-A promoter, thus
potentially allowing for tissue-specific gene expression.
In addition to an involvement in tissue-specific gene regulation, the identified
elements are also likely to have an important role to play in the regulation of gene
expression in response to various extracellular stimuli. A number of factors have been
identified as potential regulators of the rPPT-A gene (Section 1.1.5.). One such factor
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is NGF which has been shown to increase the levels of rPPT-A mRNA in adult rat
DRG neurons (Lindsay and Harmar, 1989). It is possible that this increase in mRNA
levels is mediated through one or a number of the elements identified in this study.
Potential candidates include the identified AP-1 or AP-1 like elements, AP-1, AP-1',
HeLa AP-1 and 'CRE', as it has been shown that the levels of proteins which bind to
AP-1 elements increase or vary in response to NGF treatment (Curran and Morgan,
1985; Greenberg et al., 1985; Kruijer et al., 1985; Milbrandt, 1986; Quinn, 1991).
Other potential mediators of NGF actions include the identifed E-box motifs as it has
been shown the levels of the E-box binding protein MASH-1 are increased in PC 12
cells with NGF treatment (Johnson et al., 1990, 1992). The 5' AT-rich and 3' T-rich
octamer-like sites may also be important for mediating the transcriptional responses to
NGF , as it has been demonstrated that the levels of N-Oct 2 increase in DRG neurons
in response to NGF (Wood et al., 1992). Additionally, it has been shown in this study
that, in CI300 neuroblastoma cells, a DNA binding protein recognising the octamer
binding element from the immunoglobulin enhancer is induced by NGF.
Therefore the multiple potential regulatory elements identified in this study,
within a 1300 bp region of the rPPT-A promoter, are likely to be important for
mediating many of the transcriptional responses of the rPPT-A gene.
6.2. Future directions.
The results obtained from this study, describing the identification of multiple
potential regulatory elements within the rPPT-A promoter, will now lead on to a
number of future studies aimed at furthering our understanding of the regulation of the
rPPT-A gene at the transcriptional level.
Since the work presented in this thesis was carried out, there have been reports
of a rat pancreatic endocrine cell line RINm5F which endogenously expresses the PPT-
A gene (McGregor et al., 1992). The elements identified in this study can now be
further analysed using cells which express SP. Such studies may include further DNase
1 footprinting and electrophoretic mobility shift assays. Additionally, electrophoretic
mobility shift assays using fractionated protein extracts from RINm5F cells should
allow for the purification and identification of factors which interact with the rPPT-A
promoter.
The results presented in this thesis may also be used as the basis for a number
functional studies designed to investigate the role(s) of identified elements in regulating
rPPT-A gene expression. Such studies may include transfection or microinjection of
different rPPT-A gene reporter gene constructs into clonal cell lines (RINm5F) or DRG
neurons in culture. By the use of constructs containing individual elements or groups of
elements, these studies should determine which elements can function independently or
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those which function as part of a group. Exposure of transfected cells or neurons to
various extracellular stimuli, such as NGF, should also help to determine which
elements are important for conferring the transcriptional response to such stimuli. Site
specific mutagenesis of the elements may also be carried out in order to determine their
individual importance in regulating rPPT-A gene expression.
Future studies, arising from the results presented in this thesis, may also
include the isolation of regulatory proteins present in DRG neurons which will bind to
the identified elements. In order to achieve this a DRG cDNA library may be screened
using the elements as oligonucleotide probes. Once candidate clones have been
identified their roles in the regulation of rPPT-A gene expression in DRG neurons may
be investigated. For example, the role of AP-2, which may bind to the rPPT-A
promoter (Section 3.7.2.1.3.), in regulating both endogenous rPPT-A gene expression
and that of reporter constructs, containing various regions from the promoter, may be
investigated. This may be achieved by microinjecting DRG neurons in culture with
constructs encoding either wild type AP-2 or an alternative AP-2 transcript, termed AP-
2B, which lacks the dimerization domain necessary for DNA-binding and therefore
inhibits the binding of endogenous AP-2 to its consensus sequence (Buettner et al.
1993). In a similar manner, expression vectors for other candidate factors may also be
microinjected into DRG neurons and the importance of each in regulating gene
expression may be determined by assaying the expression of either the endogenous
rPPT-A gene or of reporter gene constructs. The possible regulation of candidate
factors by NGF may also be investigated by assaying gene expression following NGF
treatment.
By the identification of potential regulatory elements within the rPPT-A
promoter, it is hoped that novel targets for the development of drugs that modulate
rPPT-A gene expression may be identified. Substance P is thought to play a role in
many processes of clinical relevance, including the mediation of pain perception and in
neurogenic inflammation in conditions such as rheumatoid arthritis. Therefore, it is
hoped that, by furthering our understanding of the mechanisms involved in regulating
rPPT-A gene expression, new approaches may be developed for the treatment of
relevant disorders including those involving pain and inflammation.
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Nerve growth factor (NGF) induces a protein in the C1300 mouse neuroblastoma cell line which recognises the octamer DNA consensus
sequence 'ATGCAAAT'. This protein is absent, or only minimally present, in C1300 cells prior to induction with NGF. This induced octamer
binding protein is detectable by gel retardation analysis within 3 h of NGF treatment and increases progressively with 24 h and 72 h of exposure
to NGF.
The octamer binding motif is a DNA consensus
sequence of ATGCAAAT, which can activate tran¬
scription of both cell-specific and ubiquitously ex¬
pressed genes1'5'15'27*29. In addition to being an activa¬
tor of transcription it can be found within elements
which repress transcription17'33. The ability of this se¬
quence motif to elicit such a range of transcriptional
responses is, in part, due to various degenerate DNA
motifs being recognised by the octamer binding protein
family, and also the large number of different octamer
binding proteins and their own tissue-specific expres-
sion2'19'26'28'34. These octamer binding proteins are a
subset of a larger family of regulatory molecules which
share a protein domain referred to as the POU-do-
main910'13'25'31. The POU domain is responsible for
binding the DNA and contains two regions, an N-
terminal POU-specific domain and a C-terminal
homeodomain. These 'POU' proteins have been shown
in the developing and adult brain to have a restricted
pattern of expression12. In the brain, or neuronal de¬
rived cells, at least five different octamer binding pro¬
teins exist26'32. The ubiquitous octamer binding protein
Oct 1 has been demonstrated to be a target for phos¬
phorylation24, and Pit 1 the Pou domain containing
transcription factor has its DNA binding affinity modu¬
lated by phosphorylation14. In light of the number of
octamer binding proteins in the brain, and that they
can be modulated by post-translational modification,
we postulated that octamer binding proteins in neu¬
ronal cells may be regulated by nerve growth factor.
We have therefore analysed the neuroblastoma cell
line C1300 for changes in octamer binding proteins in
the presence or absence of nerve growth factor (NGF).
The C1300 cell line does contain a receptor for NGF11,
and although addition of NGF to these cells does not
differentiate the cells morphologically as with PCI2
cells8, changes can be observed in several parame¬
ters3'6'11'23. Using gel retardation, we demonstrate the
presence of an NGF-inducible octamer binding protein
in C1300 cells.
The DNA consensus sequence for the octamer bind¬
ing protein from the immunoglobulin enhancer1,29 was
used to identify specific octamer binding protein com¬
plexes in the CI300 cell line by gel retardation analysis.
Three complexes were observed in C1300 cells whereas
an extra complex was observed when the cells were
exposed to NGF. As judged by competition with a
heterologous oligonucleotide the faster migrating com¬
plexes were non-specific binding complexes (indicated
by N.S. in Fig. 1). These non-specific complexes have
previously been demonstrated to bind DNA oligonu¬
cleotide probes, some of which contain consensus oc-
Correspondence: J.P. Quinn, MRC Brain Metabolism Unit, Royal Edinburgh Hospital, Morningside Park, Edinburgh EH10 5HF, UK.
175
tamer binding sequences22'33. The slower migrating
complex in C1300 cells is indicated to be the ubiqui¬
tous octamer binding protein Oct 1 because its migra¬
tion is in the same position as the Oct 1 complex from
HeLa cells (Fig. 2B). Following exposure of the cells to
NGF, a second specific complex, migrating slightly
above the observed non-specific complexes, was ob¬
served (C1300 OCT, Fig. 1). This NGF-induced com¬
plex was more easily seen as the amount of non-specific
oligonucleotide competitor was increased, removing the
non-specific complexes (Fig. 1, lanes 6-10).
The specificity of the induced complex was demon¬
strated by competition with homologous and heterolo¬
gous oligonucleotides (Fig. 2A,B). As no competition
of the specific complexes was observed except where
homologous double-stranded oligonucleotide was
added, this confirmed that we have identified an
NGF-inducible octamer binding protein. Although in
Fig. 1 the intensity of the Oct 1 complex also increases
when the cells are exposed to NGF, this effect was not
reproducible and as observed in Fig. 2 we routinely saw
no difference in Oct 1 binding activity.
Previous reports of a repressor protein present in
C1300 cells which inhibited the activity of octamer
consensus sequence containing promoters indicated
that C1300 cells constitutively expressed two specific
octamer binding complexes16. Therefore, we obtained
C1300 cells from a different source and repeated our
study, to demonstrate that our finding of an NGF-in¬
ducible octamer binding protein was not unique to our
isolate of C1300 cells. Our results were found to be
reproducible: only Oct 1 was constitutively present in
C1300 cells and the second octamer binding protein
was absent, or only minimally present, prior to expo¬
sure of the cells to NGF. This source of cells was used
in Fig. 3, where a time course of induction by NGF of
this second octamer binding protein is shown. This
NGF-inducible octamer binding protein was first de¬
tected by gel retardation as a faint complex at 3 h
post-exposure to NGF (data not shown), and was clearly
observed at 48 and 72 h post-induction. The increase in
the C1300 NGF inducible octamer binding activity is
such that the intensity of this complex obscures the Oct
1 complexes at both 24 and 72 h post-exposure to
NGF. The specificity of the complexes were demon¬
strated by competition with heterologous competitor
(NS) or homologous competitor (WT). In initial experi¬
ments to determine whether this induced octamer
binding had an effect on gene transcription, we used
the HSV IE 4/5 promoter (which contains an octamer
consensus sequence) to express the chloramphenicol
acetyltransferase protein (CAT) (a gift from R. Ev¬
erett). In agreement with previous reports of HSV
immediate early genes being repressed in C1300 cells16
we found no significant CAT activity in these cells
above background of cells transfected with pGEM vec¬
tor which contains no CAT gene (data not shown).
Exposure of these cells to NGF had no effect on the
CAT activity. Therefore, we are unable to correlate
appearance of the NGF inducible octamer binding
protein with repression of this promoter, and our re¬
sults might indicate repression of activity in C1300 cells
by a different mechanism.
We have demonstrated that NGF induces an oc¬
tamer binding protein activity distinct from that of the
Oct 1 protein in the mouse C1300 neuroblastoma cell





Fig. 1. C1300 cells contain an NGF-inducible octamer binding com¬
plex. Whole cell extracts were prepared from CI 300 cells as previ¬
ously described18. The protein extract was separated from the cell
debris by centrifugation. Whole cell extracts contained approximately
20 ixg/yul protein. Gel retardation analysis was performed as de¬
scribed previously7'27'1". Briefly, each reaction contained 0.1-1 ng of
32P 3' end-labelled double-stranded oligonucleotide probe from the
well-characterised immunoglobulin octamer binding element
(5'AGATCTAGCATGCAAATCATTGT)1'29. Cell extracts (20 ixg)
were incubated with 1 fxg of poly d[I-C] prior to addition of probe
and competitor oligonucleotides. Extracts from CI 300 cells and
C1300 cells exposed to NGF (Collaborative Research) for 24 h, at a
final concentration of 100 ng/ml, were subjected to gel retardation
analysis. Lanes 1-5 contain C1300 cell extract and lanes 6-10 con¬
tain C1300 cell extract where cells had been exposed to NGF for 24
h. The position of the ubiquitous octamer complex, Oct 1, is indi¬
cated with an arrow. Exposure of cells to NGF gives rise to a new
complex, C1300 Oct, which is indicated with an arrow, migrating
above non-specific complexes (N.S.). Increasing concentration of
non-specific oligonucleotide (5'ATCCCTTTAAATTTGCGAGCT)
N.S. (10, 50, 100 and 150 ng) was added in lanes 2-5 and lanes 7-10,
to remove non-specific complexes. This heterologous oligonucleotide
sequestered DNA binding proteins which preferentially bind to the
termini of DNA fragments 2I.
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C1300 cells would be similar to that obtained with the
same DNA probe using purified Oct 2 from our previ¬
ous studies33. However, several neuronal octamer bind¬
ing proteins in brain nuclear extract, in particular,
N-Oct a and /326 and an octamer binding protein from
malignant melanoma cells4 all migrate in a similar
position to Oct 2. We cannot determine the particular
octamer binding protein from its migration in gel retar¬
dation analysis. Therefore, the nature of the C1300
NGF-induced protein remains to be characterised.
In a previous study of octamer binding proteins
present in C1300 cells, evidence was presented for two
distinct octamer binding complexes, one of which was
presumably Oct l16. It is not possible to directly com¬
pare our results with this study for a number of rea¬
sons: (i) it is possible that a number of strains of C1300
cells exist6; (ii) it has been demonstrated at least in
PC12 cells, that the transcription factor complement of
the cell can vary with growth in culture20.
The NGF-induced octamer binding protein in C1300
cells is regulated temporally differently from the effect
of NGF on other transcription factors, which have
been found to be NGF-inducible, and termed immedi¬
ate early proteins. These immediate early proteins,
such as c-fos and c-jun, are turned on rapidly and
transiently in response to NGF in PC12 cells8'20. The
C1300-induced octamer binding protein appears to be
present and increased long after the initial stimulus
(Fig. 3), so it may fall into the class of proteins termed
'delayed early'. This protein would have the temporal
characteristics of a protein which was maintaining a
phenotype in response to the NGF stimulus. The fact
that we demonstrate this in C1300 cells, which do not
differentiate morphologically in response to NGF3'6'23,
Fig. 2. A: the NGF-induced complex in C1300 cells is a specific octamer binding protein. Extracts from C1300 cells exposed to NGF for 24 h
were subjected to gel retardation analysis. Non-specific oligonucleotide (50 ng) was pre-incubated with poly d[I-C] in the cell extract to remove
non-specific complexes. The position of the Oct 1 and C1300 NGF-induced Oct shifts are indicated with arrows. Competitor was added to
demonstrate the specificity of the NGF-induced complex. Lanes 1 and 6 contain no competitor. Lanes 2-5 contain 10, 25, 50 and 100 ng of
homologous competitor and lanes 7-10 contain 10, 25, 50 and 100 ng of heterologous competitor, respectively (the same N.S. oligonucleotide as
used in the preincubation). B: the NGF-induced complex in C1300 cells is a specific octamer binding protein. Extracts from C1300 cells exposed
to NGF for 24 h were subjected to gel retardation analysis and the mobility of the retarded complexes compared with those obtained with HeLa
cells which constitutively express Oct 1. Non-specific oligonucleotide (50 ng) was pre-incubated with poly d[I-C] in the ceil extract to remove
non-specific complexes. The position of the Oct 1 and C1300 NGF-induced Oct shifts are indicated with arrows. Competitor was added to
demonstrate the specificity of the NGF-induced complex. In lanes 1, 2 and 3, 10, 25 and 50 ng of additional heterologous competitor was added.
In lanes 4, 5 and 6, 10, 25 and 50 ng of homologous specific competitor was added, respectively. Lane 7 shows the ubiquitous Oct 1 shift in FleLa
control cells.
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Fig. 3. The NGF-induced octamer complex is present at 48 and 72 h post-induction. A second source of C1300 cells (J. Morrow, University of
Glasgow) were grown in DMEM with 10% heat-inactivated fetal calf serum. NGF (Collaborative Research) was used at a final concentration of
100 ng/ml. Extracts from C1300 cells and C1300 cells exposed to NGF for 48 and 72 h were subjected to gel retardation analysis. Lanes 1-4
contain C1300 cell extract. Lanes 5-8 contain C1300 cell extract where the cells had been exposed to NGF for 48 h and lanes 9-13 contain C1300
cell extract where the cells had been exposed to NGF for 72 h. The position of the Oct 1 and C1300 NGF-induced Oct complexes are indicated
with arrows. Competitor oligonucleotides were added to demonstrate the specificity of the NGF-induced complex. In lanes 1 and 2, 5 and 6, 10
and 11, 25 and 50 ng of heterologous competitor was added, respectively. In lanes 3 and 4, 7 and 8, 12 and 13, 25 and 50 ng of homologous
competitor was added, respectively.
may allow us to correlate the appearance of this oc¬
tamer binding protein with gene regulation, rather
than with cell differentiation. This aspect of C1300 cell
regulation may make them a better model for study of
NGF regulation of transcription rather than PC12 cells.
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Identification of a neuronal specific DNA-binding protein
within the rat preprotachykinin promoter
SUSAN C. MENDELSON AND J.P. QUINN
MRC Brain Metabolism Unit, Royal Edinburgh Hospital,
Morningside Park, Edinburgh, EH10 5HF.
The tachykinins are a family of biologically active
neuropeptides. They function as neurotransmitters in both
the central and peripheral nervous systems where they
have a wide but selective distribution (1). The family of
tachykinins includes substance P whose precursor is
encoded by the preprotachykinin-A gene (PPT) (2).
No cell lines that have been tested express PPT at
high levels, either endogenously (3), or when transfected
with plasmids containing fragments of the PPT promoter
(4), so hampering our understanding of the transcriptional
regulation of the PPT promoter. However, a construct
linking a 3.5 kilobase region of the rat PPT promoter to a
(3-Gal reporter gene is expressed in microinjected cultured
dorsal root ganglia (Peter Mulderry, personal
communication). This demonstrates that this region of the
PPT promoter contains cis acting elements which will
regulate expression of the PPT gene.
We have used an exonuclease mapping assay (5)
to explore the mechanisms by which the PPT promoter is
regulated. This assay identifies sites of protein/DNA
interactions which could be involved in the regulation of
gene expression. Multiple and specific DNA interactions
are identified within a similar 3.5 kilobase region of the rat
PPT promoter to that used in microinjection studies (6).
The majority of the interactions observed are present in all
cell extracts examined. However, we have identified one
site of interaction which occurs 3' of the transcriptional start
site and displays neuronal specificity in its tissue
distribution. The protein which recognises this site is
present in extracts from neuronal tissue (cerebellum,
hippocampus and spinal cord) and is also present in the
PC12 line which is derived from a rat pheochromocytoma.
Binding to this 3' element is not observed in extracts from
spleen and the non-neuronal derived cell lines HeLa and
293.
The sequence specificity of the interactions
observed within the PPT promoter is suggested by the
demonstration of an AP1 complex forming a specific
interaction at a previously proposed AP1 consensus
sequence (7).
Elements identified by exonuclease analysis of
other promoters have proven to have a biological function
(5,8,9), suggesting that the sites identified on the PPT
promoter are potential cis acting elements regulating PPT
expression. Further characterisation of these potential
regulatory elements will provide a basis to elucidate the
mechanism of PPT transcriptional regulation.
We are currently undertaking further analysis of the
neuronal-specific interaction with a view to purifying the
factor(s) responsible for the interaction.
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identification of potential regulatory elements within
the rat Dre-protachvkinin A promoter
Susan C. Mendelson and John P. Quinn
MRC Brain Metabolism Unit, Royal Edinburgh Hospital,
Morningside Park, Edinburgh, EH10 5HF
The rat preprotachykinin-A gene (rPPT-A) encodes the
precursor of the neuropeptide substance P [1], Substance
P is present in specific neuronal subpopulations of both the
peripheral and central nervous systems [2], In particular
rPPT-A is expressed at high levels in primary sensory
neurons of the dorsal root ganglia (drg) [3],
We wished to investigate the transcriptional regulation of the
rPPT-A gene. Deletion studies have demonstrated that
865bp of sequence immediately upstream of the
transcriptional start site direct high levels of reporter gene
expression when microinjected into adult rat drg neurons in
culture. This expression was significantly increased when
500bp of 3' sequence was included in the constructs [4],
This suggests that these regions contain important
regulatory elements for controlling rPPT-A gene expression.
Exonuclease analysis [5] of the rPPT-A promoter
complements these studies by demonstrating the presence
of multiple protein/DNA interaction sites both 5' and 3' of the
transcriptional start site.
We set out to accurately map sites of protein/DNA
interaction within this region (which would be candidate
regulatory elements) using DNaset footprinting analysis.
We have thus identified multiple elements located both 5'
and 3' of the major transcriptional start site (Fig. 1). The 5'
elements include a number of transcription factor binding
sites including ones whicfrwould be recognised by proteins
of the AP1 and CREB families. The 3" elements include
one which is predominantly recognised by proteins present
in neuronal tissues [6], Interestingly there are also two G-
rich elements, one 5' and the other 3' of the transcriptional
start site. There are reports in the literature of G-rich
binding proteins which have been shown in one case to be
involved in regulating chromatin structure (7), and in another
to mediate the effects of EGF [8]. Other binding sites have
also been identified whose function is as yet unknown.
Gel retardation analysis has been used to confirm the
sequence specificity of individual elements, examine the
tissue distribution of proteins recognising the sites and to
determine how the proteins are regulated by various
extracellular stimuli.
Most of the sites have been footprinted using HeLa nuclear
extract, although in some cases rat cerebellum and total
brain extract have also been used. Although we have not
been able to obtain sufficient material from rat drg for use in
footprinting assays some of the identified elements have
been shown to be functional in microinjected drg neurons
and have formed specific complexes in gel retardation
assays using drg extract.
In summary, we have identified several potential regulatory
elements within a 1300bp region of the rPPT-A promoter.
We are now investigating the function of these elements and
plan to mutate individual elements in the context of the
promoter to determine their importance in controlling rPPT-A
gene expression.
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Figl. Location Of Identified Potential Regulatory Elements
On The Rat Pre-orotachvkinin-A Promoter
A diagrammatic representation of the rPPT-A promoter with
identified protein/DNA interaction sites shown. Most of these
have been identified using DNase 1 footprinting and further
characterised by gel retardation and functional analysis in
heterologous reporter constructs. UD = Footprinted
elements which we have not yet assigned to a particular









Helke, C.J., Krause.J.E., Mantyhl, P.N.,Coutre, R &
Bannon, M.J. (1990) FASEB J. 4,1606-1615
Maggio, J.E. (1988) Ann. Rev. Neurosci. 11,13-25
Otsuka, M., Konishi, S .Yanagisawa, M., Tsurtoo, A &
Akagi, H. (1982) CIBA Foundation Symposium 91:
Substance P in the nervous system (R.Porter and
M.O'Connor, Eds.) 13-30.Pitman,London
MukJerry, P., Chapman, K.E., Lyons,V. & Harmar, A.J.
(1993) Mol. Cell. Neurosci. 4, 164-172
Quinn, J.P., Holbrook, N. & Levens, D. (1987) Mol. Cell
Biol. 7,2735-2744
Quinn, J.P. (1992) Mol. Cell Neurosci. 3,11-16
Clark, S.P., Lewis, C.D. & Felsenfeld, G. (1990)
Nucleic Acids Res. 18,5119-5126
Bachwich, D.. Merchant. J. & Brand. J. (1992) Mol.
Endocrinol., 6,1775-1184
Biochemical Society Transactions (1 993)21 373S
The preprotachykinin A promoter interacts with a
sequence specific single stranded DNA binding protein
Jane McAllister, Susan Mendelson and John P. Quinn.
MRC Brain Metabolism Unit, Royal Edinburgh Hospital,
Morningside, Edinburgh, EH10 5HF.
An element within the preprotachykinin A (PPT) promoter is
highly homologous to an element from the type II Na
channel promoter (Fig. 1 A). This Na channel element has
been previously proposed to be common to a number of
neuronal genes [1], We have demonstrated that the PPT
element binds a sequence specific DNA binding protein [2],
The protein binds to only one strand of the PPT element and
has no specificity for the double stranded DNA species.
Gel retardation analysis indicates that the protein is found in
both rat neuronal tissue and adult dorsal root ganglia
neurons in culture, but not in established tissue culture cell
lines. A mechanism for protein binding to the DNA is
proposed based on the fact that the region binding the
protein is the loop of a larger stem-loop structure in the
DNA.
The PPT element can also be aligned with other single
stranded DNA elements [3,4] which are known to specifically
bind proteins to give a core consensus of CCNGG (Fig. 1B).
The PPT element is also highly homologous to the HIV TAR
region which, as a single stranded RNA molecule, binds to
cellular and HIV viral proteins [5,6],
The initial oligonucleotide used in this study did not contain
all the DNA sequence to reconstitute the stem loop
structure. When the analysis was repeated using an
oligonucleotide which contained the whole of the sequence
in the stem loop structure (Fig. 1C) the situation was far
more complex than initially thought. The longer
oligonucleotide will similarly bind to a single stranded DNA
binding protein in rat tissue extract, however, the double
stranded element will now also bind a complex in tissue
culture cell lines. This binding of a protein to the double
stranded element was not seen when rat tissue was used.
The protein which binds to the double stranded form of the
DNA is adjacent to the binding of the single stranded
protein. The binding characteristics of proteins to this
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cca CCaGGc AAGggGCaGg aggt





PPT sequence of stem/loop structure
5» rrrrTTrTr,rcTTCAGGGTGTGCCTGGGAAGAAGCTGTAGGGG
The sequence underlined is the loop of the proposed stem/loop
structure
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Evolution of enhancer domains within the
preprotachykinin promoter
John P. Quinn, Christine Morrison, Jane McAllister & Susan
Mendelson. MRC Brain Metabolism Unit, Royal Edinburgh
Hospital, Morningside Park, Edinburgh, EH10 5HF.
The rat preprotachykinin-A promoter (PPT) which regulates
the gene encoding the neuropeptides substance P and
neurokinin A [1] is not, or is only minimally, active in all of
the established tissue culture cell lines which have been
analysed [2]. To search for transcriptional regulators within
the promoter, we have used small fragments from the PPT
promoter linked to heterologous reporter constructs. These
reporter constructs allow us to determine the ability of
individual PPT DNA elements to stimulate transcription.
This approach has identified two functional elements within
the PPT promoter, both of which are related to AP1
elements. AP1 elements, in general, bind heterodimers of
the jun, fos, CREB and ATF families of proteins [3,4], in
addition to several less well characterised protein
complexes [5] and tissue-specific complexes [6]. These
elements within the PPT promoter are at positions -340 and
-196 relative to the major start of transcription. The
complexes binding to these elements have been confirmed
by gel retardation and DNase I analysis. The AP1 element
at -340 in HeLa cells will bind the c-jun/c-fos complex
whereas the complex binding to the element at -196 is quite
distinct from c-jun, c-fos or CREB. The elements are also
functionally quite distinct when placed upstream of a
heterologous promoter. The sequence of these two PPT
AP1 -like elements and the AP1 consensus sequence is
shown in Figure 1.
We propose that these elements will synergise with one
another and other distinct elements within the PPT
promoter. DNase 1 footprinting analysis of this region of
the PPT promoter has determined many other specific
protein/DNA interactions several of which are adjacent to
these AP1 elements [7]. Interestingly, there is significant
conservation between the regions which are flanking these
AP1 elements. This extended homology is shown in Figure
2. These two regions are potentially recognised by
members of the same family of transcription factors. As
these transcription factors are regulated in response to a
multiplicity of stimuli, we propose a mechanism for stimulus
induced regulation of the PPT promoter via these two
regions outlined in Figure 2.
This extended homology can be found in other AP1
elements which have been associated with enhancer
function. This is most clearly illustrated by the AP1
enhancer element of the Gibbon Ape Leukaemia Virus
(GALV) enhancer [5,8]. This is outlined in Figure 2. The
viral AP1 element is highly homologous to both of the PPT
elements we have characterised over an extended region.
This extended homology may define a subset of AP1
elements. We view this extended homology as an API-like
element flanked by two 6bp boxes GTTCCC and CAGTTT
which flank an AP1 element. These two boxes were
previously noted to be important in retrovirus LTRs as they
were conserved in regions associated with enhancer
function [8], as is the case amongst the different GALV
strains.
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Figure 1
TGAGTCA API consensus
AGCA TGAGTCA ACT PPT API at -340
AAAT TGcGTCA TTT PPT API at -196
Figure 2
GTTCCCagAAAT AGaATGAGTCA aCag CAGTTT GALV API-(SF)
GTTCCC TAAgtccgAAGcATGAGTCAcTT CG CTCAGTTT API at -340
cTTCCC TAA AAt TGcGTCA TTtCGaaCcCAaTTT API at -196
The GALV enhancer element from the San Francisco strain is
aligned with the two PPT API elements.
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